<SEC-DOCUMENT>0001193125-18-019852.txt : 20180125
<SEC-HEADER>0001193125-18-019852.hdr.sgml : 20180125
<ACCEPTANCE-DATETIME>20180125165233
ACCESSION NUMBER:		0001193125-18-019852
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180316
FILED AS OF DATE:		20180125
DATE AS OF CHANGE:		20180125
EFFECTIVENESS DATE:		20180125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARROWHEAD PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000879407
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460408024
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38042
		FILM NUMBER:		18548853

	BUSINESS ADDRESS:	
		STREET 1:		225 SOUTH LAKE AVENUE
		STREET 2:		SUITE 1050
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91101
		BUSINESS PHONE:		626-304-3400

	MAIL ADDRESS:	
		STREET 1:		225 SOUTH LAKE AVENUE
		STREET 2:		SUITE 1050
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARROWHEAD RESEARCH CORP
		DATE OF NAME CHANGE:	20040112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE GROUP INC
		DATE OF NAME CHANGE:	20020509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d502300ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>(Rule <FONT STYLE="white-space:nowrap">14a-101)</FONT> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INFORMATION
REQUIRED IN PROXY STATEMENT </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SCHEDULE 14A INFORMATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the
Registrant&nbsp;&nbsp;&nbsp;&#9744; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, For Use of the Commission Only</B><B></B><B>&nbsp;(as permitted by <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B> </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant To <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>ARROWHEAD PHARMACEUTICALS, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified in Its Charter) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s)
Filing Proxy Statement if other than the Registrant) </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of filing fee (Check the appropriate box): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT>
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11</FONT> (set forth the amount on
which the filing fee is calculated and state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing party: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:3%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g502300003.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARROWHEAD PHARMACEUTICALS, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>225 SOUTH LAKE AVENUE, SUITE 1050 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PASADENA, CALIFORNIA 91101 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF
ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TO BE HELD ON FRIDAY, MARCH&nbsp;16, 2018 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">TO THE STOCKHOLDERS OF ARROWHEAD PHARMACEUTICALS, INC.: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">NOTICE IS HEREBY GIVEN that the 2018 Annual Meeting of Stockholders of Arrowhead Pharmaceuticals, Inc., a Delaware corporation (the &#147;Company&#148;), will be held on Friday, March&nbsp;16, 2018, at
10:00 a.m., Pacific time (the &#147;Annual Meeting&#148;). This year&#146;s meeting will be a completely &#147;virtual&#148; meeting of stockholders. You can attend the Annual Meeting online, vote your shares electronically, and submit your
questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/ARWR2018. Prior to the Annual Meeting, you will be able to vote at <U>www.proxyvote.com</U> for the purpose of considering and voting upon the following proposals:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect the six directors named in the Proxy Statement to serve as members of the Company&#146;s Board of Directors until the next Annual Meeting or until their
successors are elected; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To conduct an advisory <FONT STYLE="white-space:nowrap">(non-binding)</FONT> vote to approve executive compensation; and </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ratify the selection of Rose, Snyder&nbsp;&amp; Jacobs LLP as independent auditors of the Company for the fiscal year ending September&nbsp;30, 2018;
</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The foregoing items of business are more fully described in the Proxy Statement accompanying this Notice.
Proposal No.&nbsp;1 relates solely to the election of the six directors nominated by the Board of Directors and does not include any other matters relating to the election of directors, including, without limitation, the election of directors
nominated by any stockholder of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All stockholders of record are cordially invited to attend the Annual Meeting by
visiting www.virtualshareholdermeeting.com/ARWR2018. We anticipate that on or about February&nbsp;2, 2018, we will mail our stockholders a Notice Regarding the Availability of Proxy Materials (the &#147;Notice of Internet Availability&#148;)
containing instructions on how to access our 2018 Proxy Statement and 2017 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and to vote online. You will need to have your <FONT STYLE="white-space:nowrap">16-digit</FONT> Control
Number included on your Notice of Internet Availability or your proxy card (if you received a printed copy of the proxy materials) to join the Annual Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you prefer to receive paper copies of our proxy materials, please follow the instructions included in the Notice of Internet Availability. To ensure your representation at the meeting, you are urged to
vote via the Internet or telephone as instructed in the Notice of Internet Availability, or to mark, sign, date and return the proxy card as promptly as possible in the postage-prepaid envelope enclosed for that purpose. Any stockholder of record
attending the Annual Meeting may vote at the Annual Meeting even if such stockholder has previously returned a proxy. Each stockholder may appoint only one proxy holder to attend the Annual Meeting on his or her behalf. Please note, however, that if
your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Jane Davidson</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jane Davidson</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pasadena, California</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">January&nbsp;25, 2018</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Your vote is important, whether or not you expect to attend the Annual Meeting of Stockholders. Stockholders of record
are urged to vote via the Internet or telephone as instructed, or if you are voting by mail, to mark, sign and date and promptly return the proxy in the postage-prepaid return envelope provided. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting promptly will help avoid the additional expense of further solicitation to assure a quorum at the
meeting. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the
meeting, you must obtain a proxy issued in your name from that record holder. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice Regarding the Availability of Proxy
Materials for the Stockholder Meeting to be Held on Friday, March&nbsp;16, 2018: </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may access the following proxy materials at
www.virtualshareholdermeeting.com/ARWR2018<U> </U> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notice of the 2018 Annual Meeting of Stockholders; </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company&#146;s 2018 Proxy Statement; </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended September&nbsp;30, 2017; and </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Form of Proxy Card </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ARROWHEAD PHARMACEUTICALS, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>225 South Lake Avenue, Suite 1050
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pasadena, California 91101 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(626) <FONT STYLE="white-space:nowrap">304-3400</FONT> </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY
STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TO BE HELD ON FRIDAY, MARCH&nbsp;16, 2018 </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>GENERAL INFORMATION CONCERNING SOLICITATION AND VOTING </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The enclosed Proxy is solicited on behalf of Arrowhead Pharmaceuticals, Inc. (the &#147;<B>Company</B>&#148; or &#147;<B>Arrowhead</B>&#148;) for use at the 2018 Annual Meeting of Stockholders (the
&#147;<B>Annual Meeting</B>&#148;) to be held on Friday, March&nbsp;16, 2018 at 10:00 a.m., Pacific time, and at any adjournment(s) thereof, for the purposes set forth herein and in the accompanying Notice of Annual Meeting of Stockholders (the
&#147;<B>Notice</B>&#148;). This year&#146;s meeting will be a completely &#147;virtual&#148; meeting of stockholders. You can attend the Annual Meeting online, vote your shares electronically, and submit your questions during the Annual Meeting, by
visiting www.virtualshareholdermeeting.com/ARWR2018. You will need to have your <FONT STYLE="white-space:nowrap">16-digit</FONT> Control Number included on your Notice Regarding the Availability of Proxy Materials (&#147;the Notice of Internet
Availability&#148;) or your proxy card (if you received a printed copy of the proxy materials) to join the Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company anticipates that the Notice of Internet Availability in connection with these proxy solicitation materials will first be
mailed on or about February&nbsp;2, 2018 to all stockholders entitled to vote at the Annual Meeting and we will post our proxy materials on the website referenced in the Notice of Internet Availability. As more fully described in the Notice of
Internet Availability, all stockholders may choose to access our proxy materials on the website referred to in the Notice of Internet Availability or may request to receive a printed set of our proxy materials. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Record Date </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only
holders of record of our common stock at the close of business on January&nbsp;23, 2018 (the &#147;<B>Record Date</B>&#148;) are entitled to notice of the Annual Meeting and to vote at the Annual Meeting. On that date, the Company had outstanding
86,787,566 shares of common stock (&#147;<B>Common Stock</B>&#148;). </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Revocability of Proxies </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any proxy given by a stockholder of record pursuant to this solicitation may be revoked by the person giving it at any time before its use
by delivering to the Secretary of the Company, at or before the taking of the vote at the Annual Meeting, a written notice of revocation or a duly executed proxy bearing a later date or by attending the Annual Meeting and voting in person.
Stockholders may also revoke their proxy by entering a new vote over the Internet or by telephone. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting and Solicitation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each share of the Company&#146;s Common Stock is entitled to one vote on all matters presented at the Annual Meeting. Stockholders do not
have the right to cumulate their votes in the election of directors. Shares of Common Stock represented by properly executed proxies will, unless such proxies have been previously revoked, be voted in accordance with the instructions indicated
thereon. In the absence of specific instructions to the contrary, properly executed proxies will be voted FOR all matters submitted to a vote of stockholders at the Annual Meeting pursuant to this proxy statement. No business other than that set
forth in the accompanying Notice of Annual Meeting of Stockholders is expected to come before the Annual Meeting. Should any other matter requiring a vote of stockholders properly arise, the persons named in the enclosed form of proxy will vote such
proxy in accordance with the recommendation of the Board of Directors (the &#147;<B>Board</B>&#148;). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you will not be able to attend the Annual Meeting to vote in person, you may vote your
shares via the Internet or by telephone or by mail as set forth in the Notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has engaged a proxy solicitor,
Alliance Advisors, LLC, to encourage voting by our stockholders. It is estimated that the total cost for the solicitation campaign will be approximately $10,000. Proxies may also be solicited by certain of the directors, officers and employees of
the Company, without additional compensation. The Company will bear the costs of solicitation. In addition, the Company expects to reimburse brokerage firms and other persons representing beneficial owners of shares for their expenses in forwarding
solicitation materials to such beneficial owners. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are held in street name, the voting instruction form sent to
you by your broker, bank or other nominee should indicate whether the institution has a process for beneficial holders to provide voting instructions over the Internet or by telephone. A number of banks and brokerage firms participate in a program
that also permits stockholders whose shares are held in street name to direct their vote over the Internet or by telephone. If your bank or brokerage firm gives you this opportunity, the voting instructions from the bank or brokerage firm that
accompany this proxy statement will tell you how to use the Internet or telephone to direct the vote of shares held in your account. If your voting instruction form does not include Internet or telephone information, please complete and return the
voting instruction form in the self-addressed, postage-paid envelope provided by your broker. Stockholders who vote by proxy over the Internet or by telephone need not return a proxy card or voting instruction form by mail. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Quorum; Abstentions; Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The required quorum for the transaction of business at the Annual Meeting is a majority of the votes eligible to be cast by holders of
shares of Common Stock issued and outstanding on the Record Date. Shares that are voted &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN&#148; on a matter are treated as being present at the meeting for purposes of establishing a quorum with
respect to such matter. For certain proposals, brokers may not have discretionary authority to vote on a particular matter if they have not received specific instructions from the beneficial owner of the shares (&#147;<B>broker <FONT
STYLE="white-space:nowrap">non-votes</FONT></B>&#148;). In accordance with the rules of Nasdaq, banks, brokerage firms and other nominees who hold Arrowhead shares in street name for their customers have authority to vote on &#147;routine&#148;
proposals when they have not received instructions from beneficial owners. However, banks, brokerage firms and other nominees are precluded from exercising their voting discretion with respect to <FONT STYLE="white-space:nowrap">non-routine</FONT>
matters, such as Proposal Nos. 1 and 2 described in this proxy statement. Absent instruction from you, however, your broker can, using its voting discretion, vote on the proposal to ratify the selection of Rose, Snyder&nbsp;&amp; Jacobs LLP as
Arrowhead&#146;s independent auditor for the fiscal year ending September&nbsp;30, 2018. Shares subject to a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will be counted as present for the purpose of determining the presence or absence of
a quorum for the transaction of business at the Annual Meeting; the effect of abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on the proposals presented herein is discussed below. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With regard to the election of directors, votes may be cast in favor of a director nominee or withheld. Because directors are elected by
plurality, abstentions from voting and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be entirely excluded from the vote and will have no effect on its outcome. If a quorum is present at the meeting, the nominees receiving the
greatest number of votes, up to six directors, will be elected. Because Proposal Nos. 2 and 3 must be approved by the affirmative vote of a majority of the shares of Common Stock entitled to vote thereon and present in person or by proxy at the
Annual Meeting (the &#147;Required Vote&#148;), abstentions will be counted in tabulations of the votes cast on each such proposal and will have the same effect as a vote against the proposal, whereas broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> (with respect to Proposal No.&nbsp;2) will be excluded from the vote and will have no effect on its outcome. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Deadline for Receipt of Stockholder Proposals </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any stockholder who meets
the requirements of the proxy rules under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), who intends to present a proposal at the Company&#146;s 2019 Annual Meeting of Stockholders must ensure that the
proposal is received by the Corporate Secretary at Arrowhead Pharmaceuticals, Inc., 225 South Lake Avenue, Suite 1050, Pasadena, CA 91101, not later than October&nbsp;5, 2018, in order to be considered for inclusion in our proxy materials for that
meeting; provided, however, that if the Company&#146;s 2019 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Annual Meeting of Stockholders is held before February&nbsp;20, 2019 or after April&nbsp;15, 2019, you must provide specified information to us a reasonable time before we begin to print and send
our proxy statement for our 2019 Annual Meeting. Proposals received after the specified dates may be excluded from the Company&#146;s proxy statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Additionally, our Bylaws provide for notice procedures to recommend a person for nomination as a director or to propose business to be considered by stockholders at a meeting. To be considered timely
under these provisions, the stockholder&#146;s notice must be received by the Corporate Secretary at our principal executive offices at the address set forth above between 90 and 120&nbsp;days prior to the
<FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of the 2018 Annual Meeting; <I>provided, however</I>, that if the 2019 Annual Meeting date is advanced by more than 30&nbsp;days before or delayed by more than 60&nbsp;days
after the anniversary date of the 2018 Annual Meeting, then stockholders must provide notice within time periods specified in our Bylaws. Our Bylaws also specify requirements as to the form and content of a stockholder&#146;s notice. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL ONE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has nominated the following six persons
as directors to serve until the 2019 Annual Meeting and until their successors have been duly elected. Each of the nominees is currently a director of Arrowhead. Except as set forth in the biographical information below, none of the nominees is
related by blood, marriage or adoption to any other nominee or any executive officer of the Company. The six nominees receiving the greatest numbers of votes at the Annual Meeting will be elected to the six director positions. Unless otherwise
instructed, the proxy holders will vote the proxies received by them for the six nominees named below. If any nominee is unable or declines to serve as director at the time of the Annual Meeting, the proxies will be voted for any nominee who is
designated by our present Board to fill the vacancy. The table below sets forth, with respect to each nominee for election, his age and current position with Arrowhead. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><U>Nominees for Election as Directors</U></B>. The Board unanimously adopted a resolution proposing the nominees set forth below for election as Directors of the Company for the next year. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OUR BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; EACH OF THE NOMINEES LISTED BELOW. </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Douglass Given, MD Chairman</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Age: 65</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since: 2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Experience and Expertise</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Given is Chief Executive Officer and Director of Health 2047, Inc., a San Francisco, CA based health information start up and is founder and
Managing Partner of G5 Partners, LLC, a Menlo Park, CA based consulting firm that provides strategic advisory services, corporate development, and venture investment in innovative healthcare companies. Dr.&nbsp;Given is an internist and infectious
diseases doctor with a PhD in virology, a serial entrepreneur and a venture capitalist. Over the course of his career, he has developed deep expertise in biotechnology, biopharmaceuticals, specialty medical products and healthcare innovation.
Dr.&nbsp;Given has directly participated in the development of more than 15 <FONT STYLE="white-space:nowrap">top-selling</FONT> drugs, biologics, diagnostics, imaging agents and medical devices. He was involved in R&amp;D portfolio management at
Lilly, was responsible for integrating the Searle acquisition at Monsanto, chaired one of six therapeutic area development teams at Schering Plough and led Mallinckrodt&#146;s corporate research and venture LP investments. Immediately prior to
taking the leadership role at Health2047, from 2000 to 2014</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Given was a partner at life sciences investor Bay City Capital. Dr.&nbsp;Given was a Clinical and Research Fellow in Internal Medicine and Infectious Diseases at Massachusetts General Hospital
and Harvard Medical School. He is also a noted philanthropist and mentor, advising and</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>

<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">sponsoring entrepreneurial programs and innovation funds at leading institutions like the University of Chicago, Wharton, Johns
Hopkins, USC, the University of Texas and Houston Methodist Research Institute. Additionally, he assists leading universities on the public health front and serves as an advisor to the Harvard School of Public Health, the Stanford Medicine Community
Council and the Johns Hopkins Bloomberg School of Public Health. Dr.&nbsp;Given is the brother of Dr.&nbsp;Bruce Given, the Company&#146;s Chief Operating Officer. <B></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Qualifications</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Given&#146;s qualifications to serve on the Board include his extensive experience as a physician scientist, in finance and business
transactions, particularly investments in the life sciences industry, as well as directorship roles in biopharmaceutical companies. Dr.&nbsp;Given also has had significant leadership roles, including CEO of several biotech companies and Senior Vice
President, at several large pharmaceutical companies.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Michael S. Perry, DVM</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Independent Lead Director</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Age: 58</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since: 2011</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Serves on:</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Compensation Committee (Chair)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Nominating Committee (Chair)</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Other Public Company Boards:</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Avita Medical, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Ampliphi Bioscience Corp.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Experience and Expertise</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Perry is currently the Chief Executive Officer and President of Avita Medical Ltd., a regenerative medicine company based in Valencia, CA (ASX:
AVH and OTCQX: AVMXY) and Managing Director of Bioscience Managers, a global Venture Capital firm. From 2014 &#150; 2017, Dr.&nbsp;Perry served as Chief Scientific Officer of Novartis&#146; Cell and Gene Therapy Unit, and from 2012 &#150; 2014 he
served as Vice President and Global Head of Stem Cell Therapy for Novartis Pharmaceuticals Corp, a US affiliate of Switzerland-based Novartis AG, a global pharmaceutical company. Dr.&nbsp;Perry has previously served as the Global Head of R&amp;D at
Baxter Healthcare, President and CEO of Cell&nbsp;&amp; Gene Therapy at Novartis affiliates Systemix Inc. and Genetic Therapy, Inc., VP Regulatory Affairs at Sandoz Pharmaceuticals Corp., Director of Regulatory Affairs at Schering-Plough
Corporation, and Chairman, CEO or CMO at several early stage biotech companies. He also previously served as a Venture Partner with Bay City Capital, LLC, based in San Francisco, California. Dr.&nbsp;Perry holds a Doctor of Veterinary Medicine, a
PhD in Biomedical Pharmacology, and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. He is a graduate of the International Advanced Management Program at Harvard Business School.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Qualifications</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Perry&#146;s qualifications to serve on the board
include his medical expertise and his extensive experience in preclinical and clinical drug development, including executive level leadership roles and directorships in several publicly held biotech companies.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher Anzalone, PhD</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Chief Executive Officer, President&nbsp;&amp; Director</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Age: 48</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director since: 2007</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Experience&nbsp;&amp; Expertise</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Anzalone has been President, Chief Executive Officer
and Director of the Company since December&nbsp;1, 2007 and has led the Company&#146;s business and technical development since then. Prior to joining Arrowhead, Dr.&nbsp;Anzalone formed and served as CEO of the Benet Group LLC, a private equity
firm focused on creating and building new nano-biotechnology companies from university-generated science. Prior to his tenure at the Benet Group, from 1999 until 2003, he was a partner at the Washington,
<FONT STYLE="white-space:nowrap">DC-based</FONT></FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>

<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">private equity firm Galway Partners, LLC, where he was responsible for sourcing, structuring and building new business ventures.
Dr.&nbsp;Anzalone holds a Ph.D. in Biology from UCLA and a B.A. in Government from Lawrence University.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Qualifications</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Anzalone&#146;s qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer;
in addition, Dr.&nbsp;Anzalone has extensive experience in business development, biotechnology, drug development, company-building and venture capital.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Mauro Ferrari, PhD</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Independent Director</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Age: 58</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since: 2010</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Serves on:</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Compensation Committee</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Nominating Committee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Experience&nbsp;&amp; Expertise</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since 2010, Dr.&nbsp;Ferrari has been the President and CEO of
The Houston Methodist Hospital Research Institute (TMHRI), Executive Vice President of Houston Methodist Hospital and Senior Associate Dean of Weill Cornell Medical College in New York. He is also the President of The Alliance for NanoHealth.
Dr.&nbsp;Ferrari is an internationally recognized expert in nanomedicine and biomedical nanotechnology. Prior to assuming leadership of TMHRI, Dr.&nbsp;Ferrari was Professor and Chairman of The Department of NanoMedicine and Biomedical Engineering
at The University of Texas Health Science Center at Houston, Professor of Experimental Therapeutics at the MD Anderson Cancer Center, Adjunct Professor of Bioengineering at Rice University and Adjunct Professor of Biomedical Engineering at the
University of Texas in Austin. His previous academic appointments include tenured professorships at UC Berkeley and The Ohio State University.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Qualifications:</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe Dr.&nbsp;Ferrari&#146;s qualifications to serve on the Board include his extensive training and experience in the fields of nanotechnology,
biotechnology and biomedical applications. Dr.&nbsp;Ferrari has significant technical training, several academic appointments, over 300 published articles, over 30 issued patents and is the recipient of most prestigious academic awards in
nanomedicine and drug delivery technology. Additionally, Dr.&nbsp;Ferrari has extensive experience in developmental stage organizations having founded several startup companies.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Edward W. Frykman</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Independent Director</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Age: 81</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since: 2004</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Serves on:</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee (Chair)</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Compensation Committee</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Nominating Committee</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other Public Company Boards:</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Acacia Research Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Experience&nbsp;&amp; Expertise</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Frykman retired from Crowell, Weedon&nbsp;&amp; Co. in
2008 as an account representative, a position he held since 1992. Before his service at Crowell, Weedon&nbsp;&amp; Co., Mr.&nbsp;Frykman served as Senior Vice President of L.H. Friend&nbsp;&amp; Co. Both Crowell Weedon&nbsp;&amp; Co. and L.H.
Friend&nbsp;&amp; Co. are investment brokerage firms located in Southern California. In addition, Mr.&nbsp;Frykman was a Senior Account Executive with Shearson Lehman Hutton, where he served as the Manager of the Los Angeles Regional Retail Office
of E. F. Hutton&nbsp;&amp; Co. Mr.&nbsp;Frykman is also a director of Acacia Research Corporation, a publicly-held corporation based in Newport Beach, California.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Qualifications</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Frykman&#146;s qualifications to serve on the Board
include his long tenure as a member of the Board, which has enabled Mr.&nbsp;Frykman to gain a deep</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">understanding of the company&#146;s operations, strategy and finances. Mr.&nbsp;Frykman has over 20 years of Audit Committee leadership in his roles of Audit Committee Chairman
at both Acacia and Arrowhead and an extensive knowledge and experience in financial statement analysis gained in his career in finance and management.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>William Waddill</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Independent Director</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Age: 60</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Director since: January 2018</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Serves on:</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other Public Company Boards:</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Protagonist Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Experience&nbsp;&amp; Expertise</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">William Waddill began his career 30 years ago in commercial
banking and public accounting and has been in the biotechnology industry for over 25 years. Since 2016, he has served on the board of Protagonist Therapeutics, a Newark, CA clinical stage biopharmaceutical company and most recently was Senior Vice
President and CFO of Calithera Bioscience, a South San Francisco clinical stage pharmaceutical company. Prior to Calithera, Mr.&nbsp;Waddill was Senior Vice President and CFO at OncoMed Pharmaceuticals from 2007 to 2014. Mr.&nbsp;Waddill served as
the Senior Vice President and CFO of Ilypsa, Inc., a biotechnology company that was acquired in 2007 by Amgen, Inc. Before joining Ilypsa, he served as the founder and principal at Square One Finance, a financial consulting business, and
Mr.&nbsp;Waddill served as Senior Director of Finance and Administration at Exelixis, Inc., a biotechnology company. Mr.&nbsp;Waddill received a BS in accounting from the University of Illinois, Chicago, and certification as a public accountant
(inactive) after working at PriceWaterhouseCoopers and Deloitte in Boston.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Qualifications</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Waddill&#146;s qualifications to serve on the Board include his extensive background in the biopharma industry, his financial expertise, executive leadership roles and experience as a director of
other public companies.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Composition and Nominating Process </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Nominating&nbsp;Committee of the Board of Directors annually considers the size, composition and needs of the Board and, as appropriate, recommends the nominees for directors to the Board for
approval. The Committee considers and evaluates suggestions from many sources regarding possible candidates for directors. Below are general criteria for the evaluation of current and proposed directors: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The highest ethical character and shared values with our Code of Corporate Conduct </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reputation, both personal and professional, consistent with our image and reputation </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accomplishment within candidate&#146;s field, with superior credentials and recognition </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Relevant expertise and experience and the ability to offer advice and guidance to the CEO based on that expertise and experience
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Independence, without the appearance of any conflict in serving as a Director, and independence of any particular constituency with the ability to
represent all shareholders </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ability to exercise sound business judgment </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diversity, reflecting differences in skills, regional and industry experience, background, and other unique characteristics
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additionally, the Committee considers the mix of skills and experience among current and prospective
directors with a goal of assembling a Board with complementary skills for the benefit of the Company. Listed below are the relevant contributions of each current board member. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:32pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Expertise</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Given</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Perry</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Anzalone</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ferrari</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Frykman</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Waddill</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Biopharma Research&nbsp;&amp; Development</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Healthcare</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Drug Development</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Leadership</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Public Company Governance</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial/Audit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Venture Capital</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Corporate Governance Policies and Practices </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of our corporate governance policies and practices: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The positions of Chairman of the Board and Chief Executive Officer are separated, which allows our Chief Executive Officer to focus on strategic
planning and execution as well as our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business operations, while allowing the Chairman of the Board to lead the Board in its fundamental role of providing
advice to and oversight of management. While our Bylaws do not require that our Chairman and Chief Executive Officer positions be separate, our Board believes that having separate positions is the appropriate leadership structure for us at this time
and demonstrates our commitment to good corporate governance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A majority of the members of the Board are independent directors, as defined by Nasdaq Marketplace Rules. The Board has determined that all of the
Company&#146;s directors are independent, except Dr.&nbsp;Anzalone, due to his employment relationship with the Company, and Dr.&nbsp;Given, who is the brother of Bruce Given, the Company&#146;s Chief Operating Officer. <FONT
STYLE="white-space:nowrap">Non-employee</FONT> directors do not receive consulting or other fees from the Company, other than Board and Committee compensation. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has appointed an independent Lead Director. The Lead Director is tasked with assuring that the Board committees and other relevant issues
have independent leadership. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has overall responsibility for the oversight of the Company&#146;s risk management process, which is designed to support the achievement of
organizational objectives, including strategic objectives, to improve long-term organizational performance and enhance stockholder value. Risk management includes not only understanding company-specific risks and the steps management implements to
manage those risks, but also what level of risk is acceptable and appropriate for the Company. Management is responsible for establishing our business strategy, identifying and assessing the related risks and implementing appropriate risk management
practices. The Board regularly reviews our business strategy and management&#146;s assessment of the related risk, and discusses with management the appropriate level of risk for the Company. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All of the Company&#146;s employees, officers and directors are subject to the Company&#146;s Code of Business Conduct and Ethics Policy, which is
available on the Company&#146;s website at www.arrowheadpharma.com. The ethics policy meets the requirements of Nasdaq Marketplace Rules, as well as the code of ethics requirements of the SEC. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit, Compensation and Nomination Committees consist entirely of independent directors. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The independent directors meet separately in executive session on a regular basis to discuss matters relating to the Company and the Board, without
members of the management team present. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board reviews at least annually the Company&#146;s business initiatives, capital projects and budget matters. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee reviews and approves all related-party transactions or, if the size and nature of the transaction warrants, a special committee of <FONT
STYLE="white-space:nowrap">non-related</FONT> Board members is formed to negotiate and approve the transaction. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stockholder Communications with Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Stockholders who wish to communicate with the Board or any individual director can write to: Jane Davidson, Corporate Secretary, Arrowhead Pharmaceuticals, Inc., 225 South Lake Avenue, Suite 1050,
Pasadena, CA 91101. Your letter should indicate that you are an Arrowhead stockholder. Depending on the subject matter, management will: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Forward the communication to the director or directors to whom it is addressed; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Forward the communication to the Chairman of the Board, if addressed to the board of directors; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">If not addressed to any director or directors, attempt to handle the inquiry directly (for example, requests for information or stock-related matters).
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Meetings and Committees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board held a total of six meetings during the fiscal year ended September&nbsp;30, 2017. The Board has three standing committees: an Audit Committee, a Compensation Committee and a Nomination
Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The functions of the Audit Committee are to select independent public accountants, to review the scope and results
of the <FONT STYLE="white-space:nowrap">year-end</FONT> audit with management and the independent auditors, to review the Company&#146;s accounting principles and its system of internal accounting controls, to review the Company&#146;s annual and
quarterly reports before filing with the Securities and Exchange Commission and to review any related-party transactions. The Audit Committee met three times during fiscal 2017. The current members of the Audit Committee are Edward W. Frykman,
Chairman, William Waddill, Mauro Ferrari and Michael S. Perry. The Board has determined that all members of the Audit Committee are independent directors under the Rules of the SEC and the listing standards of Nasdaq Marketplace Rules and are
financially literate. The Board has determined that Mr.&nbsp;Frykman and Mr.&nbsp;Waddill are &#147;audit committee financial experts&#148; in accordance with the applicable regulations, based on their experience as noted above. The Audit Committee
Charter is available on the Company&#146;s website at www.arrowheadpharma.com. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The functions of the Compensation Committee
are to review the goals and achievements of the Company and the Chief Executive Officer for the prior year and approve the goals of the Company and the Chief Executive Officer for the next year, to review and approve salaries, bonuses and other
benefits payable to the Company&#146;s executive officers and to administer the Company&#146;s 2004 Equity Incentive Plan and 2013 Incentive Plan. The Compensation Committee is specifically responsible for determining the compensation of the Chief
Executive Officer and the other executive officers. The Compensation Committee reviews compensation recommendations made by the Chief Executive Officer for other senior executives of the Company at least annually; the Chief Executive Officer is not
present during discussions or deliberations regarding his compensation. In fiscal 2017, the Compensation Committee engaged Streeter Wyatt LLC, a compensation consulting firm, to provide advice and guidance with regard to compensation for our named
executive officers. The decision to engage the consultant was not made or recommended by management and the Committee has the sole discretion to engage or change the consultant. The Compensation Committee met two times during fiscal 2017. The
current members of the Compensation Committee are Michael S. Perry, Chairman, Edward Frykman and Mauro Ferrari. The Board has determined that all members of the Compensation Committee are independent directors under the listing rules of Nasdaq
Marketplace Rules. The Compensation Committee&#146;s charter is available on the Company&#146;s website at www.arrowheadpharma.com. The Committee has not delegated any of its responsibilities or authorities granted under its charter. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nomination Committee is responsible for proposing a slate of directors for election by
the stockholders at each Annual Stockholders Meeting and for proposing candidates to fill any vacancies. The Nomination Committee met once during fiscal 2017. The current members of the Nomination Committee are Michael S. Perry, Chairman, Edward
Frykman and Mauro Ferrari. The Nomination Committee&#146;s charter is available on the Company&#146;s website at www.arrowheadpharma.com. The Nomination Committee manages the process for evaluating current Board members at the time they are
considered for <FONT STYLE="white-space:nowrap">re-nomination.</FONT> After considering the appropriate skills and characteristics required on the Board, the current makeup of the Board, the results of the evaluations and the wishes of the Board
members to be <FONT STYLE="white-space:nowrap">re-nominated,</FONT> the Nomination Committee recommends to the Board whether those individuals should be <FONT STYLE="white-space:nowrap">re-nominated.</FONT> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On at least an annual basis, the Nomination Committee reviews with the Board whether it believes the Board would benefit from adding new
members and, if so, the appropriate skills and characteristics required for any new members. If the Board determines that a new member would be beneficial, the Nomination Committee solicits and receives recommendations for candidates and manages the
process for evaluating candidates. All potential candidates, regardless of their source, are reviewed under the same process. The Nomination Committee (or its chairman) screens the available information about the potential candidate(s). Based on the
results of the initial screening, interviews with candidates are scheduled with Nomination Committee members, other members of the Board and senior members of management. Upon completion of these interviews and other due diligence, the Nomination
Committee may nominate a candidate to the Board for election. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Candidates for independent Board member positions are
identified through recommendations from directors or others associated with the Company, as well as through a formal search process managed by an executive recruiter. Arrowhead stockholders may also recommend candidates by sending the
candidate&#146;s name and resume to the Nomination Committee pursuant to the procedures, set forth above, for communication with the Board. As described above, our Bylaws also provide for separate notice procedures to recommend a person for
nomination as a director to be considered by stockholders at a meeting, including requirements as to the timing, form and content of a stockholder&#146;s notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Nomination Committee has no predefined minimum criteria for selecting Board nominees, although it believes that all directors should share qualities such as governance and business experience at the
corporate level, relevant <FONT STYLE="white-space:nowrap">non-competitive</FONT> experience and strong communication and analytical skills. Independent directors must meet the criteria for independence set forth by Nasdaq and the SEC. In any given
search, the Nomination Committee may also define particular characteristics for candidates to balance the overall skills and characteristics of the Board and the needs of the Company. During any search, the Nomination Committee reserves the right to
modify its stated search criteria for exceptional candidates. While the Board does not have a policy with regard to consideration of diversity for selecting candidates, the Nomination Committee may consider diversity, including diversity with
respect to experience, skill set, age, areas of expertise and professional background, as well as race, gender, national origin and any other criteria deemed appropriate by the Nomination Committee. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">No incumbent director attended fewer than 75% of the aggregate of (i)&nbsp;the total number of meetings of the Board held during fiscal
2017, and (ii)&nbsp;the total number of meetings held by all committees of the Board during fiscal 2017 on which such person served. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition, two of the directors attended the 2017 Annual Meeting of Stockholders. It is the Company&#146;s policy to encourage, but not require, that all directors attend our annual stockholder
meetings. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DIRECTOR COMPENSATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors who are also employees of the Company receive no separate compensation from the Company for their service as members of the
Board. The below table sets forth compensation levels for each of our outside directors for calendar 2017 and 2018. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2018&nbsp;Annual</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fee
(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2018&nbsp;Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Award
(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2018&nbsp;Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date
Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017&nbsp;Annual</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fee
(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017&nbsp;Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Award
(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017&nbsp;Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date
Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:58pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name&nbsp;&amp; Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B>(effective<B><BR></B>1/1/18)<B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B></B>(effective<BR>1/1/17)<B></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglass Given</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Perry</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lead Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward Frykman</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mauro Ferrari</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William Waddill</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The annual fee for service as a Company director for 2018 and 2017 is $52,500. An additional fee of $26,250 is paid for the service of the Chairman and an additional
$15,750 for the service of the lead director. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For services in 2018, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director received a grant of 25,000 restricted stock units (&#147;<B>RSUs</B>&#148;).
Additional grants of 5,000 RSUs were awarded for the service of the Chairman and the lead director. RSU grants to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors vest on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary
of the date of grant. In 2017, the grant for each director was 50,000 RSUs with an additional grant to the Chairman of 30,000 RSUs and to the lead director of 30,000 RSUs. The number of RSUs granted to employees and
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors was increased in fiscal 2017 to address the Company&#146;s retention needs after a decision was made to terminate the Company&#146;s clinical trials. In 2018, the number of RSUs granted
was decreased from 2017 to amounts closer to historical levels. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Waddill became a director effective 1/1/2018 and received no compensation in fiscal 2017. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the total compensation paid to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in
fiscal 2017. Dr.&nbsp;Anzalone&#146;s compensation is set forth in the discussion of Executive Compensation and in the Summary Compensation Table. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fee&nbsp;Earned</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>or</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Paid&nbsp;in&nbsp;Cash</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards&nbsp;($)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(1)&nbsp;(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglass Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77,813</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">201,813</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Perry</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">191,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward Frykman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">129,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mauro Ferrari</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">77,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">129,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William Waddill (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This column represents the total grant date fair value, computed in accordance with ASC 718, of restricted stock units granted during fiscal year 2017 for each
director. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors vest one year from date of grant. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Waddill became a director effective 1/1/2018 and received no compensation in fiscal 2017. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of the last day of fiscal year 2017, the directors held the following outstanding stock option and restricted stock unit grants in the
aggregate: Douglass Given &#150; 65,000 stock options and 80,000 restricted stock units; Michael S. Perry &#150; 77,000 stock options and 80,000 restricted stock units; Edward Frykman &#150; 76,500 stock options and 50,000 restricted stock units;
and Mauro Ferrari &#150; 25,469 stock options and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
50,000 restricted stock units. Mr.&nbsp;Waddill became a director effective 1/1/2018 and did not hold any stock options or restricted stock units as of the last day of fiscal year 2017.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required; Recommendation of the Board </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The six nominees receiving the greatest numbers of votes at the meeting, assuming a quorum is present, will be elected to the six director positions to serve until their terms expire or until their
successors have been duly elected and qualified. Because directors are elected by plurality, abstentions from voting and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be entirely excluded from the vote and will have no effect on its
outcome. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; EACH OF THE NOMINEES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOR DIRECTOR IN PROPOSAL ONE. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL TWO </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation paid to our Named Executive Officers (&#147;<B>NEOs</B>&#148;) is described below in the Compensation
Discussion and Analysis on pages 11 through 31 of this proxy statement for the year ended September&nbsp;30, 2017. The Board of Directors is asking stockholders to cast a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote FOR the
following resolution: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;RESOLVED, that the compensation paid to the Company&#146;s named executive officers, as disclosed
pursuant to Item&nbsp;402 of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> as set forth in the compensation tables and narrative discussion, is hereby APPROVED.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although the vote we are asking you to cast is <FONT STYLE="white-space:nowrap">non-binding,</FONT> the Compensation Committee and the
Board value the views of our stockholders and will consider the outcome of the vote when determining future compensation arrangements for our named executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board has adopted a policy providing for annual advisory votes to approve executive compensation. Unless the Board modifies its policy on the frequency of holding advisory votes to approve executive
compensation, the next such advisory vote will occur in 2019. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required; Recommendation of the Board </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal Two must be approved by the Required Vote, assuming a quorum is present. For this purpose, abstentions will be counted as a vote
against the proposal, while broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of the vote. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL TWO. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>COMPENSATION DISCUSSION AND ANALYSIS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The following compensation discussion and
analysis contains statements regarding future individual and Company performance targets and goals. These targets and goals are disclosed in the limited context of Arrowhead&#146;s compensation programs and should not be understood to be statements
of management&#146;s expectations or guidance. Arrowhead cautions investors not to apply these statements to other contexts. Fiscal years are denoted as fiscal years, all other year references refer to calendar years. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This Compensation Discussion and Analysis describes the compensation program for our Named Executive Officers. During 2017, these
individuals were: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone, our President and Chief Executive Officer (our &#147;CEO&#148;); </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given, our Chief Operating Officer (our &#147;COO&#148;); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski, our Chief Financial Officer (our &#147;CFO&#148;); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien, our General Counsel; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone, our Vice President, Strategic Business Initiatives. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This Compensation Discussion and Analysis describes the material elements of our executive compensation program during 2017. It also
provides an overview of our executive compensation philosophy and objectives, and summarizes our executive compensation policies and practices. Finally, it analyzes how and why the Compensation Committee of our Board of Directors (the
&#147;Compensation Committee&#148;) arrived at the specific compensation decisions for our executive officers, including our Named Executive Officers for 2017 including the key factors that the Compensation Committee considered in determining their
compensation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Company </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We develop medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA
interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific
protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Our RNAi-based therapeutics leverage this natural
pathway of gene silencing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2017, we refocused our resources on therapeutics that exclusively utilize
our Targeted RNAi Molecule (TRiM</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">) platform technology.
Therapeutics built on the TRiM</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> platform have
demonstrated high levels of pharmacologic activity in multiple animal models spanning several therapeutic areas.
TRiM</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> enabled therapeutics offer several potential
advantages over prior generation and competing technologies, including: simplified manufacturing and reduced costs; multiple routes of administration including subcutaneous injection and inhaled administration; ability to target multiple tissue
types including liver, lung, and tumors; and the potential for improved safety and reduced risk of intracellular buildup, because there are less metabolites from smaller, simpler molecules. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2017 Business Highlights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Pipeline Overview </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or
more proteins. The depth and versatility of our RNAi technologies enable us to address conditions in virtually any therapeutic area and pursue disease targets that are not otherwise addressable by small molecules and biologics. The timing of our
planned and already filed clinical trial applications (CTA) discussed below are based on calendar quarters, not fiscal quarters. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-AAT</FONT> is an RNAi therapeutic candidate for the treatment of liver disease associated with <FONT
STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency. <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> is designed to knock down the <FONT STYLE="white-space:nowrap">Alpha-1</FONT> antitrypsin (AAT) gene transcript and reduce the hepatic
production of the mutant AAT protein. <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> is a next-generation subcutaneously administered compound that follows a previous generation AAT compound <FONT STYLE="white-space:nowrap">ARC-AAT.</FONT> A CTA
was filed in the fourth quarter of 2017. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-HBV</FONT> is an RNAi therapeutic candidate for the treatment of chronic hepatitis B infection with the goal of
achieving a functional cure. <FONT STYLE="white-space:nowrap">ARO-HBV</FONT> is a next-generation subcutaneously administered compound that follows previous generation HBV compounds <FONT STYLE="white-space:nowrap">ARC-520</FONT> and <FONT
STYLE="white-space:nowrap">ARC-521.</FONT> A CTA was filed in the fourth quarter of 2017. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-APOC3</FONT> is designed to reduce production of Apolipoprotein <FONT STYLE="white-space:nowrap">C-III</FONT> <FONT
STYLE="white-space:nowrap">(apoC-III),</FONT> a component of triglyceride rich lipoproteins (TRLs) including VLDL and chylomicrons and a key regulator of triglyceride metabolism. The company believes that knocking down the hepatic production of <FONT
STYLE="white-space:nowrap">apoC-III</FONT> may result in reduced VLDL synthesis and assembly, enhanced breakdown of TRLs, and better clearance of VLDL and chylomicron remnants. A CTA is planned for the fourth quarter of 2018.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-ANG3</FONT> is designed to reduce production of angiopoietin-like protein 3 (ANGPTL3), a liver synthesized
inhibitor of lipoprotein lipase and endothelial lipase. ANGPTL3 inhibition has been shown to lower serum LDL, serum and liver triglyceride and has genetic validation as a novel target for cardiovascular disease. A CTA is planned for the fourth
quarter of 2018. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-LUNG1</FONT> is Arrowhead&#146;s first therapeutic candidate to utilize the TRiM</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> platform to target an undisclosed disease of the lung. A CTA is
planned for the fourth quarter of 2018. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-HIF2</FONT> is being developed for the treatment of clear cell renal cell carcinoma (ccRCC). <FONT
STYLE="white-space:nowrap">ARO-HIF2</FONT> is designed to inhibit the production of <FONT STYLE="white-space:nowrap">HIF-2</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>, which has been linked to tumor progression and metastasis in ccRCC.
Arrowhead believes it is an attractive target for intervention because over 90% of ccRCC tumors express a mutant form of the Von Hippel-Landau protein that is unable to degrade <FONT STYLE="white-space:nowrap">HIF-2</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>, leading to its accumulation during tumor hypoxia and promoting tumor growth. It is the first drug candidate to utilize the TRiM</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> platform to target tumors. A CTA is planned for 2019. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-LPA</FONT> (AMG 890) is designed to reduce production of apolipoprotein A, a key component of lipoprotein(a),
which has been genetically linked with increased risk of cardiovascular diseases, independent of cholesterol and LDL levels. Amgen, Inc. acquired a worldwide, exclusive license in September 2016 to develop and commercialize <FONT
STYLE="white-space:nowrap">ARO-LPA</FONT> (AMG 890). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-AMG1</FONT> is being developed against an undisclosed genetically-validated cardiovascular target under a license
and collaboration agreement with Amgen, Inc. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2017, we continued to make progress on our long-term
strategic objectives, including the following specific accomplishments: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unveiled our Targeted RNAi Molecule platform, or TRiM</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">, which utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting, while being structurally
simple. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed a Clinical Trial Application (CTA) for <FONT STYLE="white-space:nowrap">ARO-AAT,</FONT> our second generation subcutaneously administered
clinical candidate for the treatment of <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency liver disease. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed a Clinical Trial Application (CTA) for <FONT STYLE="white-space:nowrap">ARO-HBV,</FONT> our third generation subcutaneously administered clinical
candidate for the treatment of chronic hepatitis B virus infection. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Expanded our cardiometabolic pipeline, which now includes <FONT STYLE="white-space:nowrap">ARO-APOC3,</FONT> targeting apolipoprotein <FONT
STYLE="white-space:nowrap">C-III,</FONT> and <FONT STYLE="white-space:nowrap">ARO-ANG3,</FONT> targeting angiopoietin-like protein 3 (ANGPTL3) with CTA filings planned around the end of 2018. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provided data highlighting the TRiM</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> platform&#146;s ability to target extra-hepatic tissues, including lung and tumor, represented by the following
programs: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-Lung1,</FONT> our first candidate against an undisclosed gene target in the lung, which achieved almost 90% target
knockdown following inhaled administration in rodents </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-HIF2,</FONT> our candidate targeting renal cell carcinoma, which achieved 85% target gene knockdown in a rodent
tumor model </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">CTA filings are planned in the fourth quarter of 2018 and in 2019 for <FONT STYLE="white-space:nowrap">ARO-Lung1</FONT> and <FONT
STYLE="white-space:nowrap">ARO-HIF2,</FONT> respectively </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Presented new clinical data at HEP DART 2017 demonstrating up to 5.0 log10 reduction in HBV <FONT STYLE="white-space:nowrap">s-antigen</FONT> and a
Sustained Host Response in 50% of hepatitis B patients following RNAi therapy, <FONT STYLE="white-space:nowrap">ARC-520,</FONT> in the 2001 open label extension study, and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Made continued progress on our two pro duct cardiovascular collaboration with Amgen, in which one that was previously called <FONT
STYLE="white-space:nowrap">ARO-LPA</FONT> against the target lipoprotein(a) has been formally nominated as a clinical candidate and which is now referred to as AMG890 by Amgen. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we recorded the following financial results in fiscal 2017: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Revenue </I></B>&#150; Generated revenue of approximately $31.4&nbsp;million, up from our revenue of approximately $0.2&nbsp;million in 2016;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Net Loss</I></B> &#150; Recorded a net loss of approximately $34.4&nbsp;million down from a net loss of approximately $81.7&nbsp;million in 2016;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Net Loss Per Share</I></B> &#150; Recorded a net loss per share (basic and diluted) of $0.47, compared to a net loss per share of $1.34 in 2016.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Executive Compensation Highlights </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on our overall operating environment and these results, the Compensation Committee took the following key actions with respect to
the compensation of our Named Executive Officers for 2017: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Base Salary</I></B> &#150; Approved base salary increases of 4% for each of our NEOs for 2017. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Annual Incentive Compensation</I></B> &#150; Approved annual cash bonuses for 2017 ranging from 90% to 115% of target annual incentive
compensation opportunities, including an annual cash bonus for our CEO in the amount of $715,357, equal to 115% of his target annual incentive compensation opportunity. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Equity Compensation</I></B> &#150; Granted our CEO a long-term incentive compensation opportunity in the form of a performance-based restricted
stock unit (&#147;PRSU&#148;) with a grant date value of $1,613,700 vesting upon the achievement of six equally weighted, <FONT STYLE="white-space:nowrap">pre-established</FONT> and rigorous performance milestones and granted our other Named
Executive Officers long-term incentive compensation opportunities in the form of time-based restricted stock unit (&#147;RSU&#148;) awards that may be settled for shares of our common stock with grant date values ranging from $139,500 to $589,000.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Clawback Policy</I></B><I> </I>&#150;<I> </I>Established a clawback policy allowing the Company to recover compensation from any executive
officer should the Board of Directors determine that a material misstatement of the Company&#146;s financial statements was due to fraud, negligence, or intentional misconduct by any executive officer of the Company. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Instituted &#147;Double Trigger&#148; Feature for Acceleration of Equity Awards </I></B>&#150; Amended the agreements for outstanding equity
awards granted to our CEO pursuant to our 2004 Equity Incentive Plan and 2013 Incentive Plan to provide that, upon a change in control of the Company, the vesting of such awards will accelerate only in the event of a subsequent involuntary
termination of employment (a &#147;double-trigger&#148; arrangement). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Advisory Vote to Approve Named Executive Officer Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At our 2017 Annual Meeting of Stockholders in March 2017, we conducted a <FONT STYLE="white-space:nowrap">non-binding</FONT> stockholder
advisory vote on the compensation of our Named Executive Officers (commonly known as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Say-on-Pay&#148;</FONT></FONT> vote). Our stockholders approved the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> proposal with approximately 51% of the votes cast in favor of the proposal. While this result represented a majority of the shares of our common stock entitled to
vote thereon and present in person or by proxy at the Annual Meeting, it does not meet our goal for support for our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> proposal, as 53% of the votes cast were
voted in favor of our Named Executive Officer&#146;s compensation in 2016 and 58% of the votes cast were voted in favor of their compensation in 2015. In 2015, 2016 and 2017, respectively, the &#147;No&#148; votes represented approximately 16%, 17%
and 15% of the outstanding shares of our stock entitled to vote at the Annual Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While we have received the support of
a majority of the votes cast on our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> proposal in each of the last three years, we recognize that the recent level of support indicates a concern on the part of
some of our stockholders and their advisors<B> </B>about our executive compensation program. As a result, in each of the past three<B> </B>years,<B> </B>the Compensation Committee, in consultation with our Board of Directors, has undertaken to
better understand and respond to the concerns and views of our stockholders and communicate the rationale underlying our compensation decisions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2015, we solicited feedback from institutional stockholders that beneficially own approximately 25% of our outstanding common stock and reviewed the
policies and feedback from Institutional Shareholder Services, Inc. (&#147;ISS&#148;) and Glass Lewis&nbsp;&amp; Co. (&#147;Glass Lewis&#148;) to better understand their relevant policies, as well as to supplement our stockholders&#146;
perspectives. Based on this feedback, the Compensation Committee: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shifted our CEO&#146;s annual equity award from time-based awards to wholly performance-based awards that were to be earned (if at all) based on the
achievement of performance objectives tied to the continued successful technical and clinical development of our drug products and/or <FONT STYLE="white-space:nowrap">follow-on</FONT> candidates and the successful completion of a significant
corporate transaction that would validate the credibility of our platform technology and resulting products and provide a revenue source for continued growth; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Imposed a minimum three-year vesting requirement on the time-based equity awards granted to our executive officers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adopted stock ownership guidelines of six times his annual base salary for our CEO and twice their annual base salary for our COO and CFO.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2016, we continued our engagement activities with our stockholders, soliciting feedback from stockholders beneficially owning approximately 28% of
our outstanding common stock and met with ISS to discuss the design of our executive compensation program and our actions to strengthen the link between our performance and our executive officers&#146; compensation. We believe the decrease in the
number of shares that we were able to reach out to reflects the decrease in institutional ownership year over year. Using this information, the Compensation Committee: </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued to grant our CEO a large majority of his long-term equity opportunity in the form of performance-based equity awards, in the form of a
performance-based restricted stock unit (&#147;PRSU&#148;) award that may be settled for shares of our common stock upon the achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> and rigorous performance milestones and an option to
purchase shares of our common stock. The PRSU award comprised approximately 90% of the long-term incentive compensation opportunity granted to our CEO in fiscal 2016 and, when combined with his annual incentive compensation opportunity, resulted in
approximately 77% of his target total direct compensation opportunity for fiscal 2016 being performance-based. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2017, we continued our stockholder engagement program, reaching out to our top 20 institutional stockholders beneficially owning approximately 20%
of our outstanding common stock to solicit their views and concerns and reviewed the feedback and policies of ISS. Based on </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">this review, as well as our commitment to good corporate governance, the Compensation Committee: </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Granted our CEO a long-term incentive compensation opportunity for fiscal 2017 that is entirely performance-based; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Established a clawback policy allowing the Company to recover compensation should the Board of Directors determine that a material misstatement of the
Company&#146;s financial statements was due to fraud, negligence, or intentional misconduct by any executive officer of the Company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amended the agreements for outstanding equity awards granted to our CEO pursuant to our 2004 Equity Incentive Plan and 2013 Incentive Plan to provide
that, upon a change in control of the Company, the vesting of such awards will accelerate only in the event of a subsequent involuntary termination of employment (a <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;double-trigger&#148;
arrangement). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We value the opinions of our stockholders and will continue to consider the outcome of future
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> votes, as well as feedback received throughout the year, when making compensation decisions for our executive officers. The Compensation Committee is
committed to being responsive to stockholder feedback regarding our executive compensation program, policies, and practices, including concerns expressed through the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Pay-for-Performance</FONT></FONT> Analysis </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe our
executive compensation program is reasonable, competitive, and appropriately balances the goals of attracting, motivating, rewarding, and retaining our executive officers with the goal of aligning their interests with those of our stockholders. To
ensure this alignment and to motivate and reward individual initiative and effort, a significant portion of our executive officers&#146; target annual total direct compensation opportunity is both performance-based and
<FONT STYLE="white-space:nowrap">&#147;at-risk.&#148;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We emphasize performance-based compensation that appropriately
rewards our executive officers, including our Named Executive Officers, through two separate compensation elements: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">First, we provide the opportunity to participate in our annual incentive compensation plan which provides cash payments if they produce short-term
financial, operational, and strategic results that meet or exceed the objectives set forth in each year in our annual operating plan<B>.</B> </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we grant equity awards as long-term incentive compensation. For our CEO in fiscal 2017, the grants are based entirely on the achievement
of <FONT STYLE="white-space:nowrap">pre-established</FONT> corporate performance objectives which are both challenging and designed to drive our financial and operational performance and long-term growth, and, in the case of our other executive
officers, are either dependent on the future appreciation in value of our common stock or are subject to the risk of fluctuations in the value of our common stock and, therefore, are &#147;at risk.&#148; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The pay mix for our CEO for each of the last three fiscal years illustrates the ongoing
emphasis on our performance-based compensation philosophy<B>: </B> </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g502300graaa.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that, ultimately, the creation of sustainable long-term stockholder value will depend on
our ability to successfully bring to market the products we develop or to partner with strategic collaborators to bring them to market. Consequently, the Compensation Committee strives to incent our executive officers to create that value through a
robust and attractive pipeline of drug candidates. As a result, our executive compensation program is designed to provide incentives that facilitate these efforts, in particular, for our CEO, milestone based performance grants directly linked to
goals that promote the development of our pipeline and other related business and market-based objectives. The Compensation Committee closely tracks the progress against these objectives to monitor our success over each product&#146;s development
period and evaluates our executive officers primarily on that progress. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ensure that we remain faithful to our compensation
philosophy, the Compensation Committee regularly evaluates the relationship between the reported values of the equity awards granted to our executive officers, the amount of compensation realizable (and, ultimately, realized) from such awards in
subsequent years and our total stockholder return over this period. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Executive Compensation Policies and Practices
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We endeavor to maintain sound governance standards consistent with our executive compensation policies and practices. The
Compensation Committee evaluates our executive compensation program on a regular basis to ensure that it is consistent with our short-term and long-term goals given the dynamic nature of our business and the market in which we compete for executive
talent. The following summarizes our executive compensation and related policies and practices: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>WHAT WE DO</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>WHAT WE DON&#146;T DO</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;&nbsp;&nbsp;<B><I>Maintain an Independent Compensation Committee.</I></B>&nbsp;The Compensation Committee consists solely of
independent directors.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;&nbsp;&nbsp;<B><I>Retain an Independent Compensation Advisor.</I></B>&nbsp;The Compensation Committee engaged its own compensation advisor to
provide information and analysis with its 2017 compensation review, and other advice on executive compensation independent of management. This consultant performed no consulting or other services for us in 2017.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;&nbsp;&nbsp;<B><I>No Executive Retirement Plans</I></B>.&nbsp;We do not offer pension arrangements or retirement plans or
arrangements to our executive officers that are different from or in addition to those offered to our other employees.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;&nbsp;&nbsp;<B><I>No Perquisites</I></B><B><I>.</I></B>&nbsp;Currently, we do not provide perquisites or other personal benefits to our executive
officers.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;Annual Executive Compensation Review</I></B>. The Compensation Committee conducts
an annual review and approval of our compensation strategy, including a review and determination of our compensation peer group used for comparative purposes and a review of our compensation-related risk profile to ensure that our compensation
programs do not encourage excessive or inappropriate risk-taking and that the level of risk that they do encourage is not reasonably likely to have a material adverse effect on us.</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;Compensation <FONT STYLE="white-space:nowrap">At-Risk</FONT></I></B>. Our executive compensation
program is designed so that a significant portion of compensation is &#147;at risk&#148; based on our performance, as well as short-term cash and long-term equity incentives to align the interests of our executive officers and
stockholders.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;Stock Ownership Policy.</I></B>&nbsp;We maintain a stock ownership policy that requires our CEO, COO,
and CFO to maintain a minimum ownership level of our common stock.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;Compensation Recovery (&#147;Clawback&#148;) Policy.</I></B>&nbsp;We established a clawback policy allowing the Company to recover compensation should
the Board of Directors determine that a material misstatement of the Company&#146;s financial statements was due to fraud, negligence, or intentional misconduct by any executive officer of the Company.</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;Conduct
an Annual Stockholder Advisory Vote on NEO Compensation.</I></B>&nbsp;We conduct an annual stockholder advisory vote on the compensation of our Named Executive Officers.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;Use a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Pay-for-Performance</FONT></FONT> Philosophy.</I></B>&nbsp;The majority of our CEO&#146;s compensation is directly linked to corporate performance; we also structure his target total
direct compensation opportunities with a significant long-term equity component, thereby making a substantial portion of each executive officer&#146;s target total direct compensation dependent upon our stock price and/or total stockholder
return.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;No Special Welfare or Health Benefits.</I></B>&nbsp;Our executive officers
participate in broad-based Company-sponsored health and welfare benefits programs on the same basis as our other full-time, salaried employees, except for a premium for life insurance for our CEO.</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;No
Post-Employment Tax Payment Reimbursement.</I></B>&nbsp;We do not provide any tax reimbursement payments (including <FONT STYLE="white-space:nowrap">&#147;gross-ups&#148;)</FONT> on any severance or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">change-in-control</FONT></FONT> payments or benefits.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;No Hedging or Pledging of Our Equity Securities.</I></B>&nbsp;We prohibit our executive officers and the
<FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board of Directors from hedging our equity securities.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;No Dividends or Dividend Equivalents Payable on Unvested Equity Awards.</I></B>&nbsp;We do not pay
dividends or dividend equivalents on unvested RSU awards or PRSU awards.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B>&#9744;<B><I></I></B><B><I>&nbsp;&nbsp;No Stock Option <FONT STYLE="white-space:nowrap">Re-pricing.</FONT></I></B>&nbsp;Our employee stock plan does not permit options to purchase shares of
our common stock to be repriced to a lower exercise or strike price without the approval of our stockholders.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Compensation Philosophy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our executive compensation philosophy reflects our two fundamental objectives: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to attract, motivate, and retain a highly skilled team of executives; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to align our executive officers&#146; interests with those of our stockholders by rewarding short-term and long-term performance and aligning
compensation to increases in stockholder value. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that the compensation of our executive officers should be directly linked to the
achievement of specific objectives that are expected to increase stockholder value. In furtherance of this goal, the Compensation Committee has established the following guidelines as a foundation for compensation decisions: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provide a competitive total compensation package that enables us to attract, retain, and motivate highly-qualified executives with the skills and
experience required for the achievement of business goals; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">promote the achievement of key strategic and financial performance measures by linking short-term and long-term compensation to the achievement of
measurable goals; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reward significant achievements outside of <FONT STYLE="white-space:nowrap">pre-established</FONT> goals; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recognize that pharmaceutical research, development, and commercialization require sustained and focused effort over many years, and involve a high
degree of risk and therefore balance incentives for short-term and long-term compensation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">employ outside compensation expertise and market data from industry peers to help assure that our compensation policies and practices are consistent
with industry practice and meet our goals for our compensation program; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">consider our cash resources and cost of capital to balance cash and equity compensation; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">align our executive officers&#146; incentives with the creation of stockholder value. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Compensation Program Design </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our practice is to combine a mixture of compensation elements that balance achievement of our short-term goals with our longer-term performance. Currently, our executive compensation program consists of
three principal elements: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">base salary; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an annual incentive compensation opportunity; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">long-term incentive compensation in the form of equity awards. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that cash compensation in the form of base salary and an annual incentive compensation opportunity provides our executive
officers with short-term rewards for success in operations, and that long-term incentive compensation in the form of RSU and PRSU awards that may be settled for shares of our common stock, and options to purchase shares of our common stock align the
objectives of our executive officers with those of our stockholders with respect to long-term performance and success. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee takes into consideration, among other things, our financial and working capital condition when approving performance objectives and making compensation decisions for our executive officers. Since we seek to preserve cash and
currently do not operate at a profit, overall target total direct compensation opportunities are weighted more heavily toward long-term incentive compensation in the form of equity awards. Thus, a significant portion of each executive officer&#146;s
target total direct compensation is &#147;at risk,&#148; and dependent on the increase in the value of our common stock. The Compensation Committee periodically reassesses the appropriate weighting of cash and equity compensation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of long-term incentive compensation, typically the Compensation Committee designs these awards to vest, or be earned, over a
multi-year period, meaning that long-term value creation, contrasted with short-term gain, presents the best opportunity for our executive officers to benefit from their awards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We do not maintain a specific policy on the percentage allocation between short-term and
long-term incentive compensation elements. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Governance of Executive Compensation Program </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Role of the Compensation Committee </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee discharges many of the responsibilities of our Board of Directors relating to the compensation of our executive officers, including our Named Executive Officers, and the <FONT
STYLE="white-space:nowrap">non-employee</FONT> members of our Board of Directors. <B></B>The Compensation Committee has overall responsibility for overseeing our compensation and benefits philosophy and policies generally, overseeing and evaluating
the compensation plans, policies, and practices applicable to our CEO and our other executive officers, and ensuring that the target total direct compensation opportunities of our executive officers, including our Named Executive Officers, are
consistent with our compensation philosophy, policies, and objectives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The members of the Compensation Committee are
appointed by our Board of Directors, and each member is an independent director (as &#147;independence&#148; is currently defined in Rule 5605(a)(2) of the NASDAQ listing standards). Currently, the members of the Compensation Committee are Michael
S. Perry (Chairman), Mauro Ferrari, and Edward Frykman. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee reviews our executive compensation program
annually on a calendar year basis, generally in December. The Compensation Committee draws on a number of resources to assist in the evaluation of the various components of our executive compensation program including, but not limited to, input from
our CEO, the advice of an external compensation consultant (as identified below) retained by the Compensation Committee, information provided in the public filings of industry peers and industry data compiled yearly by Radford in its Global Life
Sciences Survey, which represents a nationally-based assessment of executive compensation widely used within the pharmaceutical and biotechnology industry sectors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee relies upon the judgment of its members in making compensation decisions. In addition, the Compensation Committee incorporates judgment in the assessment process to respond to
and adjust for the evolving business environment. The members of the Compensation Committee have extensive experience in executive management, as well as compensation practices and policies. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation-Setting Process </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee develops recommendations for the target total direct compensation opportunities for our executive officers, including our Named Executive Officers. The Compensation Committee
does not use a single method or measure in making its compensation decisions, nor does it position compensation levels based upon a specific or target level relative to a peer group or other companies. Nonetheless, the pay practices at other
companies are an important factor that the Compensation Committee considers in assessing the reasonableness of compensation and ensuring that our compensation practices are competitive in the marketplace. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally, the Compensation Committee evaluates the compensation of our executive officers relative to the median of the competitive
market. However, as discussed hereafter, various other factors are taken into consideration in determining our executive officers&#146; compensation and the Compensation Committee does not target compensation at any specific level relative to the
competitive market. When reviewing our current executive compensation arrangements and approving each compensation element and the target total direct compensation opportunity for our executive officers, the Compensation Committee considers the
following factors: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our performance against the financial and operational objectives established by the Compensation Committee and our Board of Directors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each individual executive officer&#146;s skills, experience, and qualifications relative to other similarly-situated executives at the companies in our
compensation peer group; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The scope of each executive officer&#146;s role compared to other similarly-situated executives at the companies in our compensation peer group;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The performance of each individual executive officer, based on a subjective assessment of his or her contributions to our overall performance, ability
to lead his or her business unit or function and work as part of a team, all of which reflect our core values; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation practices of our compensation peer group and the positioning of each executive officer&#146;s compensation in a ranking of peer
company compensation levels; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The recommendations provided by our CEO with respect to the compensation of our other executive officers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These factors provide the framework for compensation decision-making and final decisions regarding the compensation opportunity for each
executive officer. No single factor is determinative in setting pay levels, nor was the impact of any factor on the determination of pay levels quantifiable. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Role of Chief Executive Officer </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In discharging its responsibilities, the
Compensation Committee works with members of our management, including our CEO. Our management assists the Compensation Committee by providing information on corporate and individual performance, market compensation data, and management&#146;s
perspective on compensation matters. The Compensation Committee solicits and reviews our CEO&#146;s recommendations with respect to the compensation levels for individual executive officers other than himself based on the performance evaluation
conducted by each executive officer&#146;s manager and his own evaluation of the executive officer&#146;s performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee reviews and discusses these recommendations and proposals with our CEO and considers them as one factor in formulating the recommendations for the compensation for our executive officers, including our other Named Executive
Officers. Our CEO recuses himself from all discussions and recommendations regarding his own compensation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Role of
Compensation Consultant </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee engages an external compensation consultant to assist it by providing
information, analysis, and other advice relating to our executive compensation program and the decisions resulting from its annual executive compensation review. The Compensation Committee has the final authority to engage and terminate the
engagement of any compensation consultant that it retains. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the period from October 2016 through September 2017, the
Compensation Committee engaged StreeterWyatt LLC, a national compensation consulting firm, as its external compensation consultant (&#147;StreeterWyatt&#148;). StreeterWyatt assisted the Compensation Committee in its review of executive and <FONT
STYLE="white-space:nowrap">non-employee</FONT> director compensation practices for 2017, including the competitiveness of compensation levels, executive compensation design, comparisons with our industry peers, and other technical considerations.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beginning in October 2017, the Compensation Committee engaged Compensia, Inc., a national compensation consulting firm
(&#147;Compensia&#148;), as its compensation consultant to advise on executive compensation matters, including competitive market pay practices for our executive officers, and to assist with data analysis and the selection of the compensation peer
group. During 2017, the scope of Compensia&#146;s engagement included: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and updating of our compensation peer group; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and analysis of the compensation arrangements for our executive officers, including our Named Executive Officers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and analysis of the compensation arrangements for the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board of Directors;
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and updating of the Compensation Discussion and Analysis section of our proxy statement for our 2018 Annual Meeting of Stockholders; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Support on other <I>ad hoc</I> matters. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The terms of Compensia&#146;s engagement include reporting directly to the Compensation Committee and to the Compensation Committee chair. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2017, neither StreeterWyatt nor Compensia provided any other services to us. The Compensation Committee has evaluated
StreeterWyatt&#146;s and Compensia&#146;s independence pursuant to the listing standards of the NASDAQ and the relevant SEC rules and has determined that no conflict of interest has arisen as a result of the work performed by either StreeterWyatt or
Compensia. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Competitive Positioning </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For each of the past five years, the Compensation Committee has directed its external compensation consultant to conduct a comparative study and report on compensation levels and practices relative to
industry peers, including a competitive assessment of our executive compensation program as compared to the market data for base salaries, target total cash compensation, long-term incentive compensation, and target total direct compensation.
Typically, the findings of this study are presented to the Compensation Committee by the compensation consultant in conjunction with the Compensation Committee&#146;s annual review of our executive compensation program. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because the biotechnology sector is dynamic, the comparator group used by the Compensation Committee to assess the competitive
positioning of the compensation of our executive officers is updated annually to ensure that peer companies continue to meet the established criteria. For purposes of its review of our executive compensation program in fiscal 2017, the Compensation
Committee directed StreeterWyatt to update its compensation peer group reflecting the competitive market for executive talent based on following criteria: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Publicly-held, <FONT STYLE="white-space:nowrap">pre-commercial</FONT> U.S. biotechnology companies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies with market capitalizations between 0.5x to 2.0x our market capitalization at the time of the peer selection; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies with between 50 to 500 employees. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The compensation peer group was selected in such a manner that our market capitalization was very near the median for all peer companies. Consideration was also given to the frequency or infrequency with
which a company was identified as a peer with other peer companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2017, the compensation peer group consisted of the following
companies: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Anthera Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Immumedics, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Array BioPharma, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">BioCryst, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Omeros Therapeutics, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">BioTime, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Orexigen Therapeutics, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">ChemoCentryx, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Osiris Therapeutics, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corcept Therapeutics, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peregrine Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">CTI Biopharma Corp.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Progenics Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Curis, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regulus Therapeutics, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">CytRx Corporation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dicerna Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo Biosciences, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">DURECT Corporation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Threshold Pharmaceuticals, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zogenix, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Idera Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation study prepared by StreeterWyatt and presented in December 2016 provided an
assessment of our compensation practices as compared to industry peers. Compensation levels for our executive officers, in the aggregate, were determined to be within the range of compensation provided to similarly placed executives and consistent
with our compensation philosophy. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Individual Compensation Elements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2017, the principal elements of our executive compensation program were as follows: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">base salary; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">an annual incentive compensation opportunity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">long-term incentive compensation in the form of equity awards; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">welfare and health benefits; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">post-employment compensation arrangements. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Base salary represents the fixed portion of the compensation
of our executive officers, including our Named Executive Officers, and is an important element of compensation intended to attract and retain highly-talented individuals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The initial base salaries for our executive officers are negotiated on an individual basis at the time of hire. Thereafter, using the competitive market data provided by its compensation consultant, the
Compensation Committee reviews and determines adjustments to the base salaries for each of our executive officers, including our Named Executive Officers, as part of its annual executive compensation review. In addition, the base salaries of our
executive officers may be adjusted by the Compensation Committee in the event of a promotion or significant change in responsibilities. Generally, the Compensation Committee sets base salaries with reference to the competitive range of the market
median of our compensation peer group and applicable executive compensation survey data, as well as its assessment of the factors described in &#147;Governance of Executive Compensation Program &#150; Compensation-Setting Process&#148; above.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2016, consistent with the recommendation of our CEO, the Compensation Committee determined to increase the base
salaries of our executive officers, including our Named Executive Officers. In making these decisions, the Compensation Committee considered the current risks and challenges facing us, as well as the factors described in &#147;Governance of
Executive Compensation Program &#150; Compensation-Setting Process&#148; above. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The base salaries of our Named Executive Officers for 2016 and 2017 were as follows:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:59pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016<BR>Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017<BR>Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Adjustment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President&nbsp;&amp; CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">598,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">622,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce Given</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Operating Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">419,661</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">436,477</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">326,310</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">339,363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">379,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Strategic Business Initiatives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">254,176</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">264,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The actual base salaries paid to our Named Executive Officers in fiscal 2017 are set forth in the
&#147;Fiscal 2017 Summary Compensation Table&#148; below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Incentive Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We provide our executive officers, including our Named Executive Officers, with the opportunity to earn performance-based annual incentive
awards, payable in cash, which are designed to reward them for our overall corporate performance as well as their individual performance. Generally, our executive officers are evaluated each year for eligibility to receive an annual incentive
compensation opportunity. Through a collaborative planning process involving our Board of Directors and management, corporate performance objectives are established at the beginning of each year and evaluated regularly by our Board of Directors for
their continued relevance to our status. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Target Annual Cash Bonus Opportunities </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of the 2017 performance-based incentive awards, each executive officer, including each of our Named Executive Officers, was
assigned a target annual incentive award opportunity based upon a percentage of his or her base salary. The target annual incentive award opportunities for our executive officers, including our Named Executive Officers, were recommended by our CEO
(except with respect to his own target annual incentive award opportunity) based on each executive officer&#146;s accountability, scope of responsibilities, and potential impact on our performance, and approved by the Compensation Committee. The
determination of target annual incentive award opportunities was based on the factors described in &#147;Governance of Executive Compensation Program &#150; Compensation-Setting Process&#148; above. Based on higher levels of control and
accountability for our overall performance, a higher percentage of each executive officer&#146;s total target cash compensation was dependent on his or her performance-based annual incentive awards. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2017, the Compensation Committee increased the target annual incentive award opportunity for each of our Named Executive Officers,
except for our CEO. The increase reflected the increased leadership responsibilities for each position as the Company grows and market-based adjustments. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The target annual incentive award opportunities for our Named Executive Officers were as
follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:59pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016&nbsp;Target&nbsp;Annual<BR>Incentive Award<BR>Opportunity (as a<BR>percentage of
base<BR>salary)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017&nbsp;Target&nbsp;Annual<BR>Incentive Award<BR>Opportunity (as a<BR>percentage of
base<BR>salary)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Potential annual incentive awards for our CEO could range from zero to 200% of his target annual
incentive award opportunity. There is no set minimum or maximum for annual incentive awards for our other Named Executive Officers. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Performance Objectives </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining the amount of the annual incentive award for each of our executive officers, including each of our Named Executive
Officers, the Compensation Committee evaluated the corporate performance objectives that had been established at the beginning of the calendar year (as set forth below) as well as other corporate and individual achievements and performance
throughout the year. These performance objectives addressed milestones for our lead products, research and development milestones for our drug pipeline, business development objectives, and infrastructure enhancements. In December 2017, the
Compensation Committee determined that we had largely achieved or exceeded our primary business objectives set for calendar 2017, as described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In determining our CEO&#146;s annual incentive award for 2017, the preclinical development and Amgen collaboration goals were weighted most heavily, followed by financial and manufacturing objectives with
organizational development goals least heavily, in that order. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:16pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Goal</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Achievement</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Business Development</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Meet certain delivery goals with regard to the Company&#146;s pharma collaboration</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Largely achieved<B></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee set aggressive goals that exceeded the Company&#146;s obligations for progress in its collaboration with a large pharma
company. Although one of the goals was not met, progress on the collaboration overall, including the unachieved goal, was determined by the Compensation Committee to be excellent.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Preclinical Development</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Selection of subcutaneous candidates for HBV, AAT, and thrombosis</I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Advance additional preclinical candidates for oncology,
cardiometabolic and extrahepatic targets</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Exceeded<B></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Not only did the Company select and progress its subcutaneous candidates for HBV, AAT and Factor 12, the Company filed to begin clinical trials for <FONT
STYLE="white-space:nowrap">ARO-HBV</FONT> and <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> before the end of 2017&#151;beating guidance by several months in each case.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company announced two additional preclinical targets for cardiometabolic disease and one additional target for an
undisclosed lung target. The Company continued to optimize its oncology program.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Finance</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>End FY2017 with 4 quarters of cash</I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Reach $200&nbsp;million market capitalization</I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beat Biotech index performance</I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Increase institutional ownership</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exceeded, except for institutional ownership</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company ended fiscal 2017 with $65&nbsp;million in cash and
short-term investments which is equivalent to more than a year&#146;s worth of cash at the Company&#146;s current run rate.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">At December&nbsp;31, 2017, the Company&#146;s market capitalization was approximately $275&nbsp;million.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s stock price was up by 137% vs. the Nasdaq
Biotech Index (NBI) which was up 21% year over year</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s institutional ownership had decreased during the year by the end of fiscal 2017, although measurement at December&nbsp;31, 2017 is
pending ownership filings due in February.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Manufacturing</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Establish GLP manufacturing capabilities</I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Develop plan for GMP manufacturing capabilities</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Achieved<B></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company brought inhouse kilo scale RNA trigger manufacturing capability online during the year and is proceeding with qualifying its inhouse GMP
manufacturing capabilities.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Clinical Development</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Close the Company&#146;s discontinued clinical trials by March&nbsp;31, 2017</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Achieved<B></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company discontinued enrollment in its <FONT STYLE="white-space:nowrap">DPC-based</FONT> clinical studies in November 2016 and concluded the studies
in early 2017. The Company has continued to follow certain of the HBV patients and has reported promising results post-trial.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Organizational Development</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Enhance organizational processes for vetting business and technical opportunities and strategic planning.</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Achieved<B></B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company continued to develop and implement structured processes for vetting opportunities and internal reporting.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Annual Incentive Award Payments </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The actual annual incentive award payments earned by our Named Executive Officers ranged from 90% to 115% of their target annual incentive
award opportunities. The awards are recommended by our CEO and approved by the Compensation Committee based on the overall achievement of the Company&#146;s goals, their contributions to the goals, and the overall performance of each officer during
the year. The following table sets forth the target annual incentive award opportunities, the actual award payment as a percentage of each Named Executive Officer&#146;s base salary, and the actual award payment made in cash to each of our Named
Executive Officers based on their performance in 2017: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:59pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target&nbsp;Annual</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;
Award<BR>Opportunity&nbsp;(as&nbsp;a<BR>percentage&nbsp;of&nbsp;base<BR>salary)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual&nbsp;Annual<BR>Incentive&nbsp;
Award</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(as&nbsp;a&nbsp;percentage&nbsp;of<BR>base salary)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual&nbsp;Annual<BR>Incentive&nbsp;Award<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">715,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,340</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">152,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">177,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The annual incentive award payments made to our Named Executive Officers for fiscal 2017 are set forth in
the &#147;Fiscal 2017 Summary Compensation Table&#148; below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Incentive Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We view long-term incentive compensation in the form of equity awards as a critical element of our executive compensation program. The
realizable value of these equity awards over time bears a direct relationship to our stock price, and, therefore, these awards are an incentive for our executive officers, including our Named Executive Officers, to create value for our stockholders.
Equity awards also help us retain qualified executive officers in a competitive market. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-term incentive compensation
opportunities in the form of equity awards are granted to our executive officers by the Compensation Committee. The amount and forms of such equity awards are determined by the Compensation Committee after considering the factors described in
&#147;Governance of Executive Compensation Program &#150; Compensation-Setting Process&#148; above. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>2017 LTI Awards </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Performance-Based RSU Award for Chief Executive Officer </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In December 2016, the Compensation Committee determined that the annual equity awards to be granted to our executive officers should be solely in the form of restricted stock unit (&#147;RSU&#148;) awards
that may be settled for shares of our common stock. In the case of our CEO, the Compensation determined that his award was to be entirely performance-based and granted PSUs. Dr.&nbsp;Anzalone was granted a performance-based RSU of 978,000 shares to
be vested in six equal installments on the achievement of the following milestones: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Achieve market capitalization of $200&nbsp;million and hold for six consecutive weeks </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Execute a significant business development transaction </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">File a CTA or IND on a SubQ candidate </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Trigger a milestone payment for <FONT STYLE="white-space:nowrap">ARO-LPA</FONT> or trigger <FONT STYLE="white-space:nowrap">ARO-AMG1</FONT> option
payment for collaborations with Amgen </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Initiate GLP tox for two SubQ programs </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Nominate a lead for an unannounced program </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The milestones must be achieved by April&nbsp;12, 2019 or the grants will expire.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2016, the Committee certified achievement of the performance milestones and the vesting of the following
previously granted performance-based restricted stock unit awards and option awards. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:62pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Performance Goal</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Achievement</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>No.&nbsp;of&nbsp;Shares</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Certified&nbsp;as&nbsp;Vested</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Enhancement</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enter a partnership to develop a novel therapeutic with a pharmaceutical or biotech company</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amgen Collaboration&#151; <FONT STYLE="white-space:nowrap">ARO-AMG1</FONT></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Achieved</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000 shares pursuant to an RSU award</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">None</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">File 2 new INDs</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARC-AAT</FONT></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARC-521</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Option on 100,000 shares</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000 shares pursuant to an RSU award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upsized by 20% from 83,333 shares and 100,000 RSUs based on market performance</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Enroll first patient in a Phase 2 or later study (excluding <FONT STYLE="white-space:nowrap">ARC-520)</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Deemed to be met, Phase 2 for <FONT STYLE="white-space:nowrap">ARC-AAT</FONT> launched, no patients enrolled for reasons outside of the CEO&#146;s reasonable control</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Option on 100,000 shares</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000 shares pursuant to an RSU award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upsized by 20% from 83,333 shares and 100,000 RSUs based on market performance</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Achieve a significant corporate event (i.e. a significant M&amp;A transaction)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amgen Collaboration&nbsp;&amp; License for</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">ARO-LPA</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Option on 100,000 shares</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,000 shares pursuant to an RSU award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upsized by 20% from 83,333 shares and 100,000 RSUs based on market performance</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Equity Grants to Other Named Executive Officers </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee approved the following aggregate equity awards for our Named Executive Officers for 2017: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:59pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Restricted&nbsp;Stock&nbsp;
Unit<BR>Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(number of shares)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Restricted&nbsp;Stock&nbsp;
Unit<BR>Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">589,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In view of the discontinuation of our intravenous clinical programs and to satisfy our retention
objectives, the Compensation Committee determined the time-based RSU awards granted to our executive officers, including our other Named Executive Officers in fiscal 2017 should have a lengthier initial vesting date, and a shorter overall vesting
period. Thus, the time-based RSU awards granted to our executive officers vest on the second anniversary of the date of grant, contingent upon an executive officer remaining employed by us on that date. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The equity awards granted to our Named Executive Officers in fiscal 2017 are set forth in the &#147;Fiscal 2017 Summary Compensation
Table&#148; and the &#147;Fiscal 2017 Grants of Plan-Based Awards Table&#148; below.</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Welfare and Health Benefits </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our executive officers, including our Named Executive Officers, are eligible to participate in all of our employee benefit plans,
including medical, dental, vision, life, and disability insurance, in each case on the same basis as our other employees, subject to applicable law. In addition, we provide additional life insurance for our CEO for the benefit of his heirs. We also
provide vacation and other paid holidays to all our employees, including our executive officers, all of which we believe to be comparable to those provided at peer companies. These benefit programs are designed to enable us to attract and retain our
workforce in a competitive marketplace. Our health, welfare, and vacation benefits are designed to ensure that we have a productive and focused workforce through reliable and competitive health and other benefits. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our retirement savings plan (&#147;401(k) plan&#148;) is a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement savings plan,
pursuant to which qualified employees, including our Named Executive Officers, are able to contribute certain amounts of their annual compensation, subject to limits prescribed by the Internal Revenue Service. Historically, we have made matching
contributions of 100% of the first 3% of base salary and of 50% of the next 2% of base salary contributed to the plan. The value of these benefits for each of our Named Executive Officers is reflected in the &#147;All Other Compensation&#148; column
of the &#147;Summary Compensation Table&#148; below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Perquisites and Other Personal Benefits </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, we do not view perquisites or other personal benefits as a significant component of our executive compensation program.
Accordingly, we do not provide significant perquisites or other personal benefits to our executive officers, including our Named Executive Officers, except as generally made available to our employees, or in situations where we believe it is
appropriate to assist an individual in the performance of his or her duties, to make our executive officers more efficient and effective and for recruitment and retention purposes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the future, we may provide perquisites or other personal benefits in limited circumstances, such as those described in the preceding
paragraph. All future practices with respect to perquisites or other personal benefits will be approved and subject to periodic review by the Compensation Committee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Employment Arrangements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have entered into a written employment
agreement with our CEO and have written employment offer letters with our other executive officers<B>. </B>In filling each of our executive positions, we recognized the need to develop competitive compensation packages to attract qualified
candidates in a dynamic labor market. At the same time, in formulating these compensation packages, we were sensitive to the need to integrate new executive officers into the executive compensation structure that we were seeking to develop,
balancing both competitive and internal equity considerations. Each of these arrangements provides for &#147;at will&#148; employment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For detailed descriptions of the employment arrangements we maintained with our Named Executive Officers for 2017, see &#147;Termination Benefits &#150; Potential Payments Upon Termination or Change in
Control&#148; below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Post-Employment Compensation Arrangements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have entered into an employment agreement with our CEO, and we also have agreements with our CFO and General Counsel that provide for
certain payments and benefits in the event of certain involuntary terminations of employment. We believe that having in place reasonable and competitive post-employment compensation arrangements are essential to attracting and retaining
highly-qualified executive officers. These agreements are designed to provide reasonable compensation to executive officers who leave our employ under certain circumstances to facilitate their transition to new employment. Further, in some instances
we seek to mitigate any potential employer liability and avoid future disputes or litigation by requiring a departing executive officer to sign a separation and release agreement acceptable to us as a condition to receiving post-employment
compensation payments or benefits. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee does not consider the specific amounts payable under these
agreements when establishing annual compensation. We do believe, however, that these arrangements are necessary to offer compensation packages that are competitive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition, our 2013 Incentive Plan provides for the acceleration of vesting of outstanding and unvested equity awards in the event of a change in control of the Company, as defined in the plan, except
as otherwise determined by our Board of Directors. <B></B>The Company has amended the agreements for outstanding equity awards granted to our CEO pursuant to our 2004 Equity Incentive Plan and 2013 Incentive Plan to provide that, upon a change in
control of the Company, the vesting of such awards will accelerate only in the event of a subsequent involuntary termination of employment (a &#147;double-trigger&#148; arrangement). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For detailed descriptions of the post-employment compensation arrangements we maintained with our Named Executive Officers for 2017, as
well as an estimate of the potential payments and benefits payable under these arrangements, see &#147;Termination Benefits &#150; Potential Payments Upon Termination or Change in Control&#148; below. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Compensation Policies and Practices </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Equity Awards Grant Policy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We do not have any program, plan, or obligation
that requires us to grant equity awards on specified dates, although historically we have granted such awards to our existing executive officers and employees at least annually and to newly-hired employees on the commencement of their employment. We
do not have any program, plan, or practice to grant options to purchase shares of our common stock to our executive officers in coordination with the release of material nonpublic information. Equity awards may occasionally be granted following a
significant change in job responsibilities or to meet other special retention or performance objectives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Authority to grant
equity awards to our employees rests with the Compensation Committee, although the Compensation Committee has delegated authority to our CEO to grant equity awards to <FONT STYLE="white-space:nowrap">non-executive</FONT> employees within prescribed
limits set by the Compensation Committee. With respect to our executive officers, except for our CEO, recommendations for equity awards are made by our CEO and reviewed and approved by the Compensation Committee. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the terms of our 2013 Incentive Plan, pursuant to which new equity awards are granted, the exercise price of any option to purchase
shares of our common stock awarded under the plan must be equal to at least 100% of the fair market value of our common stock (which is determined based on the closing sales price of our common stock on the NASDAQ Global Market) on the date of
grant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Ownership Policy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We maintain a stock ownership policy for our CEO, COO, and CFO to further align their respective interests with the interests of our stockholders, and to further promote our commitment to sound corporate
governance. This policy requires our CEO to own a minimum number of shares of our common stock equal to a value of six times his annualized base salary and our COO and CFO to own a minimum number of shares of our common stock equal to a value of
twice their annualized base salary. Each of these executive officers has achieved the required ownership. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation
Recovery (&#147;Clawback&#148;) Policy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2017, our Board of Directors adopted a clawback policy as follows:
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;If Arrowhead Pharmaceuticals, Inc. (the &#147;Company&#148;) is required to materially restate any of its financial
statements, the Board of Directors (the &#147;Board&#148;) shall assess the degree to which any fraud, negligence, or intentional misconduct by any executive officer of the Company was responsible for such restatement. If the Board determines that
any executive officer was responsible for causing such restatement, the Board shall, in addition to any other lawful remedies the Board or the Company may take, seek recovery of all or a portion of the incentive compensation awarded to the executive
officer for the performance period </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
covered by the restated financial statement, provided that such recovery shall not extend to payments made more than three years prior to the date the financial record was restated. In addition,
the Board may, in its absolute discretion, revoke any of the responsible executive officer&#146;s unpaid or unvested incentive compensation outstanding as of the date of the Board&#146;s determination of the executive officer&#146;s responsibility
for the financial restatement.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, our 2013 Incentive Plan provides for the recovery of awards made under the
plan in accordance with any applicable compensation recovery or recoupment policy, including as required by law, regulation, or national securities exchange rule. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Policy Prohibiting Hedging and Pledging </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Insider Trading Policy
prohibits our employees, including our executive officers, and the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board of Directors from short-term trading, options trading, trading on margin, pledging our common stock as
collateral, and all hedging transactions with respect to our securities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Tax and Accounting Considerations </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Deductibility of Executive Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Generally, Section&nbsp;162(m) of the Code disallows public companies a tax deduction for federal income tax purposes of remuneration in excess of $1&nbsp;million paid to their chief executive officer and
each of the three other most highly-compensated executive officers (other than the chief financial officer) whose compensation is required to be disclosed to our stockholders under the Exchange Act in any taxable year. Remuneration in excess of
$1&nbsp;million may only be deducted if it is &#147;performance-based compensation&#148; within the meaning of Section&nbsp;162(m) or qualifies for one of the other exemptions from the deduction limit. In making compensation recommendations, the
Compensation Committee considers the potential effects of Section&nbsp;162(m) on the compensation paid to our Named Executive Officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Where reasonably practicable, the Compensation Committee seeks to qualify the performance-based incentive compensation paid or awarded to our Named Executive Officers for the &#147;performance-based
compensation&#148; exemption from the deduction limit of Section&nbsp;162(m). As such, in approving the amount and form of compensation for our Named Executive Officers, the Compensation Committee considers all elements of our cost of providing such
compensation, including the potential impact of Section&nbsp;162(m). To maintain flexibility in compensating our Named Executive Officers in a manner designed to promote varying corporate goals, however, the Compensation Committee has not adopted a
policy that all compensation payable to our Named Executive Officers that is subject to Section&nbsp;162(m) must be deductible for federal income tax purposes. From time to time, the Compensation Committee may, in its judgment, recommend and our
Board of Directors may approve compensation for our Named Executive Officers that does not comply with an exemption from the deduction limit when it believes that such compensation is in the best interests of the Company and our stockholders.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exemption from Section&nbsp;162(m)&#146;s deduction limit for performance-based compensation has been repealed, effective
for taxable years beginning after December&nbsp;31, 2017, such that compensation paid to our Named Executive Officers in excess of $1&nbsp;million will not be deductible unless it qualifies for transition relief applicable to certain arrangements in
place as of November&nbsp;2, 2017. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Accounting for Stock-Based Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We follow the Financial Accounting Standard Board&#146;s Accounting Standards Codification Topic 718&nbsp;(&#147;FASB ASC Topic 718&#148;)
for our stock-based compensation awards. FASB ASC Topic 718 requires us to measure the compensation expense for all share-based payment awards made to our employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board of
Directors, including options to purchase shares of our common stock and other stock awards, based on the grant date &#147;fair value&#148; of these awards. This calculation is performed for accounting purposes and reported in the executive
compensation tables required by the federal securities laws, even though the recipient of the awards may never realize any value from their awards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>COMPENSATION RISK ASSESSMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In reviewing our various compensation programs, the Compensation Committee considers how our compensation policies and practices may
affect our risk profile and whether such policies and practices may encourage undue risk-taking by our employees. More specifically, the Compensation Committee considers the general design philosophy of our policies and practices for our employees
whose conduct would be most affected by incentives established pursuant to these compensation policies. In considering these issues, the Compensation Committee concluded that the use of performance-based annual incentive compensation plan and
long-term incentive compensation opportunities in the form of equity awards did not appear to create undue risks for us or encourage excessive risk-taking behavior on the part of our Named Executive Officers. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With respect to the annual incentive awards for our executive officers, the amount of an individual&#146;s award depends principally on
overall Company performance, as determined by the Compensation Committee, which reduces the ability and incentive for an individual to take undue risks at the expense of our performance in an effort to increase the amount of his or her annual
incentive award. Our performance objectives are reviewed regularly by the Compensation Committee and our Board of Directors and are considered to be generally of the nature that promote the steady progression of our development programs and would
not encourage or reward excessive risk-taking. In addition, our Board of Directors has the ability to intervene in instances where actions by our executive officers
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> Company performance objective attainment would be considered unduly risky to prevent or penalize such actions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Committee Report </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the Company has reviewed and discussed with management the Compensation Discussion and Analysis required by Item&nbsp;402(b) of
<FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K.</FONT> Based on this review and discussion, the Compensation Committee recommended to the Board that the foregoing Compensation Discussion and Analysis be included in this proxy statement.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Submitted by the Compensation</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee of the Board of Directors</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Perry, Chairman</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mauro Ferrari</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward W. Frykman</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Committee Interlocks and Insider Participation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2017, Dr.&nbsp;Perry, Dr.&nbsp;Ferrari and Mr.&nbsp;Frykman served on the Compensation Committee. During fiscal year 2017, there
were no compensation committee interlocks between the Company and other entities involving the Company&#146;s executive officers and directors. </FONT></P> <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table summarizes compensation earned
for services rendered during fiscal 2017, 2016, and 2015 by our Chief Executive Officer, our Chief Financial Officer, our Chief Operating Officer, our General Counsel and our Vice President, Strategic Business Operations, collectively our
&#147;Named Executive Officers&#148;: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Summary Compensation Table </U></B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(1)($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>(2)(S)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(3)($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards&nbsp;(3)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity<BR>Incentive
Plan</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(4)($)**</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(5)($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">616,068</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">537,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">715,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,889</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,871,214</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">592,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">368,797</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">448,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,889</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,411,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">564,911</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">751,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">426,840</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">575,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,889</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,319,760</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">336,099</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">152,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,809</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">725,371</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">321,692</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">307,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">184,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,431</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">956,530</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">302,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">260,123</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">123,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,074,101</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">432,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">589,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,340</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,599</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,384,189</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Chief Operating Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">415,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">922,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">251,796</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,399</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,877,895</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">396,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,126,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">312,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">282,464</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,399</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,128,867</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">390,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">177,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,599</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">804,990</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,949</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,399</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">834,743</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">286,385</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">156,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">314,970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">146,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,040,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">261,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,481</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">483,155</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Vice President, Strategic Business</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">251,732</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">230,479</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">88,962</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">581,658</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;Initiatives</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">240,062</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">442,208</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,540</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,460</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">778,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported in the 2016 base salary for each NEO have been restated to correct the amounts listed in the Company&#146;s 2017 Proxy Statement. Due to a clerical
error, the 2016 amounts were over stated for each NEO by approximately $15,000 to $25,000. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This bonus amount represents a signing bonus and relocation allowance for Patrick O&#146;Brien, who was hired on December&nbsp;2, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These columns represent the total grant date fair value, computed in accordance with ASC 718, of stock options and restricted stock units granted during fiscal year
2017, 2016 and 2015. The assumptions used to calculate the value of the stock underlying the option and restricted stock unit awards are set forth in Note 8 of the Notes to the Consolidated Financial Statements included with the Company&#146;s
Annual Report on <FONT STYLE="white-space:nowrap">10-K.</FONT> </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These bonus amounts represent the amounts earned for performance under the Company&#146;s Annual Bonus Incentive Plan during calendar year 2017, 2016 and 2015 and paid
in fiscal year 2018, 2017 and 2016, respectively. The Annual Bonuses are described in more detail in the &#147;Bonus Incentive&#148; section. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts consist of 401(k) matching contribution, as well as life insurance premiums for the benefit of each executive officer. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts reported for Christopher Anzalone in the Stock Awards column reflect the grant date fair value of an April 2017 restricted stock unit award that is subject
to vesting upon the achievement of specific performance conditions, as described above in the Compensation Discussion and Analysis. We determined the performance conditions that were probable and not probable of being achieved as of the grant date,
as defined </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
under applicable accounting guidance, and assigned a grant date fair value of $537,900 based on this evaluation. If we had determined that as of the date of the grant it was probable that 100% of
the performance conditions would be achieved, we would have assigned a grant date fair value of $1,613,700 for the restricted stock units. The amounts reported in the Summary Compensation Table for these awards may not represent the amounts that
Christopher Anzalone will actually realize from the awards. Whether, and to what extent, a named executive officer realizes value will depend on our actual operating performance, stock price fluctuations and the named executive officer&#146;s
continued employment. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amount reported for Christopher Anzalone in the Stock Awards column reflects the grant date fair value of a January 2016 restricted stock unit award that is subject
to vesting upon the achievement of specific performance-based conditions. We determined the performance conditions were not probable of being achieved as of the grant date, as defined under applicable accounting guidance, and assigned a grant date
fair value of $0 based on this evaluation. If we had determined that as of the date of the grant it was probable that 100% of the performance-based conditions would be achieved, we would have assigned a grant date fair value of $3,321,000 for the
restricted stock units. The amount reported in the Summary Compensation Table for this award may not represent the amount that Christopher Anzalone will actually realize from the award. Whether, and to what extent, a named executive officer realizes
value will depend on our actual operating performance, stock price fluctuations and the named executive officer&#146;s continued employment. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts reported for Christopher Anzalone in the Stock Awards and Option Awards column reflect the grant date fair value of a March 2015 restricted stock unit and
stock option award that is subject to vesting upon the achievement of specific performance and market-based conditions. We determined the performance conditions that were probable and not probable of being achieved as of the grant date, as defined
under applicable accounting guidance, and assigned a grant date fair value based on this evaluation. If we had determined that as of the date of the grant it was probable that 100% of the performance and market-based conditions would be achieved, we
would have assigned a grant date fair value of $2,703,600 for the restricted stock units and $1,536,624 for the stock options. The amounts reported in the Summary Compensation Table for these awards may not represent the amounts that Christopher
Anzalone will actually realize from the awards. Whether, and to what extent, a named executive officer realizes value will depend on our actual operating performance, stock price fluctuations and the named executive officer&#146;s continued
employment. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien was hired on December&nbsp;2, 2014 and thus compensation reflected in 2015 is for a partial year of approximately ten months.
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Grants of Plan-Based Awards </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth cash bonus and equity grants made to the named executive officers in fiscal 2017: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Grants of Plan Based Awards Table </U></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Future&nbsp;Payouts<BR>Under
Non-Equity<BR>Incentive&nbsp;Plan&nbsp;Awards&nbsp;(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Future&nbsp;Payouts<BR>Under&nbsp;Equity&nbsp;Incentive&nbsp;Plan&nbsp;Awards&nbsp;
(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:17pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Minimum</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other&nbsp;Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards:&nbsp;
Number</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of Shares of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock or Units</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)
(3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;Awards:</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities<BR>Underlying<BR>Options (#) (3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise&nbsp;Price<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date Fair<BR>Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">622,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,244,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">135,745</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">305,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">589,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">157,914</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Bonus</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">79,303</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">N/A</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RSUs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">139,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts listed represent cash awards granted to our named executive officers in 2017 and paid in fiscal 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These restricted stock unit awards are described above in the &#147;Compensation Discussion and Analysis&#148; under the heading &#147;Equity Compensation&#148;.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Options are priced at the market closing price on the date of grant. Options have various vesting parameters, but generally vest within 48 months or less after the
award is granted. Restricted stock units have various vesting parameters. The restricted stock units granted in 2017 vest two years from the grant date. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">We determined that as of the date of the grant it was not probable as defined under applicable accounting guidance that any of the performance vesting conditions for
these restricted stock unit awards would be achieved and assigned a grant date fair value of $0 based on this evaluation. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT>
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information, with respect to the Named Executive Officers, concerning the outstanding equity
awards covering shares of the Company&#146;s common stock as of September&nbsp;30, 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Outstanding Equity Awards at
Fiscal Year End Table </U></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:21pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name&nbsp;&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercised</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options
(#<BR>Exercisable)<BR>(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercised</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options (#</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercisable)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive </B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Plan&nbsp;Awards:<BR>Number
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercised</B></FONT>
<br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options (#<BR>Unexercisable)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Price&nbsp;
($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Expiration<BR>Date</B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares or<BR>Units&nbsp;of<BR>Stock&nbsp;That</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Have Not<BR>Vested&nbsp;(#)&nbsp;(3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of Shares or<BR>Units
of<BR>Stock&nbsp;That<BR>Have Not</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vested ($) (4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive<BR>Plan&nbsp;
Awards:<BR>Number of<BR>Shares or<BR>Units&nbsp;of<BR>Stock That</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Have Not<BR>Vested (#) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive<BR>Plan&nbsp;
Awards:<BR>Market&nbsp;Value<BR>of Shares&nbsp;or<BR>Units of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock That</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Have Not<BR>Vested ($)
(4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Christopher&nbsp;Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/11/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">21.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/11/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/8/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">112,650</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/8/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/4/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">56,325</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/4/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8/16/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/16/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/21/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/21/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/16/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">170,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/16/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.01</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/6/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">69,991</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">53,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,251</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">33,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">360,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,558,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4/12/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">978,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,234,740</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Kenneth&nbsp;Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/4/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/4/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8/16/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/16/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/21/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/21/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/16/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">68,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/16/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">54,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.01</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/6/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">44,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">31,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">72,164</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">33,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">144,336</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">145,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">627,850</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Bruce&nbsp;D.&nbsp;Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/26/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/26/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/16/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">110,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/16/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/28/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">170,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.01</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5/6/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">44,790</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">216,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">433,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">380,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,645,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Patrick O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/2/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">61,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">28,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5.22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/2/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/2/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">43,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">145,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">627,850</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Peter&nbsp;Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7/20/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2.79</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7/20/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9/21/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,311</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,689</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">53,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">31,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/6/2025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">389,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options are priced at the market closing price on the date of grant. Options have various vesting parameters, but generally vest within 48 months after the award is
granted except for the grants made on 10/8/2009 and 3/4/2010 which vested over 24 months. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">The amounts reported for Christopher Anzalone in this column reflect the January 2016 and April 2017 awards that contain performance-based vesting conditions. These
awards and their vesting conditions are described above in the &#147;Compensation Discussion and Analysis&#148; under the heading &#147;Equity Compensation&#148;. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock units have various vesting parameters. The restricted stock units granted in 2017 vest two years from the grant date. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Value is based on the Company&#146;s Common Stock closing price of $4.33 on September&nbsp;30, 2017. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Options Exercised and Stock Vested Table </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information, with respect to the Named Executive Officers, concerning options exercised or restricted stock
units vested during fiscal 2017. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Acquired
on</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized&nbsp;on</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise
(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Acquired
on</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized&nbsp;on</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting
(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">540,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">685,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">188,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value is calculated as the price of the Company&#146;s Common Stock upon exercise, less the exercise price, multiplied by the number of shares exercised.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value is calculated as the price of the Company&#146;s Common Stock upon vesting, multiplied by the number of shares vested. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Termination Benefits - Potential Payments Upon Termination or Change in Control </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has the following severance or change of control arrangements with its Named Executive Officers: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Anzalone&#146;s employment agreement with the Company provides that, if the Company terminates Dr.&nbsp;Anzalone&#146;s
employment without Cause or if Dr.&nbsp;Anzalone terminates his employment for Good Reason, on his date of termination, Dr.&nbsp;Anzalone will receive a <FONT STYLE="white-space:nowrap">one-time</FONT> lump sum payment equal to the sum of:
(i)&nbsp;one month of base salary and (ii)&nbsp;premiums for thirty (30)&nbsp;days of medical and dental benefits. To receive such payments Dr.&nbsp;Anzalone is required to execute a general release in favor of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of Dr.&nbsp;Anzalone&#146;s employment agreement: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;<B>Cause</B>&#148; means (i)&nbsp;the conviction (by trial or upon a plea of nolo contendere) of a felony or other crime involving moral turpitude or the commission of any other material act or
omission involving dishonesty, disloyalty or fraud with respect to the Company or any of its subsidiaries or any of their customers or suppliers, (ii)&nbsp;reporting to work under the influence of alcohol or illegal drugs, the use of illegal drugs
(whether or not at the workplace) or other repeated conduct causing the Company or any of its subsidiaries substantial public disgrace or disrepute or economic harm, (iii)&nbsp;the engaging of gross misconduct and the failure to cease such conduct
and rectify any harm to the Company resulting therefrom within 30 days after written demand therefor by the Company identifying with reasonable particularity such conduct and harm, or (iv)&nbsp;any other material breach of the employment agreement
by Executive and the failure to cease such breach and rectify any harm to the Company within 30 days after written demand by the Company identifying with reasonable particularity such breach and harm; and </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<B>Good Reason</B>&#148; means (i)&nbsp;Executive&#146;s duties, responsibilities, titles or offices are diminished as compared to
those described in&nbsp;the employment agreement without Executive&#146;s written consent, and the Company fails to reinstate such duties, responsibilities, titles or offices within 30 days after written demand by Executive identifying with
reasonable particularity the diminishment, (ii)&nbsp;the relocation of Executive&#146;s base office to an office that is more than thirty (30)&nbsp;highway miles from Pasadena, CA, (iii)&nbsp;the failure of the Company to obtain a satisfactory
agreement from any successor to assume and agree to perform the obligations under the employment agreement and (iv)&nbsp;any other material breach of this employment agreement by the Company and the failure to cease such breach and rectify any harm
to Executive resulting within 30 days after written demand by Executive identifying with reasonable particularity the breach and harm. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to his offer of employment by the Company, Mr.&nbsp;Myszkowski is entitled to severance pay equal to three months&#146; base salary plus an amount equal to the premiums on his medical and dental
benefits for the same period upon termination of his employment without cause. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to his offer of employment by the Company, Mr.&nbsp;O&#146;Brien is entitled to
severance pay equal to six months&#146; base salary upon termination of his employment without cause only upon change of control as defined in the Company&#146;s 2013 Incentive Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has not entered into a severance arrangement with Dr.&nbsp;Given or Mr.&nbsp;Leone. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additionally, pursuant to the 2004 Equity Incentive Plan and the 2013 Incentive Plan, any unvested awards held by plan participants,
including the Named Executive Officers, become fully vested upon a change of control, except as otherwise determined by the Board and except with respect to the outstanding awards held by the CEO whose awards will only accelerate upon a qualifying
termination of employment following a change of control. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following tables set forth information regarding potential
termination and change of control arrangements with our executive officers had their employment been terminated on September&nbsp;30, 2017: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Termination Payments </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:58pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Triggering Event</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Benefits<BR>($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(1)&nbsp;
($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(1)&nbsp;
($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="font-size:1px">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Termination by Employer without Cause</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,838</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,651</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,489</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,862</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Change in Control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">844,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">935,212</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,294,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,294,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">197,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">671,150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">868,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">389,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">389,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Involuntary Termination Following a Change in Control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,838</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,651</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,793,540</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,847,029</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For stock awards the value is calculated as the number of unvested shares multiplied by the Company&#146;s closing stock price at September&nbsp;30, 2017 of $4.33. For
option awards the value is calculated as the number of shares issuable upon unvested options multiplied by difference between the Company&#146;s closing stock price at September&nbsp;30, 2017 of $4.33 less the applicable exercise price.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Anzalone&#146;s employment contract also provides for payment of the values set forth above upon his resignation for &#147;good reason&#148; as defined in his
employment agreement. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL THREE </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Audit Committee, with the ratification of our Board, selected the accounting firm of Rose, Snyder&nbsp;&amp; Jacobs, LLP (&#147;<B>RS&amp;J</B>&#148;) as the Company&#146;s independent auditors for
the fiscal year ending September&nbsp;30, 2018, and that selection is now being submitted to the stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A
representative of RS&amp;J will be available at the Annual Meeting to respond to appropriate questions or make any other statements such representative deems appropriate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Stockholders are not required to ratify the appointment of RS&amp;J as our independent auditor. However, we are submitting the appointment for ratification as a matter of good corporate practice. If
stockholders fail to ratify the appointment, the Audit Committee will consider whether or not to retain RS&amp;J. Even if the appointment is ratified, the Audit Committee may direct the appointment of a different independent auditor at any time
during the year if it determines that such a change would be in the best interests of the Company and our stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required; Recommendation of the Board </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In order to be ratified, Proposal Three must be approved by a majority of Required Vote, assuming a quorum is present. For this purpose, abstentions will be counted as a vote against the proposal.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE &#147;FOR&#148; PROPOSAL THREE. </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>AUDIT FEES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee regularly reviews and determines whether specific projects or expenditures with our independent auditors, Rose, Snyder&nbsp;&amp; Jacobs, LLP may potentially affect their independence.
The Audit Committee&#146;s policy is to <FONT STYLE="white-space:nowrap">pre-approve</FONT> all audit and permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services provided by RS&amp;J.
<FONT STYLE="white-space:nowrap">Pre-approval</FONT> is generally provided by the Audit Committee for up to one year, detailed to the particular service or category of services to be rendered and is generally subject to a specific budget. The Audit
Committee may also <FONT STYLE="white-space:nowrap">pre-approve</FONT> additional services of specific engagements on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. All engagements of our
independent registered public accounting firm in 2017 and 2016 were <FONT STYLE="white-space:nowrap">pre-approved</FONT> by the audit committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the aggregate fees invoiced by RS&amp;J for the fiscal years ended September&nbsp;30, 2017 and September&nbsp;30, 2016: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year&nbsp;Ended&nbsp;September&nbsp;30,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit fees (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">195,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">185,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit-related fees (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All other fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">208,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">194,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees invoiced by RS&amp;J include <FONT STYLE="white-space:nowrap">year-end</FONT> audit and periodic reviews of Forms <FONT STYLE="white-space:nowrap">10-Q</FONT> and <FONT
STYLE="white-space:nowrap">10-K.</FONT> </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees invoiced by RS&amp;J related to Comfort Letters and Consents for financings and registration statements, and other agreed-upon procedures.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REPORT OF THE AUDIT COMMITTEE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following is the report of the Audit Committee with respect to the Company&#146;s audited financial statements for fiscal 2017, which include the consolidated balance sheets of the Company as of
September&nbsp;30, 2017 and September&nbsp;30, 2016, and the related consolidated statements of operations, stockholders&#146; equity and cash flows for the fiscal years ended September&nbsp;30, 2017, September&nbsp;30, 2016 and September&nbsp;30,
2015, and the notes thereto. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Composition.</B> At September&nbsp;30, 2017, The Audit Committee of the Board was comprised
of three directors and operates under a written charter adopted by the Board. The members of the Audit Committee were Edward W. Frykman, Michael S. Perry and Mauro Ferrari. All members of the Audit Committee were &#147;independent,&#148; as defined
in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act and Rule 5605(c) of the Nasdaq Marketplace Rules, and are financially literate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Responsibilities.</B> The responsibilities of the Audit Committee include engaging an accounting firm as the Company&#146;s independent registered public accounting firm. Management has primary
responsibility for the Company&#146;s internal controls and financial reporting process. The independent registered public accounting firm is responsible for performing an independent audit of the Company&#146;s consolidated financial statements in
accordance with generally accepted auditing standards and for issuing a report thereon. The Audit Committee&#146;s responsibility is to oversee these processes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Review with Management and independent registered public accounting firm.</B> On December&nbsp;8, 2017, the Audit Committee consisted of Edward W. Frykman, Michael S. Perry and Mauro Ferrari. On that
date, the Audit Committee met separately to review the Company&#146;s consolidated audited financial statements and held discussions with management and RS&amp;J. Management represented to the Audit Committee that the Company&#146;s consolidated
financial statements were prepared in accordance with generally accepted accounting principles. The members of the Audit Committee discussed with RS&amp;J matters required to be discussed under the applicable standards of the Public Company
Accounting Oversight Board. The Company&#146;s independent registered public accounting firm also provided to the Audit Committee the written disclosures and the letter required by the Public Company Accounting Oversight Board regarding the
independent registered public accounting firm&#146;s communications with the Audit Committee concerning independence and the Audit Committee discussed the firm&#146;s independence with RS&amp;J. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Conclusion.</B> Based upon the Audit Committee&#146;s review of the financial statements
and discussions with management and RS&amp;J, the Audit Committee&#146;s review of the representations of management and the report of RS&amp;J to the Audit Committee, the Audit Committee recommended that the Board include the audited consolidated
financial statements in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September&nbsp;30, 2017, as filed with the SEC. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This report is submitted by the Audit Committee of the Board. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Edward W. Frykman, Chairman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mauro Ferrari </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Perry </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>VOTING SECURITIES OF PRINCIPAL STOCKHOLDERS AND MANAGEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the beneficial ownership of the Company&#146;s Common Stock as of January&nbsp;19, 2018, by (i)&nbsp;each
of the named executive officers named in the table under &#147;Executive Compensation and Related Information,&#148; (ii) each director, (iii)&nbsp;all current directors and executive officers as a group, and (iv)&nbsp;the holders of greater than 5%
of our total shares outstanding known to us. Unless otherwise specified in the footnotes to the table below, the persons and entities named in the table have sole voting and investment power with respect to all shares beneficially owned, subject to
community property laws, where applicable, and the address of each stockholder is c/o Arrowhead Pharmaceuticals, Inc., 225 South Lake Avenue, Suite 1050, Pasadena, California 91101 unless otherwise indicated. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;and&nbsp;Percentage&nbsp;of&nbsp;Shares&nbsp;Beneficially<BR>Owned (1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>5% Beneficial Owners</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Executive Officers and Directors</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Anzalone (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,596,588</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Myszkowski (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">404,772</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce D. Given (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">851,856</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">154,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Leone (6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">192,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zhen Li (7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Douglass Given (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">215,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edward Frykman (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200,352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Perry (10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">232,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mauro Ferrari (11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">87,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">William Waddill</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Executive Officers and Directors as a group (11 persons) (12)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,085,047</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than 1% </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on 86,787,566 shares of Common Stock issued and outstanding as of January&nbsp;19, 2018. Shares not outstanding but deemed beneficially owned by virtue of the
right of a person to acquire them as of January&nbsp;19, 2018, or within sixty days of such date are treated as outstanding only when determining the percentage owned by such individual and when determining the percentage owned by a group.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 1,139,799 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 322,416 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018 and 16,666 restricted stock units that
vest within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 528,500 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018 and 50,000 restricted stock units that
vest within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 124,375 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 192,708 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 137,083 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 65,000 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 76,500 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 77,000 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 24,845 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 2,688,226 shares issuable upon the exercise of stock options that are exercisable within 60 days of January&nbsp;19, 2018 and 66,666 restricted stock units
that vest within 60 days of January&nbsp;19, 2018. </FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EQUITY COMPENSATION PLAN INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information as of September&nbsp;30, 2017 with respect to shares of our Common Stock that may be issued
under our equity compensation plans. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity Compensation Plan Information</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;to&nbsp;be&nbsp;Issued</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>upon exercise of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>outstanding&nbsp;options,</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>warrants&nbsp;and&nbsp;rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>average</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>exercise&nbsp;price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of&nbsp;outstanding</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>options,</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>warrants&nbsp;and</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>securities</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>remaining</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>available for</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>future&nbsp;issuance</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>under equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>plans&nbsp;(excluding</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>reflected in</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>column (a)) (3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by security holders (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,203,493</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">244,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans not approved by security holders (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">454,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,657,543</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">244,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes options outstanding representing 2,119,286 and 2,986,207 shares of Common Stock under the 2004 Equity Incentive Plan and the 2013 Incentive Plan, respectively.
Also includes 3,098,000 restricted stock units subject to the 2013 Incentive Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 444,050 inducement option grants and 10,000 inducement restricted stock unit grants issued to newly hired employees. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Current Executive Officers of the Registrant </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The names, ages and positions of our current executive officers serving as of January&nbsp;19, 2018 are provided below. Biographical
information regarding these officers is set forth under the following table, except for Dr.&nbsp;Anzalone, whose biography is set forth above with our other directors. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position with Arrowhead</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher&nbsp;Anzalone</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer&nbsp;&amp; President and Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth A. Myszkowski</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bruce Given</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Operating Officer</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick O&#146;Brien</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Zhen Li</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Chemistry&nbsp;&amp; Manufacturing</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Kenneth A. Myszkowski,</B> Chief Financial Officer, joined Arrowhead in 2009. Prior to joining
Arrowhead, Mr.&nbsp;Myszkowski served as the corporate controller for Broadwind Energy, a public energy company which provides products and services to the wind energy industry. Previous to his position at Broadwind, Mr.&nbsp;Myszkowski was
controller for Epcor USA, the U.S. headquarters for Epcor Utilities, Inc., a public energy company. Prior to Epcor, Mr.&nbsp;Myszkowski was controller for two <FONT STYLE="white-space:nowrap">start-up</FONT> ventures: NanoInk, specializing in Dip
Pen Nanolithography, a nanofabrication technology, and Delphion, which provided <FONT STYLE="white-space:nowrap">on-line</FONT> tools for intellectual property research. Mr.&nbsp;Myszkowski also held several corporate roles at FMC Corporation and
Premark International, both Fortune 500 conglomerates. He began his career in the audit practice of Arthur Andersen&nbsp;&amp; Co. in Chicago, Illinois. Mr.&nbsp;Myszkowski received his undergraduate degree from the University of Illinois, and his
MBA from the University of Chicago Booth School of Business. He is a certified public accountant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dr.</B><B></B><B>&nbsp;Bruce Given</B>, Chief Operating Officer, joined Arrowhead in 2011. Dr.&nbsp;Given was a member of the Board of
Directors for ICON, plc. from 2004 until his retirement in 2013 and Chairman of its Board of Directors from 2010 to 2013. Dr.&nbsp;Given served as the President and Chief Executive Officer, and as a member of the Board of Directors of Encysive
Pharmaceuticals, an <FONT STYLE="white-space:nowrap">R&amp;D-based</FONT> commercial pharmaceutical company, roles he held from 2002 through 2007. Subsequent to his tenure at Encysive until 2011, Dr.&nbsp;Given was President of Bruce Given
Consulting, a firm that provides consulting services to biotech companies. Since October&nbsp;1, 2009, Dr.&nbsp;Given has been a director of Calando Pharmaceuticals, Inc., and from February&nbsp;2010 until its dissolution in October 2014,
Dr.&nbsp;Given was the Chief Executive Officer of Leonardo Biosystems, Inc., in which Arrowhead held a minority equity interest. Prior to his tenure at Encysive, Dr.&nbsp;Given held several senior executive roles at Johnson and Johnson, Sandoz
Pharmaceuticals and Schering-Plough. Dr.&nbsp;Given obtained his bachelor of sciences degree from Colorado State University, graduating Phi Beta Kappa. He received his M.D. degree with honors from the University of Chicago, Pritzker School of
Medicine and completed his medical training at the University of Chicago and at Brigham and Women&#146;s Hospital in Boston, where he was a Clinical Fellow at Harvard Medical School. He is board certified in internal medicine and endocrinology and
metabolism and has authored 33 scientific publications. Dr.&nbsp;Bruce Given is a brother of Dr.&nbsp;Douglass Given, a director of the company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Patrick C. O&#146;Brien</B>, General Counsel, joined the Company in December 2014. Mr.&nbsp;O&#146;Brien has practiced in the healthcare legal field for over 20 years. Before joining the Company, from
2012 to 2014, Mr.&nbsp;O&#146;Brien was with Shire, as global pharmaceutical company, where he was Group Vice President, Law. Immediately prior to working with Shire he was a partner with the international law firm of Holland&nbsp;&amp; Knight LLP
in its Washington, DC office. In 2010, Mr.&nbsp;O&#146;Brien <FONT STYLE="white-space:nowrap">co-founded</FONT> the law firm O&#146;Brien Gould PLLC which joined Holland&nbsp;&amp; Knight in 2011. From 2009 &#150; 2010, Mr.&nbsp;O&#146;Brien was a
partner in Burke O&#146;Neil LLC. From 2001&#151;2009 Mr.&nbsp;O&#146;Brien served in several legal roles with Johnson&nbsp;&amp; Johnson, including serving as Vice President of Law for J&amp;J&#146;s Centocor Ortho-Biotech unit.
Mr.&nbsp;O&#146;Brien previously served as Regulatory Counsel with the United States Food&nbsp;&amp; Drug Administration. Mr.&nbsp;O&#146;Brien was awarded a BS in Pharmacy and a PharmD from the University of Arizona before completing a residency in
Clinical Pharmacy with the University of Illinois at Chicago Hospital. He was also awarded his JD from the University of Arizona. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Dr.&nbsp;Zhen Li</B>, Senior Vice President, Chemistry&nbsp;&amp; Manufacturing, joined the Company in March 2014. Prior to joining Arrowhead Pharmaceuticals, she was Director of Chemistry, RNAi
therapeutics, Process Chemistry at Merck, a global pharmaceutical company, from 2009 to 2013. Prior to her tenure at Merck, she held leadership positions at Schering-Plough and Novartis, and led teams in drug discovery and process development in
small </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
molecule pharmaceuticals as well as RNAi therapeutics covering a range of disease areas. Dr.&nbsp;Zhen Li was Director of Chemistry at Merck Research Laboratory and led a team in research and
development in the field of siRNA. She led multiple development programs from early to late stage at Schering-Plough. Dr.&nbsp;Zhen Li served as the Head of Process and Analytical Research&nbsp;&amp; Development at Novartis Chuangshu. She began her
pharmaceutical career at Merck where she did research in medicinal chemistry and process development. Dr.&nbsp;Zhen Li received her bachelor of science degree from Peking University and her Ph.D. from Harvard University. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under Section&nbsp;16(a) of the Securities Exchange Act of 1934, the Company&#146;s directors and officers and its significant stockholders (defined by statute as stockholders beneficially owning more
than ten percent (10%)&nbsp;of the Common Stock) are required to file with the SEC and the Company reports of ownership, and changes in ownership, of Common Stock. Based solely on a review of the reports received by it, the Company believes that,
during the fiscal year ended September&nbsp;30, 2017, all of its officers, directors and significant stockholders complied with all applicable filing requirements under Section&nbsp;16(a). </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REVIEW AND APPROVAL OF RELATED-PARTY TRANSACTIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Board has adopted policies and procedures for the review and approval of related-party transactions and has delegated to the Audit Committee the authority to review and approve the material terms of
any proposed related-party transactions. To the extent that a proposed related-party transaction may involve a <FONT STYLE="white-space:nowrap">non-employee</FONT> director or nominee for election as a director and may be material to a consideration
of that person&#146;s independence, the matter may also be considered by the other disinterested directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our
Code of Business Conduct and Ethics and our Corporate Governance Committee Charter, each of our officers, directors and employees must disclose related-party transactions to our Board of Directors. In order to avoid conflicts of interest, our
executive officers and directors may not acquire any ownership interest in any supplier, customer or competitor (other than nominal amounts of stock in publicly traded companies), enter into any consulting or employment relationship with any
customer, supplier or competitor, or engage in any outside business activity that is competitive with any of our businesses, without first disclosing the proposed transaction. After the proposed transaction has been disclosed, a determination will
be made by our Board or Audit Committee as to what course to follow, depending on the nature or extent of the conflict. Furthermore, our executive officers and directors may not serve on any board of directors of any customer, supplier or competitor
unless such board service has been disclosed to us and approved by our Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining whether to approve or ratify a
related-party transaction, the Board and/or Committee may consider, among other factors it deems appropriate, the potential benefits to us, the impact on a director&#146;s or nominee&#146;s independence or an executive officer&#146;s relationship
with or service to us, whether the related-party transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related party&#146;s interest in
the transaction. In deciding to approve a transaction, the Board or Audit Committee may, in its sole discretion, impose such conditions as it deems appropriate on us or the related party in connection with its approval of any transaction. Any
transactions involving the compensation of executive officers, however, are reviewed and approved by the Compensation Committee. If a related-party transaction will be ongoing, the Audit Committee may establish guidelines to be followed in our
ongoing dealings with the related party. Thereafter, the Audit Committee reviews and assesses the ongoing relationship with each related party to see that it is in compliance with the committee&#146;s guidelines and that the related-party
transaction remains appropriate. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of September&nbsp;30, 2017, a majority of the members of the Board are independent directors, as defined by the Nasdaq Marketplace
Rules. The Board has determined that all of the Company&#146;s directors are independent, except Dr.&nbsp;Anzalone, the Company&#146;s Chief Executive Officer, and Dr.&nbsp;Douglass Given, the brother of the Company&#146;s Chief Operating Officer. <FONT
STYLE="white-space:nowrap">Non-employee</FONT> directors do not receive consulting, legal or other fees from the Company, other than Board compensation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Vincent Anzalone is the Company&#146;s Vice President, Investor Relations and the brother of Christopher Anzalone, the Company&#146;s Chief Executive Officer. Vincent Anzalone earned base salary and bonus
of $228,461 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
during fiscal 2016 and $64,167 thus far in fiscal 2018. His current base salary is $220,000. In January 2016, Mr.&nbsp;Anzalone was awarded options to purchase 40,000&nbsp;shares of the
Company&#146;s Common Stock at $6.15 for performance in 2015 which vest over four years from the date of grant. The exercise price is equal to the fair market value of the shares on the date of grant. The grant date fair value of the option is
$184,383. In January 2017, Mr.&nbsp;Anzalone was awarded 65,000 restricted stock units for performance in 2016, and this award vests two years from the anniversary date of the grant. The grant date fair value of this award is $100,750. In January
2018, Mr.&nbsp;Anzalone was awarded 35,000 restricted stock units for performance in 2017, and this award vests in four annual tranches from the grant date. The grant date fair value of this award is $128,800. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>The Company will mail, without charge to any stockholder upon written request, a copy of the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended
September</U><U></U><U>&nbsp;30, 2017 including the financial statements, schedules and a list of exhibits. Requests should be sent to Arrowhead Pharmaceuticals, Inc., 225 S. Lake Avenue, Suite 1050, Pasadena, CA 91101, Attn: Corporate Secretary,
Phone (626)</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;304-3400.</FONT> </U> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stockholders Sharing the Same Address
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may satisfy SEC rules regarding delivery of proxy statements including the proxy statement, annual report and Notice,
by delivering a single Notice and, if applicable, a single set of proxy materials to an address shared by two or more of our stockholders. This delivery method can result in meaningful cost savings for us. To take advantage of this opportunity, we
may deliver only one Notice, and if applicable, a single set of proxy materials to multiple stockholders who share an address, unless contrary instructions are received prior to the mailing date. Similarly, if you share an address with another
stockholder and have received multiple copies of our Notice and/or other proxy materials, you may write or call us at the address and phone number below to request delivery of a single copy of these materials in the future. We undertake to deliver
promptly upon written or oral request a separate copy of the Notice and/or other proxy materials to a stockholder at a shared address to which a single copy of these documents was delivered. If you hold stock as a record stockholder and prefer to
receive separate copies of a Notice, and if applicable, other proxy materials either now or in the future, please contact us at the address provided below. If your stock is held through a brokerage firm or bank and you prefer to receive separate
copies of a Notice and, if applicable, other proxy materials either now or in the future, please contact your brokerage firm or bank. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arrowhead Pharmaceuticals, Inc. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">225 S. Lake
Avenue, Suite 1050 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pasadena CA 91101 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Attn: Corporate Secretary </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Phone <FONT
STYLE="white-space:nowrap">(626)&nbsp;304-3400</FONT> </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Matters </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company knows of no other matters to be submitted at the Annual Meeting. If any other matters properly come before the meeting, it is
the intention of the persons named in the proxy card to vote the shares they represent as the Board may recommend. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BY ORDER OF THE BOARD OF DIRECTORS</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Jane Davidson</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jane Davidson,</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pasadena, California</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">January&nbsp;25, 2018</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g502300img01.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ARROWHEAD PHARMACEUTICALS, INC. 225 SOUTH LAKE AVENUE, SUITE 1050 PASADENA, CA
91101VOTE BY INTERNET Before The Meeting&#151;Go to www.proxyvote.comUse the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the
<FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.During The
Meeting&#151;Go to www.virtualshareholdermeeting.com/ARWR2018You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.VOTE BY <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903Use</FONT></FONT></FONT> any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day
before the <FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you call and then follow the instructions.VOTE BY MAILMark, sign and date your proxy card and return it in the postage-paid envelope
we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:E35946-P00586 KEEP THIS PORTION FOR YOUR RECORDSTHIS PROXY CARD IS VALID ONLY WHEN
SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLYARROWHEAD PHARMACEUTICALS, INC. For Withhold For All To withhold authority to vote for any individual All All Except nominee(s), mark &#147;For All Except&#148; and write the The Board of
Directors recommends you vote FOR number(s) of the nominee(s) on the line below. the following:1. Election of Directors ! ! ! Nominees: 01) Christopher Anzalone 04) Douglass Given 02) Mauro Ferrari 05) Michael S. Perry 03) Edward W. Frykman 06)
William WaddillThe Board of Directors recommends you vote FOR the following proposals:2. To approve the compensation paid to the Company&#146;s named executive officers, as disclosed pursuant to Item 402 of Regulation
<FONT STYLE="white-space:nowrap">S-K,</FONT> including the compensation tables and narrative discussion.3. To ratify the selection of Rose, Snyder&nbsp;&amp; Jacobs LLP as independent auditors of the Company for the fiscal year ending
September&nbsp;30, 2018.NOTE: Such other business as may properly come before the meeting or any adjournment thereof.For Against AbstainPlease sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other
fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.Signature [PLEASE SIGN WITHIN
BOX]DateSignature (Joint Owners) Date </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g502300img02.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Notice and Proxy Statement and Form <FONT STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com.E35947-P00586ARROWHEAD PHARMACEUTICALS, INC. Annual Meeting of Stockholders March&nbsp;16, 2018 10:00 AM PTThis proxy is
solicited by the Board of DirectorsThe stockholder(s) hereby appoint(s) Christopher Anzalone and Jane Davidson, or either of them, as proxies, each with the power to appoint (his/her) substitute, and hereby authorize(s) them to represent and to
vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of ARROWHEAD PHARMACEUTICALS, INC. that the Stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 10:00 AM, PT on
March&nbsp;16, 2018, online at WWW.VirtualShareholderMeeting.com/ARWR2018, and any adjournment or postponement thereof.This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be
voted in accordance with the Board of Directors&#146; recommendations.Continued and to be signed on reverse side </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g502300003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g502300003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 3@$M P$1  (1 0,1 ?_$ )4  0 !! (# 0
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MZ'<\9WR%:6.DY!JT[3+; OB^II,5RRQKF(F8];I\Q"NF#M0H&+T,01 P" @
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M]NA>JCC?'TG1ZQL(IB^\RN#IJS3T;67F37#RI1<),/X%TQFSRC5A)%2BB P
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MA5!W(Q3,,TXIEGM0S;2;LO#N)"+>E;,5H\A3(F3,4Q#<#<QP' <!P' <!P'
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M+5*)T>=8C24F[ LPL4+G!+-*MOB7M?:PCZ+MT(NWJCUP4LJS71 /=.@(B!Q
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<' <!P' <!P' <!P' <!P' <!P' <!P' <#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g502300graaa.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g502300graaa.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!V17AI9@  34T *@    @  8=I  0
M   !    &@       9*&  <   !     +     !53DE#3T1%  !, $4 00!$
M "  5 !E &, : !N &\ ; !O &< :0!E ', ( !) &X 8P N "  5@ Q "X
M,  Q  #_VP!#  D&!P@'!@D(!P@*"@D+#18/#0P,#1L4%1 6(!TB(B ='Q\D
M*#0L)"8Q)Q\?+3TM,34W.CHZ(RL_1#\X0S0Y.C?_VP!# 0H*"@T,#1H/#QHW
M)1\E-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-S?_P  1" $V CT# 2(  A$! Q$!_\0 'P   04! 0$! 0$
M      $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A
M,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'B
MX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%
M!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B
M,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'
M2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:
MHJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ
M\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#U.SMI=1GOI'U&\C$=RT:+#( H  ]O
M>K/]CM_T%-2_[_#_ .)I="^]J7_7])_):U* ,K^QV_Z"FI?]_A_\31_8[?\
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MH]DLDK)'$C;1(TBX;@'.<\=>] %3^QV_Z"FI?]_A_P#$T?V.W_04U+_O\/\
MXFKSW<$:*[SQ*C#(9G !'K4P.0#0!E_V.W_04U+_ +_#_P")H.C,1@ZIJ7_?
MX?\ Q-:M% &5_8S=M4U+_O\ #_XFC^QV_P"@IJ7_ '^'_P 36K10!E?V.W_0
M4U+_ +_#_P")H_L=O^@IJ7_?X?\ Q-:M% &5_8[?]!34O^_P_P#B:/[';_H*
M:E_W^'_Q-:M% &5_8[?]!34O^_P_^)H_L9CC.J:EQ_TV'_Q-:M% &5_8S?\
M04U+_O\ #_XFC^QV_P"@IJ7_ '^'_P 36K10!E?V.W_04U+_ +_#_P")H_L=
MO^@IJ7_?X?\ Q-:M% &5_8[?]!34O^_P_P#B:/[';_H*:E_W^'_Q-:M% &5_
M8[?]!34O^_P_^)H_L=O^@IJ7_?X?_$UJT4 97]CM_P!!34O^_P /\*H%Y[#4
MI[87L\B>3&X\YP2"2X/;V%=)7.ZA_P AV?\ Z]HO_0I* +N@G+:D>1_IS]?H
MM:M9>A_?U+_K^D_DM:E !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &?K4,TUM'Y$32LD\<A12 2%8$]2!5"]MKN>>YE^P-(+FV$*J[)F(
MY;KST.0>,GCI6_10!SIT>X$=U\B/,TEN4D)&3LVY/Z&J.DEVU8*[IDRW C\H
MCS8MS$DN"#QP,?45V%07=Q'9VLUS,3Y<2EVP.<#F@#-NK"Y-Y#(I>?\ <20F
M9M@9"Q4ACC' P>@S6;_85R^GO"\<K2^5%"5D:+8P5@3C:!D<'[W/M6\M^6$;
M-;2QJ[8)D*C P3GKTXJP;B)02TB  ;B2PX'K0!BZKI$MU-J+)!&PEL1#$3C[
MV6./;J*M6]E/!/?M#%&JR1((E/W2P4@Y [=*O2W<,4/FM(FTC*_,/F^GK26U
MY'<6\$P^43*&56Z\C.* .<&DW\YE,\+$2"W#+(8P/D?+<+QC'3/-6YM.N([Z
M2X2W$D(NQ*(5*C</*"Y /&<^N*VFN84&6E11G;DL!SZ4IN(@^PR('_NEAF@#
M,T^QD@T:6VGM(VWR2DVX8;2K,3@=NA]JJ0Z5=&2'=')]ECNUDCAN) [1J%(/
M.3W/ R?PZ5O)<12 %)$8,<*58'-!N(5VYE0;CA<L.3[4 8<6G75K<I-]D$\:
MO<;859?E#OE2,D#IQ^-.TG2)[:Z22X1&V68A#YS@[B2![8(_*M&]U..TE$31
M32-Y9D/EJ#M4'!/6IXKR"58V25#YJAD&[EAZ@4 4-)L[B*QMH9&FMV@&UD7R
MRLOOT)Q^1K._LN]6.V'DR@6\LNY8C$2X8DAEW9'0XYP>?SV;_5;6RMVE>1&(
M(4(KC)). /;FIX[J.0A=R"0J&*!P2* ,>QTB2VN)&,>0+)(8V=@S @MD<8]1
MVJ"+0Y5M8$-M$'72S;MT_P!80/ZYYK?^UP8),T>!U.\<=Z<ES$YQ'(C';NPK
M \>M &;-:W,;Z?<QQ>:]O&4DB# $A@,D$\9! ZD5!=6UQ-JD%Y)87#H(&39'
M,H93N!&?F Z>YK86YA92RR(R@XW!@1GTI#=VXC$AFC",<!MXP30!F1P7EF]X
MD5J9A<2&6-PZ@*2 "'R<\8[9I#ID]K::8(%$KV/WD!QO&TJ<9[\]ZUO/C\SR
M]Z^9C.W/./I4-S?Q6UQ##+\OFAB&)  VXZ_G0!0N(KJ2]BO&L&D41/'Y)=-R
MDD<\G;SC'4]JS_[ N?LEW'+%'+(]@D*$D'Y@6) SVY6NE-Q$NP-(@+_=!8?-
M]*/M$>]DWIO499=PR!ZF@#G-4L9(9&9;9'CDN[;9&" &V\'Z=J'TF\\Q;@1R
MJC32N;>(Q%D#!0#\V5SP<\_Q<5T)N8?*\TS1B/\ O[QC\ZK#5838?;-DFPR>
M6% !).[:/UH RVT2407D:Q!RUG%#"TC ME=V<GCU7\JD:QOH[R9K2$;75V87
M!5D9RN 5Q\PR<9!XQFM2WU*WF60L3"8GV2++A2IQD9[=Q5CSH\$[UPHR?FZ"
M@#FDTN^*W$LD$C%GMW5)&C!;8V6'R_*..G/XU.NGW<=ZUV;4R1_:FD$ 9=V&
MC501DXR"#W[UT(.:6@#G+31YU>-KB&,@6\ZA<@A"[@A1^'%;6FQ20:=:Q3<2
M)$JMSGD 9JS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5SFHG_ (GL_7_CVB_]"DKHZYW4/^0[<?\ 7M%_Z%)0!=T'.[4L\'[<_P#)
M:U:RM#^]J7_7])_):U-PH 6BDW"C<* %HI-PHW"@!:*0'-+0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %4M:MY+K2+RWA7=))"RJ,XR2*NT4 8EYI\
MX6Q,:R7/DR%Y%D<$X\MACGW(%9<&C:C#;B)XRVV:.7,;*24 (\L;N/D.,9X/
MUKKZ* .8&ESPHH^R274;P2)Y<S1YC9FSDX^7'^[G'O5Z2RN%T6S1(PUY:+&R
M*".67 (S[C(_&MFB@#EYM&N<0%HY'5H7$RQ>62)'.6/S\8[9'/%68M)96U+S
M8&D\^)(T?>-[ ( >>Q^M;]% '-PV5_&UI,]NSBWN'*Q@1K(R&,KEL':3G]*C
M33;Z."V9+<_:EW Y9'B ,F[# \_BO-=110!D7NG/>:FDCM*L'V=HV,;[226'
M'KC%4WT>7^TG(280&2)HC$8PL:H!\IR-PY!Z>M='10!S@T>4:/Y'V9//:\\U
MNG*^=NSG_=_PHATVZ62*+[-M:.[:=KH%<,I)X'.[."!TQQ71T4 <Y;:-(ECH
M\+VT>8)O,G7C'W6Y]^2*;!I-S;"%K>UB61'N202,$-NV X[=*Z6B@#E(]*OI
M3(9[=MLCVQ*2>6,['R_"\8Q^)J?^SKB#59;@60GM2\FV%2G&Y4^;!('4,#WY
MKI** .<ATJX_M%I)5F ^T&9)$,>T#;@ DC=[8Z5/?6-Q]JL9FA;4%@\S?O\
M+##< !@<#UK<HH Y*YTK4_L4=JL(;$0PR%/E;>3M);G & -M2W^EWTLMPEI$
MZ12L7D,IC.[E3A#U&0""&&.:ZBB@#FX].GB>*X^RSS)Y[/);R&('E-H( POZ
M]S3X],N?^$?CL_*$4JW 8HC#Y%\W=P?85T-% &)>Z?+"B+9Q-*))2T[ML:0_
M+@$%^/0?3I66-/NH7TRR8#=<0".Z7.<+&0<^_!V_B*Z^DQS0 #@4M%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SFHY_MV?
M_P"7:+O_ +4E='7.ZA_R';C_ *]HO_0I* +FAYSJ6>?]-?\ DM9MP;W-R(!<
M%#-F239+D\-A  PXSM^9#@Y&>]:FA?>U+_K^D_DM:E &!>R74TJ-:_:-X4!
MA;8'!._=V/X_A5=/M0D1A]O$6X&(R,_!RN_?GM][[W'7':NGHH YRY>XEN&E
MA^V&-CN)3>%,1"XVC^]][I\W6G0K>?:+7?\ :C]TKDMC;EL[^V<;>O/ZUT-%
M %>YN#;Q;PA<EU4*#C)) '\Z9Y]W_P ^8_[^C_"EU'_4Q_\ 7>+_ -#6K5 %
M3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/
M\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\
M/F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/\*MT4 5//N_^?,?]_1_A
M1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\
MQ_W]'^%'GW?_ #YC_OZ/\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %
M3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/
M\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\
M/F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/\*MT4 5//N_^?,?]_1_A
M1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\
MQ_W]'^%'GW?_ #YC_OZ/\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %
M3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/
M\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\
M/F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/\*MT4 5//N_^?,?]_1_A
M1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\
MQ_W]'^%'GW?_ #YC_OZ/\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %
M3S[O_GS'_?T?X4>?=_\ /F/^_H_PJW10!4\^[_Y\Q_W]'^%'GW?_ #YC_OZ/
M\*MT4 5//N_^?,?]_1_A1Y]W_P ^8_[^C_"K=% %3S[O_GS'_?T?X4>?=_\
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M_O+^=&]?[R_G1L7^Z/RHV+_='Y4 &]?[R_G1O7^\OYT;%_NC\J-B_P!T?E0
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M_'Q-T^Y_7M72#I7.>'/^/B;_ '/3W_S]:Z,=* "BBB@ HHHH **** "BBB@
MKEM7GF34)52:15!& &.!Q_*NIKDM:_Y"4O/<?R_SQ0!6^TW'_/Q+Q_MG]:/M
M-Q_SWE],;C_G-1>O^?\ /]*.P_+K^G_UZ )?M-Q_S\2_4.:/M-QU^T2?]]G'
M_P"JHNY_S_G^M';_ .M_G\J )?M%QT^T3>GWSG_]='VFX_Y[R_@YYJ+O_P#7
M_3_Z]'8_Y_S_ %H E^TW'_/Q+SS]\_YQ1]IN/^?B7CU<_K47I_G\?_K4>O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JZ=_P >[_\
M7>;_ -&-6/J'_(=G_P"O:+_T*2MC3O\ CW?_ *[S?^C&K&U'/]NSX_Y]HO\
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M;_F/\:Y763G49<C'3K]/Y4 4?7_/^?ZT>G^'Z_\ UJ/7^O\ 7^E'IUZ_C_\
MKH .Y_S_ )_I1V_IG_/YT?YX_P ]/6CMV_'I_P#JH ._]<?K_P#6H['_ #_G
M^E+W[_CU_P#UTG^>/Z?UH .X_+K^G_UZ/7_/^?ZT>G3I^'_ZJ/7^O]?Z4 '8
M?SQ^O_UJU/#W_'^W;Y#Q67Z=>OX__KK3T D7I(4GY#]V@#J**9O;_GF_YC_&
MC>W_ #R?\Q_C0 ^BF;V_YY/^8_QHWM_SR?\ ,?XT /HIF]O^>3_F/\:-[?\
M/)_S'^- #Z*9O;_GD_YC_&C>W_/)_P Q_C0 ^BF;V_YY/^8_QHWM_P \G_,?
MXT /HJN]W'&=LGR'&<,RCC\Z3[=!_?7_ +[7_&@"S15;[=!_?7KC[Z]?SI/M
MUOUWIC&?]8O3\Z +5%5OMT ZNO'7YU_QH^W09QO7.<??7KZ=: +-%5OMT']]
M>?\ IHO^-)]N@_OITS_K%Z?G0!:HJM]N@_OKUQ]]?\:/MT']]>N/OK_C0!9H
MJLM["S!596)Y #J<_K4V]O\ GF_Z?XT /HIF]O\ GD_YC_&C>W_/)_S'^- #
MZ*9O;_GD_P"8_P :-[?\\G_,?XT 0:=_Q[O_ -=YO_1C5CZA_P AVX_Z]HO_
M $*2M?33FV;@C]_-Q_VT:L?4AG79^2/]&BZ8_O24 7M$&6U('_G^D_DM:8C4
M9P.IR<=ZS-!&&U(?]/S_ ,EK5H 8D2(,(H49)X]32E000>AIU% #%C55"JH"
MKP .U+M'O3J* *FHC$,>/^>\7_H:U;JKJ/\ J8_^N\7_ *&M6J "BBB@ I".
M#2TAZ&@#D-3_ .0A/U^^?\_YZU4]:MZI_P A"?\ W^_^?_U54_SQ0 >GY=?\
M\>]'<_Y_S_6CL.GK^'^'M1W/]: #M^.?\^_M1W_S_G_"CMWZX_'_ !]Z._X=
MJ #L?\_Y'O1W'^?\GVH['IZ\_P">GM2]QU_'U_Q]Z $]:.PZ>G7_ #Q[T?YX
MH[#IZ_A_A[4 ;'AS_CXFZ_<]/>NB'2N=\.?\?$W7[@KHQTH **** "BBB@ H
MHHH **** $Q7)ZU_R$I?J#^G^>*ZVN2UK_D)2_4?GC^?O0!1]?\ /^?Z4=A^
M77_/'O1_G_/]?6CL.GK^'^'M0 =S_G_/]:.WX_Y__51W/]:.W?.>W^>OO0 =
M_P /7_/'O1V/^?\ /]:._;IV]/\ #VH['^M !W'Y_P"??VH]?\_Y_I1W'7T_
M'_'WH_R,?Y__ %T '8?EU_SQ[UJ>'O\ C_;_ '#67V'3_P"M_A[5J>'O^/\
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M_P *.Q_S_G^M'I_G\?\ ZU !W/\ 7_/6CTZ]>W7_ /7ZT>O^?\_7M1V'^?\
M/U[T 6]*_P"0C!T^]_G_ #ZUV KC]*_Y",'^_P"E=A0 4444 %%%% %73O\
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M^&/\*.Y_K_7^E'I^?3]?_K4=_P#/^?\ "@ [=^OX_P#ZZ._X=OZ?UH[?I_\
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M 8^8G&X]^QP>WY5=\Q<?ZV/_ ,"C_P ]/I_GK0\B[&_>Q_=F_P"7H_WQ[?\
MZ^M %)K5ESF1/EW'C/;\.OO6EHENT-ZQ9D. 5.W/7 /I44TBXE_>QGY9?^7H
MGL/;G^M7]/<-=RXD1OG_ (;@O_ .W]: ->B@44 %%%% !1110 4444 %%%%
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MVL]J6@?Y-I5C(,1+ELJ>?0@<9_2MZB@"GJ(/V>/'!\^+K_OK5G$G]]?^^?\
MZ]0:C_J8_P#KO%_Z&M6J &8D_OK_ -\__7HQ)_?7_OG_ .O3Z* &8D_OK_WS
M_P#7I,2?WU_[Y_\ KU)10!A7LC"Y<&;D&/I(H_CJNTK8;]\?^6G_ "U3^_\
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M_P#UZ,2?WU_[Y_\ KT^B@!F)/[Z_]\__ %Z,2?WU_P"^?_KT^B@!F)/[Z_\
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M (?LEO\ \\(NW\ H^R6__/"+_O@5-10!#]DM_P#GA%W_ (!WH-K;G.8(N?\
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M)6CF1;I5\Q65?W6=H8Y;OSST]/>M>B@"M#;LD[S2.'=E5>!@ #T_$YJS24M
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MH[=*:]K;R(4D@B92""K("""<G]>: ,N]OKHV5G)''-#+-/Y;H@7=C#=-_'.
M>>U5[77I#]CB:-999%"R;<C#X)QTQ_#ZUMM9VKP+ UM"85Z1F,;1^'2C[':[
M@WV:'<J[0?+&0/3Z4 8[Z].!&B6ADG8,7C4.=NW'R_=Z_,/:I;'49[S48PP2
M.%X9&5 V6^5U7YACCO6B;"S,2Q&TMS$IRJ&,8!]0*DCMH(I&DCAC1WY9E0 M
M]30!BV>H7?D))()&DGE\N/SBBQ_Q<C;D]!W[D5+'KF^$,T<8)6,C$F02SE.#
MWZ9K0_L^R D L[?$O^L B7YOKQS20Z?;1+&ODHQCSL9U!*Y.>#VH R;;6+H-
M<32I&UM$ 6RV&5=[*S=,< 9_"MBSN&N[-9]FP2 L@!R2O\)^I&#27%A;S1.A
MB12Z-&750&"MUP:L1HL<:HHPJC 'H* ,ZPGGDE*S&7&PGYPF,[B.U9SW=ZMG
M=;[ITN80LF%5&0J20"#@_+QWYXKH\5%':6T:NL=O$BN<L%0 ,?4T 4[.XE2>
M\BF=Y5M]F#L&XY7)X _I4>K7<BI:F!YXA*Y!V0[G^Z3C:0?3TK4"(K%E4 MU
M('6@HK$$J"5Y!(Z4 <_'KMXL,AFLB6@C;S2 P =4W'G&,9XZYY%+)?7Z:B@=
M8L/&BK&)#M#,6Y)Q[5M-:6SRF5[>%I"-I<H"2.F,TZ2W@E5EEAC=6&&#*""/
M2@#'&MW!$NVUC(ABWO\ O#R=[+@<=,KG/O3O[:GA=A=P0HBLZ;ED)Y5=V>G3
M%:_V>$+M$,>W:%QM&,#H/I0T$+9W1(<Y)RHYR,'].* ,0:]<-&2EM'N02F3<
MS+@)MZ C/.[OZ5(=;E^Q-=?9T*M($B16+-][;\P _EFM6.UMXTV1V\2+@C:J
M #!Z_P A^5'V2VQ(/L\6)?\ 6#8/G^OK0!CWVHWK6EFT44T,TLC*R(%W<!B/
MOXX. >><4D&OR2-;1Q0K.\L6?E)7+^7OQDC _/O6NUC9M"L#6L!A7[L9C&U?
MH*5K.U9M[6T);;MW&,9QTQ]* ,AM>FS&D=H99-I:145\C#8P/EX/7K@5)I^H
MSW=XK,$6)[;S4C1LGEN,\<&M(V%FT:1FT@*1G**8QA3[#M3X[>")F:*&-&8D
ML54 DGKF@#(BU&6*PCO9+A)7N%4K"5X5CV&T%CCISG\*BFUNXEL3+'$(1+;>
M9$Y)^9L9P.,<>_-;)L+-O,S:P'S#F3,8^?Z^M*+*U#EQ;0ABNTL(QDKZ?2@#
M-N-1N1I5[(46.X@;9^[.X'A3D9'^UWJ"VU:Z1)(60//&9&;SV"D*NT@$KD%L
M,.G%;CPQ.CH\:,K_ 'E*@AOKZU']ALQ$D0M8/+0[D3RQA3Z@=J ,J379DS(;
M5/)WE 2YW9V!N1CCO4\FKN)RJ0J85N/)>7<2 <+CH.IW'VXK2:"%L[HD.22<
MJ.<C!_3BHQ8V8\O%K /+.4Q&/E/MZ4 5M7N9+>T\R$C?O Y&:J6VH3RV*S,P
M+-<K'G QM)'^-;>!Z4R:"&>,QSQ)(AZJZ@@_@: ,:]GNX+F_*7CE(+7ST0HF
M 3NXZ9QP.]:JW S'&RN6=<Y"':/J>@IZVT")L2&-5V[=H4 8]/IS4F .E '/
MMJ-W#-=S?O98+=I=Z&/"@*/EVMC))/UJ2/5[Z:7R%LUC;RW?>Y91@;>@*Y_B
M_2ML1H 5"* >HQUJ*&SM8.(+:&,<_<C Z]>GT% &';ZM=6MG&9528I%$\K-(
M=S;S@8XJ8:U>&!)/LL&3%'*1YIX#M@#IUK7:UMV=':"(M&,(Q094>@]*=Y$.
M,>4F,!<;1T'04 8LFOM&8T>%/,\[RY%4L<?/MR#C'7UQ3O[;G"@O;1#S,>5^
M\./OA/FXXZ@\5K-:6SLK-;Q,RDE24!()ZXI6MX64JT,94J5(*C!!ZCZ4 9::
MO</??91:[]C*DK1[F )[@XQ@>Y]:KSZE<P:O(KLRVB3*A)"[ #'NZ_>SG\*V
MOL5KOC?[-#NB&(V\L90>@]*7[);>>;C[/%YQ&#)L&[TZ]: ,:+7Y7B:3[.-D
M<@61_FPJE00<8SW],4L&NSSPK(+/8)2@B9]RK\Q[DCT],UJBPLP% M( $;<H
M\L?*?4>]+]AL\2#[+!B7_6#RQ\_U]: ,C[;=-I5M(CN9I;EHV,)0G&YON[N.
MPZU,-5FCF6(QAE$B0L9' D+%=V< 8Z>GO6F]K;R0^3);Q-%U\MD!7\JBDTZT
M9HF6"-'B(V,B $ =!TZ>U &8VM22M;I"JAY8U<C?D LKG!X_V:=::O.19PSQ
MQM/<QHZ%&X8<EST[ 9_$5JQVEM&2T=O$A+;B50#GUJ-+&!+B*9(PAB5E15
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M&O?W]-_[XD_QHQKW]_3?^^)/\:** #&O?W]-_P"^)/\ &C&O?W]-_P"^)/\
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?[YD_QJ%-,OIKN6YO9;;>Z(@$(;&%+'O_ +U%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g502300img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g502300img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#2 *) P$1  (1 0,1 ?_$ +8  0 " @,! 0$
M       &!P4) P0( @$* 0$! 0$                  0,"$  !! ,  0($
M 04-!08" Q$% @,$!@ !!P@2"1$3%!46(9;6%Y@B(U9VMQA8N!DY67D*,534
MESI!82355]A1,C,T);4F-K:A-75W.'AQ@7)3M"<W$0$  @$" P<$ P " @,
M     1$"(1(Q05%A@:$B8@,S\'(3(W&14K'!T3+A\4+_V@ , P$  A$#$0 _
M /[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@>727FMXI"*L(NL_NM";K1^H,WL$09)/3'#59E7
M4;S>#+$CH4:04(SB?0"\<)$@,LKGS"J]Q667'D+0DNV45<]PKPP:G4L=OO\
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M;N2.1$.2]QKM.*>3-Q\.ZIY$DPM'E<4M'D91Q9 @7YW'D!;\4Z&%<FS L\=
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MI%%+5XK6>Q]/#\2$WKQV\EZ@6IG'^;AZ5XY\V?YMVVR6(5XX&>=6VGU*:6C
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M8UM'%;?T"_Q 4LAN)$BE)-:<^F2Y#CQG55SG/".>K>%AF8# 8# 8# 8# 8#
M8# \1\O(^5YN]5%F[K-!:9&W]?T9TC7.?0W56]D18=%Z33GASDV3*Y*R3<%N
M#2RT.F9?P=2Y*^&U:9.IKDX+)_/)C'[4;JY)!&$P6L3M2I)(+0(M:FQ6>H#:
MY6(!,VC6K2T+D\TF2C,E[4I$KZMAOTJ;2E<.0/+2I6IWGW80[(>64?!),\SN
MKL0Y!JE?AVAFXN@KI'T#+N2:\T&"V8$::#O5\DEJ$'DM/+0^B>I&WL+Y4Q7+
M\PQ@JQG:[\R+%%QM2:X(N@NB#V;+LO\ K6^XV6_3%2FYH<B%CPJQ+6S#>&1&
MWWGDN-K:4M#!-&3H73>V7?BQ^SULG=K"B/W)(,9:553FF^BS..07 #9PS7PP
M?3O-;"8CEESHS;[3+B%PVW%H87):2VH5$32JJ.KS6;"T.L%A?1:F%I]:X7JR
M2&E<[-V(R: 6_C>[II,Y40KIX;;JN6L_WF$U-+/1M"]Z8E,*<;9?+.UZV\:#
M7>"%3<3Y Q-HN,V;*E_*B XHV#6_HA=9CF*ZY/B-P8AJ(JT39ZP\IAAY+HQG
M6G94EQOY[QS-7IP>3)$;SOHE.&RQ[).ZVN3QZH!!:!Z1K?X:NXV9T$U,8NT6
MU6N^0[J5-NLAA4TI$:#H2W+^<J1':;6MJ.O*M"2<\W7;O5!ZX(8+4(U\(UHP
M<0"$%T6 0%.5B6*M!& .46(B:S>ZF:+1EZ;6/D#"05AQ;R&G_E2:>5F.@WSR
M$=ZO?:C2G9SW/J5(H98Z=HP&I6"^1 _0!JD+J]=%V33PB1;*42ICY&>F6P^M
M8*W0G&F778Z/42(BNUA0UG\TS;]3K!RO/U(E]Q#/7ZW"@E'EA88,@;XFXZQ6
MG21@LQ+,1@,BY(E?^&E-1'V4[U\[28>Y \L/KK-X\HIG7>D4_C*2ZX=?KM>T
M(^?4Z;(IL+[_ $&\S)YAX\;E1C)*ZC;FP#^A'^M Y<9QW3R'4J==BB*K5U[*
M?\T1\^RPZ<--6"4/.EXNE6.O<VB5URO0KMMBMSZ<3@S0\LP6L7%FYI*6F9K4
M=B\H&0]ZB#7YK+)?*E]4OG?[5R'J%CA)W//@N@*H5+F @]8D%+)3*/;X%:OO
M4:W!FS6Z\0L]@$MEI8H9)5J"B?!99VA:'%(432T68L7F$>Z+(' 1=DKW.6G
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M?3"?0N'(A)6X]'+Y6S'7Q^&OC\/C\/R_#\FOC_V_#7QW\-8</W 8# 8# 8#
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M.M-N*8<^<PIQ"5J9>^6XS\UK:M;VVY\EY:?5KX;]*MZ_V;W@<F P& P& P&
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M&I=RC*E.S1OW'ZD,0VU$=:CZ2YO"3$<D*YET_P M[1,&3[)2_L-?'6BL1I4
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M,2''8B18[:6F(T9IMB.PTC7P0VRRTE#;3:=?[-)UK6L#GP& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M<>"O473"F/BUL5-\6P_#DP& P& P& P& P& P& P& P& P& P& P& P& P&
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M3M19.T?)D.1]H;4I6]:V6I6EA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&MZ1Q#FKT2'K7DE5D-46
M_A^+<S*H@@4&.>6UVY+-HHT<G$M$9@_V-Z2=BC&-R&-L:AZ4S*$RMORMN'5S
MT3VD\UY7X_5#HW$H_7VZU;[93"IQRXO.E$V>L4^'6C($!=+#)LA^QUQD@!@U
MZ:Y]?Z!,*<[ =WJ*C;:_@+F=5?T3Q&Y6>YV3L-2MT+JOW9PW)B2/EMBHDR:P
M4[Q+GTY!TN[:K561_P!Y[5.CO?5/S9T/<-"G/FNJ=]0W3;T? X%I7"N=\N.V
MADI8JJ7Y[=3EXG"8I3\4]'K]S%W^U6F1 =<@);DWFW(FOK6PXPY'7/VIK>MI
M2G9+UM4$#PB:'C$11?4-P7'JK"YS+E0*$"CQI_-8,"M0X[#D%@DB,OH<]-6B
MJFV-7K3*3^X3!;0W'TR7<X.;^/O++^'KM@K71P]R#5)V-7Z19:_4!@@BD:&Z
M7SWJ^G9EAT\X[9;00<I,9B:>A:B?<&I&Y.T_/3\S8F99^Y^*-/MUC,O5_H$.
M)/\ L58A31UK',]8+MQW*YT^BH)V0G<;'+L1]XH#O$M E\D\\N',@?N%OQE/
MP]B,I82Q^!=!+BA J#:R,-8J=8)$CZZ*^ZU;-6*R=!.SV;R[63E/L-DD-"ND
MSHS3WW&.\EU#<E6U;VXTX-TLQWRE<:ZC8*QQB=TABI7BO4:RAH5>@B"!FS?A
M*UP ,-N</F)=:*P(T4H#&_4R$2EIDP]OQ'E)4_IYH1<:H](\#Z=LB -MVEQY
MX']9)F5]Y=MCU6;+=<IA25/'I9OZ["+)(MM&CS6GR! TS'2^\RN.\C37RR[V
M$J/A53Z-3:\_TN^A(UDCTJM4Q1 #6Z_5 @V>!'\76S(I\7XJ?9LZV>'M?,FQ
M_E29NGMK0PPF-'9:&Z9X)%4?#:@$PH\VF[P[%")<X:IM+*C:97A46/6G ]?9
MK%I0QZI6YW0VAP;YDTTG<9V;ZT)TS&;CMMZ)NE9/-.$\_P"#UJS4@C9M$-]B
M,2ZM#(EOO+ILTP^'/O#0I+[S8+&*)FH0AR<MV5&BC8TE*?BY&TK_ .83-N#D
M/BQ!YC;:];4W&,:17P3T2!'&T\97)$LB3IU'I9%^<:B$9\J95="Z+&>'A_AI
MF%(<WOYSK;,1N.)FT;UXTU.VSNBVNH=#BP9YZQ] $,%158AL2J_)+].JAOIM
M8)$H!(0:(MF;%SZ2'G.Q9(R6L?(VVA_3[+4K8N8XJXJGAGR\C4"51IW0U$CM
M+(R*01MY*I*>EQ+8$I/& 49QF;"(UR:1-4K7)QTZ&Y'(O,PB?J;>^9]*MC!<
M\5B3/"*AD8)ME=EE*.GHQ1LI:D5RJM6&3*,W;KUQ,$GY,*!%3J44F]:EQY&F
MTM-.-PT:]&M*4G0W2S97G8-',NP<.H-MK)&\78ITR]TUJ.F""E5"T%+1#-H-
M$)PQ@Q&E%^=="*L3T.KBIDZTU':6PI2-NK'.YX(L/\)!0B<.( +_ /0KKI('
M:*V\Y3ADTBB^!%<V5*G6DRV4B$+34YQ'F3$E0;UQ%-2I3J]2OBS#U&&Y;G).
M(TGAM3M^RUA&'V+>D2[<+58!P ''(1X5;%U;<:<^QZ(OVB3N,MQMAUU33*I:
MT(_^;>U$F9E4(SPFK % ])#HDTO ^4!<MY"R5T#,LQMBA6&QV"H?:;,ZXWJJ
M1H 8RP%+:1&DZ*A!D=A6V-[?<=+N1#FGCGQ;H V0BO\ 0WK60C4_D"G# :E?
MA%08-#1S8S7I->?FPG'ZU+N('ED5UQIE]4AF+/1)]&FW(NUEF93#A'$-#.:>
M1'+;/8:O!(7DIJJF(E/@"(CE.&-\'YYS\4@HW!%" T^S/UL*R4>6VTIKY<EM
M&]H2CY#))G6)9$=XB4QV75+72;M"BN13-=N$>Q"P B?))1$WSIM_GS0Y$<1B
M#'5W@?U*:(F2IK!6+)%_'>F-OJ2^V-S&(\) T"CNU>OWR("-_(B I%HB4($I
M7X9C<*E\"9#."ON#:=RVJB0^N9=<?7';++6]],IAU<;8W:VS4KP]%.BF*^JZ
M0$C1YSIQ /-?HXEZV($=7&V*)98)>R.%4K,F89.R(7")_3L.(C,)CR&I*W-R
M,&YA?YC--E*G?>K?N>VQ63E& Z8J=?@N#A1FN=%KXTR=<<7-U8^E04]1ENN'
M%IC.S-MM:VPA3CZWQN6)5N)UU7-^V<MA7YH@ Z?/N3\=-<%M1P5!U;TSZT3'
MU_4LG8&II!NUBI\N?'<F[;24=>0B+#94AC1)E7]7\0R\#KK]_L%_"G(BB]2N
M1)^%21PRRSKL$Z'V;H3H\01^NFR:7465=,B1UQTOD9)*&VXTZZU\QUV07=HS
MW0_'NJ]9Z5;XLOI#:(+\RLW"U\^36Q1&2DS.IY'G@F1*,3WEMK %J]7'T_;_
M *92]R8[JUO;;5IG0B:AA27A[1+I]U(@KY':!69FR;;<KP2O25H5/L'D/,;9
M&F8DC<=88$GR&GPTQ?E+TE0R+OUH_?4+&Z8>Y\.3 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'F]',*
M\=1;H8N]!9CMX[7SWOT)(]H?,<AP>>F>4;D#HC<<FI4R*5E\R5'601Z$LN3U
M)VA>V]I<*CW0_&UZ^V>,8W*I@,6[7;: MD *&MXB3?PYO?1?ME.M2Q%Y'BY-
M31,Z LI,7N(X1^\(=DPWX;CZ5L%B:1PEXSV05XZV[EX:P1;C=KSTH'T&Q%[@
MZ?) 9\R1TRHV,Z/G,&K(2L)*MPZN!^C5&?)K>FLM*1ZF_FZ;0+\U\GP?\0D6
M_G->YW9;)7UBZV/ZHH/&'U&2V*!G.I1;<VV[7QLFR/)%!N;.V9MFMLMJU('P
MX3:$O)<TAQL;GHKE_/G.9AY]7A31CU8^_P!L.UX;!$*$_86;7=[5:]@8[;4^
M0/0$!P#<6#"9888TWJ*M7PTEQ#3))FWCR+X5W3=1Y#2"/4Q+M?Y1*BN,L,!K
ML],,MCIE37IU!LST8M9JY^(@@&6*G01L^,(CQ2*UQ8K:VT:PN[6V'G> DLB-
M&Q9=TJR'6X5)@&_LU+=K3QT32]=F%!JV0,@S,4K+@5RN]984-G.;4127 L3W
M'-OOJ6R7<MJO^'5?KMA$V>*?C.' UD%V2(9= ;<-IF-]ENG4+._HN\7>FI(7
M();&P!"3ZMNOPX:=.?,9VF.V2<K3OHG-Q/3+6X>'=&AB7V!H[FSD*$AJ:ZQ8
M 70JIU&7$6\R5BK;)N#JJJ,Y%VG3B67]N[WM*?0HET\ZEO!>K"0 VOAN@B*C
M8CB:O7XY%BM1X,F[2*KSNK,EZN41HWJ4:#W63S66;-0]*<7*:>DK=^8XVJ0H
MNY?U@\;QYCDO)N;,R0RWN46&HV,3*LHV;<(;<P!&(#Y.X"BQ/1:%(CPC,C[:
M_J1M<-2&D_#;2=HP7K:C@/A75ZMT3ER!'083,+GK=?L$;FD*+(KK3;5="\?!
M.W4)'#'$2X18K9.6^H@\I"F9[!A^-(VYI3WU9=UPF'=/&B??^IB;X,Z74Z:;
M)_3CJI+L5*C6JTC[ 'YGUT#H!399$_"&IKY43<YA8D/7!E;=V+=7O2M+TN*2
M,M*?G!/&6T<EZ2Q-(V)TK2*Y4#+@N'KUQQL_HMRO%M*.EA(Y9LM.@0J)S:?#
MK+.I/RTR6$Z<:;1Z=IT)FT(M_@F0LY*V36[U71<4Y>[K<78 BH$0Z[Q%O5YL
M=R?#]9(,6B4[:7J3^(-L5Z9';B+@.-?.TW\5:0@;DDF^$D1DFP_6;6'!PW[0
M3LDR:JHN2+2#G3;X*O+EAIQ]D_$<@WLZT(;#FC$M$N03'Z;VY\-M*:?&Y).1
M>)XCB?0(M_3:FI06O<W U4?$TU. - T@J95ZN<^+;!9T9+JYE^L.G5QYB75Q
MS)"5)]:G'%.[$Y7"+0O$ZC7>PV3H=6N--^45O5CME9LU*K0Y1D&:L71>7WJU
M$$GX9=R,Y:E2.>/B_KFFVW=Q)FM.Z7Z'6WX76B6TOQD9YIXU= X_-Z%N"JP#
M"CQGH*M$6X32(U9#@WCY0//._(AL%!M=3(.1XLN*U,6_*<V]IY]R2JEZVK^Y
M^,/XL$R YR]\>$TRYQMR E(A4-:J:Y>;#SVIT@".#"I=N2,D49":"T2BP&HV
MI;TJ1(VA]'H2K8NEDW7Q6>MUOB'I%R:)CI&P.R*;D'>M5BJS .XEKA."\M,N
M$X$.J5R[QRWV(W$>B2TR@,=J/M6]:WK9+T=_EG!:%Q,=8.;B+"%!V+JE(K0&
M Y5P VIV%4+EO*JQS68?'H@.ON/[&*0U-0XO][@O3FVM*5M25++,V\[U;P_9
MBW(16T=?Y@RNLWVL]!L/-Z90(X5UI=.K'#:]-=W%7;R9AEZZ5*JL,FM/JW!=
M:LVEN1WU>AQ\LY+F\?/$;7$+G"M3UE'%FQ7.*U00HX&-)5<<%AU^GT.EN#80
M9@Q,%.5J:W0D%VXKJ%[A%B4Q;.]:=6M9)FV+">*X2)UX8:/WBK&G(-UL/2XE
M6U7=-6&[H:.VLTT8Z*_(L,QNT&N;F.FCX@@@F(V@?%::U\O2I#"8PO1+NS^+
MM/ZA=9EZM!8*S((C =6&-FJ_'*?0K9IO:*=!BQ)$HDPE6IMCZY"*I82A.ES@
M<;?[IW3#L81.E*.(^ +LATC.*=8)DU2KU*M1>62D6"$JSAB*+RI;-C7!L+*8
MEJISEY<^QG(JD3(K,%A'Q1Z6E1R[NB82?!<1.;,#Y-BKT8#((=%(!@ ^DH8%
M0B%VF^0I,=8YD'1M$*5:01#O"7?JT-MJ=>",.HVTZM"HY-S,\$XO8^5]OZ19
M;"Z'C@C8I59KYN:R*B7KHQ@WT&]="?.VB0-LY_9Q0R$25!'/RV1\SZ2.IOZ=
M*&_C@F;A7;/@;96$,1HG3JH)B))<S?(+"<W?'EC\CECTYX-?K :5;Y!"=TXZ
MHA)V4F,JBQYCDM;CR'?EI0H;E@<U\.W^8=##7D'9Z\EFL #(:I5^%728$'7G
M))6^N15-B0M@B1)PPR,O:WRT)?H8?-1D3D:TO3&HPG*X>Z,.3 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8&LXSX/]'AU-0BE=6]!4E12%+,.V(J?F11OUEL-6Z%.H3D^)8F*4V(+RX#
M^FH\/:WVX'R&W8JUMRXYWNU2J=XE]>G6&L3R';CQ,'7;IN5%%1+(9 3XM12^
M'L0F?HN1$77Z^Z5JUS+$PTOY,7<P&3CQ52V-Q?BX3='1G;WPOJEYZGT,Q%++
M?YS"*4XG6>>W&Q6$+4KJ5*UUV#T^"1G54@3+QJG%?"5<D(]4/6F3L0HC<=4>
M7MW8B8B.UTQ7C!V1V530=TZVBU4RIE8!<I,=-7=BRWYQ9?DIPE L4-H@W"BC
M8,KGT]EAO<N=J:P45I_2-;DHD"XY<7U=/'/IO1>O=,/233%9I96WU9T>2:N-
MY;L%IH<6@\Q'6/G?V8.6CA@%+(V,23F*?87'G+)-[^+/RGUR'!<1#"R/$OK[
MTT@J)U2(#B?BH:<DOCCW079G1((FQW$T_#N<?12%$ )N-:L$6K$VAVY#; >-
MMV-O3C<!F -T)56^'=7*<28"6.P2BMFE=1U:)59OQPQ!A6+EE7EKJG/^>W(O
M5YYZ8,GR^=A1!,TY%^M8E6;4E4AEYF0^A0F8M$E^)?939^_&[!UF +_$:;3,
MK@^JS;.-$@K20K'2:Q6;:R,%:K>FI@0?;!&E-OO$9.Y 9,I,SYWT^HHN$CC>
M+?06N-GN?";<%YX6L/3>C7A3=)-WAT4$"76D6FK#JU /2)0NR2U!R)F+-^?Z
M8K;;D;7T[+'RV=(&Z+M,;#XP+L%&!T.4=96%K/5NDWZO15S+&E(D+::7U6NU
M !$E,E&R+?X2*W^+)1KYWR$(A>EI*?@UI!+UM47\T+L=@L-I)7KK<(B..1V_
M_L\/.LXF*2-":5UJKUBT$8(G[,ZP6&2;L$D/_/EE'9$P"F8E]I?TK$0MQR37
MG_BU=@MHZ@7M]VB3EWOFUHH7XS#&+=N]E9]EN!VRP[43^OE(%5N?41A6.,@-
MC5+WMJ VOYC;>F8L<3,<D3;\.>E6'4-?3NLM7%<2;/MT>*B3<84 ;T"[<SZ(
M&Z*0$H2<T]$ :Z5:1Q&O1$JU]F%05Q6_W2DJT-T<G4C>&?3I^[3NW=D-6"4:
M+V0LD@[:K Q"*2I]/Z:+IY*=70PL ^,,4$]=1OTSKA4LAZ*$C.(3%=8CH:&Z
M.BPNK\6ZU?NAPV0=L)C:?#YG7)EG9GERPRMWCI%=LNH@T$X^#+_?85=M=!+6
M,?9?E14_#ZD3(;W(=C*:T(F*9+F7#>QTJW5223O8:;2!UEEW$F#:-7*=*#-N
MU+IE6%<NK39+>HA&D5I%Q%NQYTU:)#NPZ/5#;5\I;0F85R<\6>UE6*X)BWNH
MC6 ]^+6T]<&9UDDW*^.R[4"(-&;%]R$3U09!&D1R &8''SHT'2)+;B)&XC>A
MFA<,[8_%_J:O'L=QJF] KP<QJU6(T2LGTDV"]'CDH5@= 3 ,WZ U*&EJW9YL
M"<K:&FW9+45;+,J&XXF0@1,7<H?>O#'HYX#8AXWH0TNNUQ;2JR!;18.B1@)^
MQV5_MC4"VD90LK)*)FTT?T4+]%%9TVR[]A;9TN-IF"]%+&4+.O7B='O-^I-D
M*JKTX2(IW+:M:%2'K!",$XW,;*;/MCH;0Y]J(Z*/KL"]NZ<=;4RJ*E"DOMOK
MTV2,JA7=7\->D),K>Z+UPK=A3\FIK+LN6BQ18EH$!J7'"O5\V$A#QQ%U 6QP
MTRA\M\Y-2\P_(T]%;>=<6LLY1R61>?&>T6F-S0SNRBBMYHO'Q?-3Y0Q.LT!/
M0--7;DELM HP8'/R2,.NWJ'S\A"GN;9E2?23]2T/MZ=8=)$JOA>&_21\EDS)
MN=7M<GYZWB]2,$;H,"685($\\&L4<O;(CA&TKKE752VEP9#K<I^7H;!U+:5I
M3^M#<F%)\7>QUVTTHD=[X9L@"M$*]%+#Y$NT?5GZM%'";I96'UR3DF/L\9[K
M7XTAJ2[\Y352?E"U*7\Y2E"9BGP9\/B,[H]TO84Z&JTTK=+)=JR:$R;+HW"-
MVTGX\3R90E#1*C#=SH<;CQ&&VG2GV)#!1.EI;1M]I8W:,G2O&CIM9X63YN_U
M8NY=R5O"V"7<GK,5)M2$BHH*$3FP$P0=3( 'K>X(=GSH7KG:T0F/.+F25.+7
ML7%]B W7PJMAT66JHNR@9=1*U*UUM0BV'+D8&QXQWGM7@:@P1,E$Z6-(%>K
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MQD)WIR&Y"@1VGHJOWGYC#+#4GT?.3'BZ<^F:).LVM#"& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M(:1'>VXZZZIEQ"8OE6E5A?EF*ZI71,@]9'>8-]"ZF3.%K1#H]DD$@Y'JEN-
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M^%Z,.#N7&86)*'#*4ZID]LFX*DH(,R_I=15Z9UK6RQ.,2V@X<& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MX]#,C%:K</\ !YRCQJYWF(U>KK;)]J'PFC#))T*]!KCC\>#(<W#6EEIES;L
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M66T-,LM(2VTTTVG2&VVVT:TA#:$:UK6M:UK6M?#6!R8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MP'W!^6+WRSH=4N=AMY 1:X).+\X.09**9/P4R%)BQ5Q5I<)EC$1<=:;7L.#
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M[3;^-&#F!T9+DS=\'$>:DV"(QU#28#J$Z>>3^^;;:&[W>L\:6]/]OSV;@OC
M>\L+%[;OCN&YY6>567L1@.SR;CEML[=0JP4C89BALGG]EMU$L$R<(&J>AJ''
M)<20EUOX/Z^._2-_N7MN;>5E4S_3W,[O[<SP!XU"E\UN_:>?608_XQUITN[9
M.*/5B#,9!"(2I9*PQ>C&K=$&U)V&T\DT32_%_>7H[R$31;]WJ]\<W]IGVMK]
M4H%G+^UIPOED^:Y+0[2^D<:Y*W;1J(TAQEEZ>FCG[Q7--SVD:>:TR2>7IM>M
M.);<TIM-<S[F<?\ Z3K^QF]J/_#X\4?^3M3_ . PGY/<ZR?V,WM1_P"'QXH_
M\G:G_P !@_)[G63^QF]J/_#X\4?^3M3_ . P?D]SK)_8S>U'_A\>*/\ R=J?
M_ 8/R>YUD_L9O:C_ ,/CQ1_Y.U/_ (#!^3W.LG]C-[4?^'QXH_\ )VI_\!@_
M)[G63^QF]J/_  ^/%'_D[4_^ P?D]SK)_8S>U'_A\>*/_)VI_P# 8/R>YUD_
ML9O:C_P^/%'_ ).U/_@,'Y/<ZR?V,WM1_P"'QXH_\G:G_P !@_)[G67BFY>,
MWL(<Y[?T#A?0O"/Q5HIGF%?J)ZYW.W\DYE7: /7?(B9]2 PBI4C%-GK 9B;4
MM#(\=*;;TVO3CB-I^&'6[W9BXF5^\^]MSV0NO#[63Y!X@>#W68E*F+%V-WFM
M"YU<FAYA,/<] 5R4$3+A?=GXOI6ACYNE;TM&_P FE:WLDY^['&9>*8=-_P!/
M(3B%7P_@EPDG*&\]X'TAD:CQNJPV06$>10J4<IHL=//;$@4'ZP&C:E6IF5,C
M-5B,ZAV>ZRWO:M'5^[U2>J<L_P!.?<NBBN9AO%7PZ2<+IM0Z,0*\EH84!^-Z
MA:J)32/-&2I3<5!.ZSCW1!S4!,%,H=/^*OD2U[VUIUH;O=J[E,>:^/7^G8Z=
MS&@=4'^.O@16PO0W:N,'![E3^5@[.$M-KJX6WQ*99Q6I,M FRC@U@BKFH^:Y
M&C[=UO;VT*2K;1-WN]9=#GGCQ[!G3KCQ7G%7\'/%U[I/<3]Y!@N>/\?YK^,J
MHU0@G4SY _?PD0A+D5T"6A<C(_0.I^H=?W*AJ4TAM_;B!.7NQSFED]U\'/9,
M\>+]QKG/0?;Y\;&CO;W;BY69L/C/-8M<!A>?.5!%SLUQL-D(UX6#!@&KQ!>=
MVEQ^4MCYJVF5Z97\!&?N3%Q,Z,U1_!?V"NEDZ8$Y_P"-_M^W$YT15G31PE?J
M/."1JS[I3*)-MV)$1FUD9":Y%>:=F;^7K3#3[*U[TEYK:Q.?NQQF5+R_'KV%
MFB75A _P!X,:)<9[SS_QXND:!XXUN,G=SZ.:D5<&;KTLTT)@V:BQ+>)+!9A6
M$Z\TR7 DXFDK>AN)P;O=ZSP>K>4>U;[0O8N6\UZ[5O;Q\9(U8ZG0*=T>N1C7
M%:9#,QP-XKHZS"&"T2,U-C12;0\HVE]MMYY"'=*2E:]:TK9)]SW(FKE/M^S-
M[4?^'OXH[_[M<>J7Y?\ N_+!UK"?D]SK+SK2O #V9+6>E58Q[=/CASNR-VPG
M3( :[\BY1N28,"BTX"]N(_3S5N@0(DXX.>ACUD'H2BDEI;<1+ZT+TDN_W.LK
M$->V)[*E<+/@CWAEX6"3,99UM\7/YC2X\UM=9JPN['T[CKA:<VH34C<0@]K6
MM^B+(0O_ &*P?D]SK*HX?A/[&LJRBZNOP7\6HLLA(6/D$7^&5_8 <5W6N>6Z
M+#6=:%.#",28!Z6/>T1AN2!C.M.:>D-;TGU-%W^[5W+*5OP5]C&PU>!:'O"S
MQ% -2Y>H$@6<XQ6XQ49)2U-?DNSX[(N0A 8>R-DJDE$*6*C)CN[<DI^4YZ1O
M]WK+EK/@)[*MKL](I0OP"\7]VN[D[,-CA%\7IJG@NZN,LA>4Z:EL1WAK*Y8^
MN_.9C-/NS/IYL9Y;*&7=.:)O]SK*Q9'M@>RY#M!*ESO"3P^'VD2VR],"D>.U
ML=+W'?#&K"B5"^M$L-$X:0]<GON/1E/--:B.)6I*T[3@_)[G655#?"#V,"MR
MBTV+X0^*K;TN4=&,&Y_" XRON&0)2F"7Q[9(B%C-NL395]&)BSTZV-D+DH:1
M(VZMMM;1=_N]99YOP"]C2:U"V'\-_#0O+)O2$#QT;DM6CSI4>&Y6DRB6FB R
M)\D1\BXBW8\MS:(TY!&+J,MY4EC3A-_N]92'G/MM>R?U<8#)T?PC\2"2;$B6
ML6.E\2"!3J]01HLQ,U( &@L Q"W&%FX;ZMO,HU\J4TK6]Z<1\6A^3W(YRQ8'
MV]/8]L9.,$'^%GB2T7F6RRTF..*<*&AY*K%5;43I$^(YHI7XK<://M(>3"&R
M'5(CEI+2FX:WW$J3IH;_ '>LI':/;)]E.F.S8]F\+?#87-@$D!GQB^25:276
M8='@RK F&'A#))0B3DP+*/<:CQV77G?K&M(2I2]:P?D]R><H9 \"?8J(S9D&
M/X>>'FE0SE>KVIC_ !0/'%3IUHK5>MH>0+,/ D"R0=8:U#]OSV750H;\IIF0
MZTZXA"FAO]WK+N7#VZ?9CHG1=\ZLW@%XN#9C%&C7J<5=X@ >@HC%K0W4JX%&
MM0PTJ8?L)TFW*VW#AH=?0U%VO:/@K6]-#?[D\Y3:I>UM[,=];.O4KPB\/+5&
MK/VS1N8"Y%5R4&&X8!0K,-83.BC'(<N3)KY*-+TTRMQQ+$EI2DZ^8CU#\GN=
M901OP"]B=QR(U_-'\+6')D23-TB9R"OP50F8<RRP'VS*9@5C8";J;3"[:8T[
MZ>0XH9*TA"OD.>EH;_=ZRF5A]KWV9JQ7TVPMX.^&\6L(-G@4X_)YE0X8L;,J
MJ;#^)]2)4QF.AS8!VJST24-?,=1N,YOT[TVO>A^3W.LJQLO@S[&M>A@I#7A'
MXE&I-A*-"H8V!QJKQ)D)U14F&>>L'WD<,8J[4::$G?'1%<5QU$*0II+FF7/2
M7?[O64HF^W;[(4#0]U[PR\,%Q2(1!UEZ)R^E3I"X\JP0JL,CQ!4*&^8*SBUA
ME[AL,Q([[FY#6T*2E2D:43?[O675IOMZ^R5=J*&OPWP<\2VAAD*^=9'?J:JQ
M(ZU#B!P-@F)V)"#BDN3)B@[0.EK;82ZK3$UI7P^"L:+.?NQSE-.>>UC[/O3X
M1TI4_;^\4YP@*=:",ED<AI+P\VB16Z[:89@-(BL/IDB9HNS1]MK5Z%J5I7[G
M6OAO9)]SW(YRL'^QF]J/_#X\4?\ D[4_^ PGY/<ZR?V,WM1_X?'BC_R=J?\
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M_P#@,'Y/<ZR?V,WM1_X?'BC_ ,G:G_P&#\GN=9/[&;VH_P##X\4?^3M3_P"
MP?D]SK)_8S>U'_A[^*/_ "=J?_ 8/R>YUEK5A>.7)_;7][OPJI_AS6(O%N,>
M?G$O):M]YX9479</E\ZV\$J\&_4;I(.JNR'Q8"T-KF[@NJB-LM_2[=TE*=R'
M]N3FZN<_;F<N,2_I;RLC 8# 8&ACH7_4E^//^4SU3^L@G)S:1\4_<V.]_P#
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MW8YQ(S)%@(&VX4%MY]SZ:$PTRG?H;3K1)F9FYXK'PC75%.^(UMC:=>HU\KB
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MU:*9./!1Q:75+*F#,&(L%=?GQWW YIL<0?93*C[;?2T\M.E:TK?Q"4X# 8#
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MN.J9-SU1CDY"),Q+\AE,V1\M:/GN^L7+/53E'-Z++7/IM, UB6Y%%PGG@D)
M[<B(#K0.G!6)2(WRVY38BK5J! BZ<TKY$:,A"/3KX_$7*P<(8# 8# 8# 8#
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M0+/96!C:61K-@/18;14RT/93I#"9+KFFDZUI/PU@N>')QR^@T,>.F%R%UJ<
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MK5:BIL+T;G/61)BQVRT6HQ9+24'7WD=9F,R"4J6ZVR%BQ-*U";^GV-TNA#\
M?#Z ,)!X?$0$<:7J5AHA&*@U;_3*J=KIU?H%A#*<W8MNH8)4^K#X*EI4EU+<
M9*D+2YM2U%W9..;[?_B/.;*M+Y+J(V5Z'*ZLA(B\](!?A^^D=VS9DY1U!;@/
M5SW5B_'9G12*"V.AE-$G]2FGM*^&ANE8](\6^'<YZ)9NL4^HD!?1+F=?L5LL
M[UXZ 6F6,BX#_#41HQ',VD@/GAP(+XQA(YQE0\.A2MP68ZEK4HES5<GH'"&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MURL1W?Q#0:P?L8=L<LL9VM%5N! @.2XI[;FVXZ4.>MQ"G7"37)?F$:P^L/\
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M@M:DQDRIA @1D[>,(AC9;R$.:CN/:96AM"4-I0@FJT;"\.# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MVW&R#!$O%CK9WKYB7Y+3>]>M:4[%2Z+'9.1RDB51NG\_D(/)(K"K9N !U!5
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MG:+G?Y7:KR$7%B)G-S"B1E=';(R(^DM;B,+6ULZW1K,1K+9=AR8'D[R#\?\
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M><=2EW<.+#C^EE*]-H]+:?W"=?'XJ^*MD=S 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&AGSD_OQ
MO9-_B9[@7\BP+)S:8_'EW-\V5F8# 8# T,="_P"I+\>?\IGJG]9!.3FTCXI^
MYOGRLV&L4HE! F9H=F,^5AC)TH>S,9)R(KLMB.XZRA^,$AD#$EM2TZ^+45AZ
M0Y_\K:%+WK6! N(]$G=6YF O!,,FODB,NS#2 ?6BK2X<ZK6LY5)>GX!X6$L
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M3-QXLEWZCZ9]Y$5];8G&8XJOI'FR&<IU8,],JMA"'CU7"V"5$#B1;0: 8/\
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M.)DYILP3*'#TXH>/'3IPG)G$"$Z3(FSILEU]]UQUQ:]DF;UE8>!T28P<:&D
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M+N;YLK,P& P&!H8Z%_U)?CS_ )3/5/ZR"<G-I'Q3]S?/E9F P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M:+DXPD:24Z/-1M1$+]"7Y(VQU3SDO8^BW[K29EB)UN/RT13"@4>2JD4YJJ]
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M 8# 8# 8# 8# 8# 8# 8# 8# T,^<G]^-[)O\3/<"_D6!9.;3'X\NYOFRLS
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MYLK,P& P&!H8Z%_U)?CS_E,]4_K()R<VD?%/W-\^5F8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M^18%DYM,?CR[F^;*S,!@,!@:&.A?]27X\_Y3/5/ZR"<G-I'Q3]S?/E9F P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MW-\^5F8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MZLVF)!$@^D!6939K2MSR3I*UM*<<CLJE,[+,P=SY=Y/F>G$;75#7UO/R!FB
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ME$CY3/ST-.;VG2_0CU:U\?3KX_##ESX# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MB7C0([)*>WM;3"]HES4+<U\4(W\%?E3K_9APSF P& P& P& P& P& P& P&
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M*E[TJG5-2=Z4E59 [2K6];UO6Q<7>MZWK\F];UAS/%)L(8# 8# 8# 8# 8#
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M2?VHWMK_ -/KPZ_:.Y)^EF#9GTD_M1O;7_I]>'7[1W)/TLP;,^DG]J-[:_\
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MPW3B//%TZSA;#-BS)1M9&):9,.>C6XOR)_KBJC(<'NNO',WQN7K_ /5%R?\
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MORCP?K]7@?8O]2C_  Y]H7\V_*/!^OU>!]B_U*/\.?:%_-ORCP?K]7@?8O\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g502300img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g502300img02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#2 *) P$1  (1 0,1 ?_$ *P  0 " P$! 0$!
M       &!P4("00# @$* 0$! 0$!                 0(#!!    8#   $
M @(0!0,# @4% @,$!08'  $($1(3"105(18Q(M16=I;6%Y<86)@9.5D*([>X
M>3I!420E5]AA,G&A0C,F4D,U)R@1 0 " 0(#!@4$ P$! 0     !$0(A$C%!
M46&!H0,3,W$B8G(C\)&QX<'1,D+Q4O_:  P# 0 "$0,1 #\ _P!_& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M@^(E;NPW!=JMA25E"Y0U1HET7Q=PDX).WJ2Q+RTY12)82I,$ @P)FRQ$RO\
MPB#V994"INO9I:]I2IH@]<UW&G>83:7OZCX5GCD:849K@[.S@?H(QA3I$A(A
M;T$(ACWK00A$+>M;$1,S4<7VKNPH3;4#AMH5K)FJ9U]84999C"Y8Q*-*V>1Q
MB1-Y#HRO#<?X!V-*O0*0&!\V@C#YO 6M"UO6A,5I/%,!BT (AB\?* .Q;\-;
M%OP#K>]^ 0ZV(6_#7V-?3O URJKK"D;GFQ%<P-_D!\U/IJ(W[]6Y+ )[!7=+
M5\YELQ@\:>W-NF\;CZYH7KI+ G0D3:K+)<B0$!-,( 4:4,99B8B^2;.]X5LQ
M77".>7-].(MBQ:_GEH1*.!:'<\AQA5:/,,8)B[&O9"$QD0#;'6P&DH)"A06H
M4?$[$4 82S-A%35\D#G/6]&UM.$-=S1_D;')G.V:DI!K"JKRP0L;O95X,SX_
M5TPLDJ^K/U7?2G%NCBO:Q6B6*$C2< )*XQ.:86 0C&9U36NKZJFTTT0%$Y4
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M-\I&U!)QF(MBKG[3B522^:UJ7$G.36&Q5M.IW%&-LF-4B'+UT%@IU@+X^>S
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M%B& 2<H827,Q2AJMX)BS'!&F/6E,II-G%K13=O:6XJ3[W$H0GG=K(K3D6H*
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MB+6:=E[K+#B1C$<(O2,@@L(-;+V(8F;6CA# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M_MAP)^G?HC_XYX7Y.UL'+UO3A511Y5 8S0Z^^3"8]N5L4OG%@M-1)3S$_C+
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MJ%Z8(4XC!!V(80@$6=M:7;*VXY]R)9HH)H>$<H/M=Z;FX21PMRTK?BDT&[B
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MO3 "0(P6A;&$(!%G;6EVW&PR8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,ZR?P9O:C_I\<H_H=B?W!@]3S.LG\&;VH_Z?'*/Z'8G]P8/4\SK)_!F]J/\
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M@,!@,!@,!@,!@,!@,!@,!@,!@<&>Y/YXWLF_@9[@7^2S%DYNF/MY=SO-E<S
M8# 8'!BPO^27SS_M,VI_J0#DYND>U/W.\^5S,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@<&>Y/YXWLF_@9[@7^2S%DYNF/MY=SO-E<
MS 8# 8'!BPO^27SS_M,VI_J0#DYND>U/W.\^5S,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<&>Y/YXWLF_@9[@7^2S%DYNF/MY=SO-
ME<S 8# 8'!BPO^27SS_M,VI_J0#DYND>U/W.\^5S,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<&>Y/YXWLF_@9[@7^2S%DYNF/MY=S
MO-E<S 8# 8'!BPO^27SS_M,VI_J0#DYND>U/W.\^5S,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@>,EQ;U"Q8W)UZ,]P;M)Q."$E40:L0A5E[-2;6)@#$<ETJ
M*#L1?G"'SAUXZ\=8'A;I)'7=4I0M+\RNBU%Y_C$;<Z(5JI)Z9GHF?$ITQYIQ
M'D.^TWYM:\!?1OZ< V22.O1ZA,S/[*[*4GCM4G;'1"O/3>4?I[^(*2GFF$^!
MGVN_-K7VWT?9P/F*4Q@#^7$Q2-A#*34HEQ4:$[M^G\Q$$.QB6%LVU&G$:4(
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MZ%[-;(^K>6Y,]N)0?-H1B!J.4@7K"];!OQV66+7T;P5*08# 8# 8# 8# 8#
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M!?Y+,63FZ8^WEW.\V5S,!@,!@<&+"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P&
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M,T268$6_H%K!CA.47%*8F/O2<M1:85W#V:K>Q+0W=+4-_H.45)RW8\ZAW0+
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M=NO77W"7=73U'.<1NNU;K[<L_K%,2Y1Y>GHZ-;Y9A'./-T*=5*1Z4?$H'=%
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M 8# ^9PC $FC)*]<T!8Q%$^<)?K&!#O8"O4']H7Z@M:UYM_1KQ\=X'%NOO=
MZCFG3-D<NO/MQ/L)F%*0^ V/=#XMZJIJ0,]?UO9@97N*2XE.SMNE$R&:&&KA
M'MK:,:TH)8="UK8P>,=-F-7?'L6+PC[LM!=GT-74@*L&E8SU)*.?E5Z2WFQ'
M9R9<XPQ*A3J#5Z1:[*F],MVWLN_A]N9GP@E3:2H"8H3@#L/FJ983C/9:V:O]
MR#FUUAO+B>Y+KH&#W=U!!(7,(;6E?6J"U65]W-G MC9E<&ER!@9CY)"WB1F?
M MCVI;VU*XJ B++UYPB#HFV>,<&P]]]7\V<MI8XLZ)NRNZ;3S ,BW$QSZ1(F
M$4F,B;<0[2%*P%*AZ.=W!N0*BA[3)PF*#-F@"6 8Q!#LD8SEPBU8/?N,\(QN
ML:^N=^ZQHUJJNUVB5/=:SE7/&8M@FZ&#JFMOF (XJ]?8G-RC;D])4JQ$6':T
MA6>$@16C?M,+MRNJU2%M[MXV>+]4\M-73%.+^A$BU4U'5.EF[.;+/GJ%#IT7
MQDI*%1LA1+6YMW\0H:2S!.2<C6QF$!#K>]#;E5UH^ >]N,S&)DDA72E3',\C
M<;B:&901*D9YZQTY[;%SS>2#Y>3YW%.JJ5J;C5$@ :47MK*T'9_D\Y?F)MF>
M"S&#I&A)4^5'&HU;D$?W^^J\<K:III9Y B<5MD5BT(V!>Y3V*$I3#=N<51I9
M2W"&M#_@>*TD.A;$/6L%3^RA9'W#6M66EU.QWQ/J$JNIN<&2AG$^:KKD2+)P
M4X72@D!J1MLFMSF! = 3'1S:2D\8"4N=%,ET,T11)0B?(,NV9B*NY; QKH:D
M)=2@.CV*T(>?1(HT\S$RU5KJ4S0U'%XZ:O)?GQR=GK3>4U-[,:U*0JAJ?2]
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MQ+1(=Z5@\YPC4Y8U,1?&VE*;V9.OH/7_ #JB"0SVSLCVV*QX*Z"JF$=B6!S
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MZ4-SS12I@O9D-I:,TLYIX4LKN9PV1.M+Q4<":&T44*EJ.7..YNN5-S@D==*
M.80"/">B":F$73A7),SN\EB2PI$U)XNRRBL4B?<J:;(:4UA1UF+KJ,WC :;L
M^0_-Y=#F]@FQ<(26$2^G+F%0H:=)6Y65\0+0DZDT;=.U_0]@S%W?4!<1@*($
MCM4RG62J-2R;NA$%,C5E6!U47$I](&U$PC5-)KM65&[>]E)-FGN9[HWMGJ$Z
M(^+V-O7@AE=];VE!&Y.IMUD;PQ-1:W63?(YW\SE4V;#937]_VY%V"CX"\-;
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ME XP\39XE7IMNW;X=E9PD@">>;\2'TQMCC+:>G;PDL\M"U:ZG$=;*^>X>?\
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MI*I7-7"N(RJDDZ97"/35<8C%HF6M3LR%1ES*DC8 T+2]*ET:(+;C5*@@Q4-
M6!/LST0!!HMSP94NFJL*ERN> @D<#+EZZ-.JM\^ !M4<[P]D<8U&7K8-[VG
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MNW!L&;HLX]M4D&C++$/8 G.8IR%3\_=6SN46BYR*O7. ([*:X@BL)GAD@BT
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M'VL'RU;=7P1JE#%,6VD%;!!/S9SEBLMQ>V=_D\S D3R9I/1FM7S+:AZ)=BS
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MU^#WO:@IQT1'V]LK61DU#'NPGW<>30^QXX[P-LYT<G)G@LFE\Q>7]1%+,:+
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MJE9<V?9._G/L98I,%[LM[J%Y^O:)H@\8BL9C;\U2/G./K&I4A:TI G%O4J5
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M6DGE4QE:L?R7,A*$K>D;BU-Y_FW\/Y1B,IXOV+D2D5LOG,H"*0&R&5J*'42
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M/-S:B=;EM6<*6^3E2(3M*!5RF<'%"2TGM8(BY%PZNHFUG1D0SM*Q^1,6X#6
M"+:K9>ME[);T617K'/=P-Z<Y&]1A554_264Q/;"L94VR7)MC\GB+LWO'SYI>
MFQ0PO$6EKF@6@$4 \LM1LP@Y.H+*.+$32CWKC"F91!8-#@+Y80SP2"I(5#7-
M"\-#DH2M22R:RMQI=%!+VQO4>D2Q',:F9S@@7HU;<J2A.3J4QY)XPX7=,,M
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M5CQ2)!B-K)(\3)W"[;(US@C;6Z,3][11Y$CC$34M*;2IM=&M&24]/Q0D!ZU
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MNTQZ21=#.8Q;%UO*7J-[3JCC=M4M:[#LF.0J'4Z1#R:=L%]G4IJR@(NU(7]
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MY.;8W+D,A 3MM.5Z4-0]FI]C"87H0=;UY_.$ J8BU=.G:,#9QUHE61:6[=+
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M<,P?E#KS#&(6_IWO>!DL#@SW)_/&]DW\#/<"_P EF+)S=,?;R[G>;*YF P&
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MJ:K^$9D_QF.5U(+0B8X#5$<FL6J(3= 5A<I4MTXE$;=33K,6*).8VO2A@C+
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M^GPWK_OA'] 86:#1A9@#"]^/@, @C!OR[WK?@(.]AWX;UO6__K@ FEBV/03
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M)6R0^+/LR>E6RV&.L3I(W!0E+$L-&V,[:I=E@T2<CSFKC]H4HQ%EEZ$(S>O
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M5*_F)Z52:#TB_(#*YY<=T<_!Q 6>TS[BK=&US=&I=&]/44*?_;9K=R46DN+
M/VI)TGGQ3S:SN3L P OF,G3!J,1H=Z&M%]6BM!4:T9K#IOP_SWMI$'M8VI%K
M\7WM 8/#X;81/NJ$V[%[):9D $CCO#!O)22G%4>1IQ':*^$-FZ4HQ7&-Z_\
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M?T-5ADYH.$,_+S\Z1#W9($_]7*K<>-S2_5ERV[:4%I"N9#"T",4SB;)5<B;
MK"UJK0T[*F0D*F3U#EAP QK++&-)UX:-MJK]IBWWJ+4I#+%JQXC54![?KJV[
MUH>26+2K?7A59Q#E"UZHE3C 8OSLQQ.,[8K"G$@8B7MJ4>*Z2!2#7N))8S5)
M9EI)SCEQI3O37+5^TL\UU JXD\=A?3O6O;/N*TC'87'9$J='M?P?W=,SWJ4W
M44D82A&(EW."-A9I0$2G02VA2,9(CM&'A"8,9B=9X1$?O#K3[D?%%EV[SMS%
M4G.#2C>*^Y[M.!N<OHE8J@0DUH5##JUE< 88J4EN!J?:IE*Z&/+JU/2=LE)/
MRE:8V><1I2HI*9HQCE$3,SQES\D7MA=;:<N,GR'Q98[1'ERLZ38KLKFUKU:%
M\S[0C+?T<&S6V@;">844SUNE8>.69 4]1A:J2"1R!R$!E,\S6$\XZ-;XU[?!
M$RO:A[H-=^SRT,VDL4M^T8'VFP1+I%GL"K8]"KO07_8*25UQ&K.,BD5*Z6T[
M1V+D$-"10YK#T<%^'/"QF'I#P$A+OQTZ:+%M3BCKD<2<#.8N%JYH5DLSVZ.O
M^'%7/R#H>",C%2U@6[*8G+(O=2B0QIO<&B9LDH-;5X31(@?/PK-DF*]%://-
M()&6/.;UB42M#VG^EC'KK<55U57+,_\ 1/.?#)9=L-LUB;4ZNTDY_>XD;U%S
ME+B71I<' 9'2K9'R]C=QIE\<<M(RT[P'T1C"*K&>-1?*91R2>UETUN!U,EUS
MZ9>$!;X_W$S(N7[DO"H8$W<[VCT3NNS:KNJ"AIQB15*SQ>$&Q5\*2L[ 6<Y1
M4$B--:MC&,PHJ&^.NNCM+[=:>Z:XIF!\J6Q33K!P\H\X<FU:;::I[*7QNW;'
M#2C,=::& )"6I.!9%JS=DR9L&\ 5'$N+@:H*++*^$'L=<\JNXGC,N,<X]K?W
M$8B[V3(*$=H@0X\ZS*S:K]OU*Z6HM0-RCE_KY\O%YO\ 4V F&284W2JHM7"P
MDQHH_1III=>I-$B!H\.1O?CS[VSK7[:%YP"_HL? FEG4T;6O;?"-DP50ZSA.
M)V*H[F_V[YCS/,7<QI4>J<GD(K'<DNO@]"]9> XQ7YM^ M[J;HF.VI_E)97P
M/T@Z^Q) >#4L6B3AT7'JVH&-N\24S\++$E;E7UX0"=2IL_.(VIC1H$AD;CZK
M0%J4H1X1^'HAV9Y<ANCU-W)I;-/:TZ\DK$^N\?I2-UK0KMV/,;=1^WG&;$IZ
M?-4>@SYS%%J;*FC,.U&1TYY5R9=;+.YRGY&H 4F;M/ G!(H*>"_+AK?CWUQ=
M8K<XZMZ1>VK4=(P>0O[KU'S=&*!L^DI':<X1.T@.O?G1PC<OBC!8%A,#<U-+
MV5*-L1\7>G4M(!,K0N*@\1>]#WE8C*-]SPES4M'VP>JU\+K-XF5+U[UO)YWS
M]U$?:M9/ET:KYBH_O3JNTBK;6]+1A\=DQR22-=;I%^X<@<VT()*QL[(C,9RA
M;//!J-QG%](OP>6T/:8ZJ*<>F2(=&Z^F%HWYQ?Q#"GSJTB8LL9D<VMOG21-Y
MG5]?S1 ^,ZV2^EV?'6Q*6<[B3K6LX"8)#R7Z.QA&(SC2^$3/Z[F$<_:XZ4(A
MM)^?GDZZZX87[LT];R1<%W4Y7[-3<YO^,UFV55<<"+I9@0U P1FO'>(OQB=E
M9@'N4<%*%"UJV)2,9!8WQKKKIJZ$F\8]$E>U#Q3R>C0LI5Y4DL]O,5B(D\P(
M2,Z=-SW<U+3"V]-TG+" AV+3QJ%N6TX ZUIP%H)6M?XF&=T;YRY3:G>6O;8N
M6D>H.=>A#X?&F23)>E/<\E/2$T;I^8X2"5TET!,YS).8XTN (\?UB96HU2SJ
MP,P=!(8%@3#0@":(\9E,LHF)CLA$O<.]LVV;FZ [9L6DZ#K:2JNM?;U1T7'[
M6,F$:ADE@EYQJ1SKYR.0IW0@+RI36K 7MB: .[>,WX4MC"6J" L!(A%QSB(B
M^4J^OCVH^@T;G>4>Y^@\7;N:G#JWER]6;G9JDT$5LUKQ>)\LOU67,0*'V\W2
M&JC)-JY5S7)C44J*VV256U?&J#@K@D'Y%C..?%N=9G$%UR+V=VGBF+;EKK:I
M;53S66@LVSV ^5MD<CW1D)L-ZBKI9D*1,D?$.(5LV*&M -L++*T0B(3DF#WK
M1HJS&4;]W)J["O:MNJE[T1V_1-8U7#7J)=_=2V)7:M1-ER:/L?(MD\:R:&5Y
M6YS,TG[5-E=._3;J4Z/$6;P%[ 88:YA#Z_E%A9SB8J>G^6OE4>U)V*YLC]';
M)J""0: V)=/MC6!8]7QN=UA%(FN'S]:MD.'6SLTQ:DF"*QYL:)5"WIM);P&G
MN,AD+2402[+S598BB(U.>-]T_P!+H(]HBR7Z11.!3NJX"]\UUQ8/N\KZ[K)5
M.0GP^+0CIA^K%TY#96R(E&EI2&=C&S.ZDENWK:>+*M$FE  :$D19GU-+CCIX
M(G6GMA]L(.@>3;'NE7*YBH@E8>W@D-LF%V33JF343*>:X2PLM\P5XD5DQQWL
MIS@EDR9"Y+'(,*5>G-4KTI3.P"1 *4:JSGC4Q':Z6\!<-R_FOBJQ*]7I6VM>
MIKD47ZMG5E-4E7S)<%\DEAVP923X)^-5*-B20*!R=I"B1)=$DH E")"#U-#$
M(QEE>7TN+<.]I'LI'!)8SQSF:MJ)E!G!G/O-TC>&/H5NE*J]N@ZQZ]J"VK2O
M-U<"$:94SEV9#XBXN?QB\6WE>?O2=P"$W1.LCIOQZ\Y_ALG<GM/] R!@NR?,
M428)%/Y_[G%IWY-H6?*X3(U-W<>+QS@VJ:[+0VZ@?J<+!#II,P2PJ*2%(4S'
M.:<TXXT"ST#=&8SCARKQ6#1OMQ6S7UV<[N-Z<]E]=4LW\O5]1$>!>-P5W)9M
MQ4\MUB6L]V,X"C^VIL@EAM\O@4\9FCYA&"]NI22-$MG@-%Y#Q4G**FIJ;_=I
M"G]GCKEMY^YOJ112K8WQNG87TS4DX@M3V-0@'5_LVPY9#7*!]KU\\6O&G:+1
MJ3+H8Q;9RW/92&P(F)$28@"86<<6.4UOQN9Y_K1LV]^V?U4?V-$[$>J@BEJ.
M+'[C//'49G;4INIL+L3]6.OZGBL)<*"5UZ-L)=%+K#96S*W#28CT6%9M5M>F
MT%<,183.^-M=E4VB]R3VXIQV'>-JV$CKZ'S5K)]K^_Z.I)9(Y9IE51SKJ36
MSRBII$C2@-),:%4? A$J1OXMB^4J]:&7Y3-^;*F&48QW^"BXS[<G7(>[";VL
M<V42(E3*H!/X[<L5G5,D*(O&F3E9KJ65<^6*?*(PJO!U@CE.DSH,QFCR[<:=
MA.I3P?M,Y%';&7=CMJ&K;][+O23'0/&D.;8:JD*A@Y7D\#Z/AT%LNJSIW&^M
MI>GKA*=TO$IW?;-)XON3-<<A);&CDS*)+*(RD;D06< TPST^HN^+GXMTUOMB
M7#8O1C*NO.+QZT^?C/<0M&_9LVRV<$.()K3CS[=4!H&+KY5%$NDJ-Z5NM[1<
MP]<Q"+TDWK7Q8R=E#\F$WQ$:<:_RWR]M>M^F^>><Z"YGO6 MH4U5T.B1N5I$
MVRFFBT<X)L>:MS?5I4?&V#<U#/%ZP3LBDA\$XF%&>O\ !:(")-LP:&,IB9N'
M/QE]K*Q7SI.K[4M"I*ME+'$O=H[/ZI<'-Y>69X<TG/-NU/("ZK4I4QB?9QSM
M^>-(PN9K3K?JHE2$I4+>]DY6]]143_Y79[CWMW37L:[IK,_J+%YQ$D'MH=1T
MW5)4DEYC0!BZ[FLLA[U2LF3M 3RBT2Z/EM2L]'(!Z%ME4^!A6P&["/43'*,8
M[;\&J[][<W:;[?K3,'>$Q5_LMZM[ART8CW2ONPT,XY?JZBH#4;/?_.S7!-IQ
M/LD)L5[A4J+ 6V"VP28,V.5/(RSD_@(UOQK]].K=GN[E"[K8[1XIO^DJ[;Y<
MZ4U((ZW2E_M>05H_T)$*Y5VG%I38KN35DH;E5DL]]HH['?5B4MAYR=60LT!&
MO%\#L>5C'*(QF)<Y_P"')[D+] XY1C8UQBI"Z6Y_]UBG8-T(EO83DLGDJ[ L
MYIGE,2M''6)L!+(2QEQU*-K7*SC!O#.J..,3D>F40:?&]^-WVQX)=.?:KE=Z
MM+;K?#%5\Y1.%^W7V725>4D1:L1DK1&.L;%D-7.]2V.@=X:,I M4.CA''!P)
MD"SQ<6U824L/"6N&$19(SB.=ZPWL[+Y3Z#N?CKBN!BAC1?,DH^R>;9[TYS_*
M+#21YHZ/CD!KYUCT]A#C,G@(HV_&I)ZZHY&6G>! :G@]F"!0+7G!E9QRB)GM
M<RFCVJ^W&_G:2U^PP*&5\].W-'O(0"/PIDNSYNUQ&7]DWY65B<UQQ++5*9(I
M=2&N)1Q60H>#B@&-IA =#UK9N&]^-WVQX+@E/M-W!%^P*LE-=L+ZFH6.D\GK
MZV?JXFU2HY9S3(JIGKK.+U J=+C89'8PV*XY0]K'E^-ARW:N:_,ER!Z!H&R%
M.B;XK7BK^0^U;=,CY<L:K[ XQJ*V.C87UI7G1#KT,_VI#'1S[MC;)U4YV5)V
M%:[2=*.55L_N-#.BF.:0R/6F9)\2-"E-^"WZ@2[XN[TJO@L":>W9T^KE3C-Y
MASO"ND*2%VSU5<[EQ/(+F8XZQRR$W/0M)P.CYJ-P>"CZ\/=Z,D<(?$0&=P%H
M"-.ZC<6[S*R2 #B1E%5=34:JBDGL[]=R&HY03/=1>UN@H1[?_']2\_66OM9X
MVKA/1]2=!6S8LM6QE_>S$[P@6P2O9&PLK=+EA8')U3(C "V )Z@L=Y=J^I%]
MER[#=^<T6OT!8?*#W D#LXPZL%G5>[63QBR2JQFAK+:_(=NU#%2(5(#@C+12
M97-9>B*2KA!$!I-&%:+6PD[UAC&8B)OC_:D>(^2.BZ@]M_HCF690&!P&4R!L
MO6*T''V?\W#1-5L+DE8(XC7SMT'(ZC0-U6O5T.CZ0=\X?&@GTE:0*4]2(2SX
MC>%RF)SB>3GPR^S%;T28!N42JR$,MB1ZG?:+6P*0(;.4%N3#TE0%NI7;MZS$
M"\U:,E/.I363<G;S9",(E<F1E_!;'LH0P[C7J1/PN?VY/A8WMK>XO9MD];3%
MEC-9TG*KPH[NBK7F9UO-8+!(G:;O9ULP*:4$>:" 1=-;ZQ(]U_&ES4\O\Q=7
M-\9G=V6B;DR1O$'1XC/&(CN8)W]J[JU[0W^_5WS!7_-E73OHSC*U$G'D:M2J
MK#0SBKZ5HRS:WL&#+2Y8P.5&FN"&R94V2E&QO1!D9=#$&AFFEK-^H ;\=+FY
MJ=7:3V^V:WJ0A\(Y"EU36LCA].45'I8.ZK4F\7E!Y\NL.SK,.;>?V-3#8PU1
M63?F?@C0BTH6M:CX!K0JVUO+ =L.U&SGE4_-#F/.?:9G3M>?0K.S\VU8745O
M>YKR-UPML9IF<?8_K?SQ$FB($W'4;W%TY:.7(G9AFK6_/AB?S"0/6Y 9Z)GJ
M&'@U6XSTC7_S3S&^UOT4DCRBN3X>\IZ/98[[P%>QR"TS>+' YDP5/U=>=12_
MF:%U8\R,"F-Q$22#QEU 4G7 &VL0=? G ]!0(.#?'?HZ\>VS4MTT?R- :SOF
M'U= YQ'7N?Z11:IV"(QEF;84OG+^X084H:*[2-];DV6NC"I,HD@XZ06RG/!I
MXTVM@%X[,9S$Y7#>[#+@SW)_/&]DW\#/<"_R68LG-TQ]O+N=YLKF8# 8# X,
M6%_R2^>?]IFU/]2 <G-TCVI^YWGRN:H.@[FCW.=$W)?\N;G=WBU*5A.;5D;5
M'P(S7UR8X%&W*3NB%G+<%:!"8YJD38,!&CCR2MF;UYAAUX[T6(N:<SE_O*5X
MP-STGEW+7449L4IWY5!"J?/:JI=)_9D1[/>I'%J%F$5 RVDX1I,%XF,46-3H
MVN+BB<656$'Q)80;$,!K9/6*U\$]C/NJP5^L1@B#AS_>,8AT@OM3Q^FN)X,K
M ZOTW8S9'%;N]4"K3M-A.,U#MKD38LC'UH+:3(PHDB0Q,4L&1LM4,;)KMX]R
M'P?WF*.GD7E$W04U?3/#ZGN"DN>>B7V1L,3:2>?;TN&TU%2.U<3LH<M-,<5E
M-OYS4JEBYH^8-J1M?D!R8]4(9Q9 GRYC31L2[^X+7C9R9>O9B:N;.>JAHN=6
MM&5XFA%'%+Y-X=2EFK*PL.W80C%(2TJZOVM:QN[D08I/3+%34U&G%D;V82 P
MFWYMO-5;3[M%!22VY[2L:AMGO$PBO250\UQ4]*WQ;Y-;+K:KE.&=?95:KARC
M6WNL:O<ZJEA,B7F (-3#CBK11)WF)]0NR:OL<RUONG],.5?LLT@UAH'AF=^4
MO;LMUF>I;3\/B[^NE'1/N7R7F.U'9UBS3(I@TLFG>J&S2%*A3NBTA">'2PLS
MUAB"&-;(B:[9_AT?[0[9NCF?LCGBNH+54VO2NYKS!UA;$WJNLVZORIPO>*9?
MZ,,:).GE-ARJ'-+0T,$;E;R4-&!;LYT7K$9!11ANP>6LXXQ.-\[0J.^^/R!,
M[AIVKX@DF#TS7!KG9 BGAKE6[/\ 5Z3]3Q)EF=1,"VM':=I;<?DVVJ3-9<@=
M6=C<&F.JW(@I6HUH*D2<OIY5;9/H[W%*NYDL:P:KG,#LITF49IRMK>K]MC:*
M-J]WE^<VZ4//S77]8_&R) -5/6BT)$PHUZ5<%&221($1X31%B,V69C"9BXZJ
MP3>ZK"7:>ABL<Y\O%]A\LMF[N<:/N !U6MU>7ITO0;/.G&94[%A.=AII1&1.
MSE6;\ULL@?VUL8')P:E =*@%^B:<79--18G[^E=1SG#G*VNB:/DT%L"Z:7D7
M0[]!XU/J;T@9*2C#XWL"BP(>JG%G1AQL!?(G!<:!CB3<6?,G(+8M'MM)T G1
MTMKTYN8CA"R[9]TZ22R\>?:\YNKR?$50Z>XS7_(-E]%O[+ 5U7SI1NKI?.;(
MK>(-JB6&V6R.*(P;5I,_G,:9">I1+4Q)_F!KU:D8:3,\:M>/3GN&,O*%_P!R
M-$S2V5/8E7'/W+$U)JBOJ]ABEW7R?H[J64<[1]UCDV>9\RN#X\KGO2(E0RJD
M2)$D2IM*"5AYR@9!1,<=T=[9'F_L*/\ 0U=W7,3ZWG-3RGG>S["I^WJTL%P@
M.WV-3:O&%DEJTA/*(Y,7NO'-G=HK)VY:F< .X480J=A.,*](S>B3C4_%I%$?
M>KIB;L+\CC%,V?*KF(NFI*)@]+0.:4)8JFS)I=T0F$]@IT8M:$VT]4NG8D42
MKQ_5ORI:_)PLNFD[1FC/43[/+Z<]RTY'[IL AQG1K]*Z(NAJK#CV,-I?2UK$
MFU@Z,4"NEX@,.GZ;G.,LR"P#I59MC:)G;.V&K&1&HCI;LO)*VX>EL1P!LG3M
M1&1^[K$X/IRALZY4Z4CG139<5)4R+FDK5.OU@.+QTE"[#F-'R-FD[+:JNKUT
M4EPJT=&Q6I$]E&,CDF."N+*()$?L;+YQ7^E6JO=.FEH]/<B0>I:IL:!4/.^I
M>E**L6U)^UUDIB=I+><Z'N1XL.(PE4BF[G*H@JAMQ04*8IU<$+>@>2&A<).>
M).$0A%V5$WQI*(][V-+2%CEIR"D[8?YM%[EYKII+7]=3'GNUE$I=NLGF5QRG
MW*.SFOKE?*P4 -D,*<$;RF.>B3V@983#/.08$W8].>ZI\%E0?W4XU9[Q5-;U
MSS1>\IO^?3+H**3:D"UU1-3M2:'EBS&.I;QE]@SAWLE'7:R.,,RDS>G:]LSD
MYJ7SXH/PQ7B$>@DG"KF9BF2Y5]V?G'KJ_P!TH*N4$A2N*EKM-]KN5+GZMW9O
MG[-3$W0P">*UD6B<WD%A5:>:[N1*QC32UI95#\S>=8F#Y2QEA$X3$6\<B]VZ
MA(C:T>IN2P2UVJ9.77<PY&E!9S;%A-];N,<W6);'<DZ5ZE.MM-,S]3>$*):'
M((#%)ATE3 -3E; ?Z8V3,7RJVGMQ^\O)(U!K;ONE:LG5AQUEY;H:\8+3TV8J
M_A383%[8ZAN&BVJYG.R";%52-U:IDWP9&L2,!+9HTA"K0*=&[$J6@0FHPCA/
M59T']T6QHAUKT!5-]TO9Q%7)>HN1.>87(F5#5!S9SW+.G*!K"01Z!V@XM,_-
M>IZZ.5O2A2G5N# G>D+2G5IQ"4;($7O9)P^6)CC2^>O^Z+AHWIV!\U02B5KZ
MQV+RSTU=X[M-DD,"DB+O2[=%0IE!,0<Y$B<W1AC"Z5)3'L)B<2I3\P1 ;B%8
M0+Q)28XQ,7/5J[1GO6QECY:A\XZNJJUX7:R+D?D"_!+7%-4S R=![Z;>V^I6
M&4P 22QOJ]7#.]W,6IT81*SV#32R&EN!^BDVA^F6?+^:L>%MJQ^X\PVG[='5
MO9]",R9-*N>:^Z.]2*S1?')7'F^V:*A[N^";%$GK>6/,/G4*<CR$2I,Z,;T:
MD7MJL P'%&;& LFVLHQGFTKY4]X"TW*.V$DZ%A":TYXIL+EBK^<H;4522CG2
MU[?L3I2M9)/SXRZT]T39!ZR)02' B:\Q)8#@Z-\:?FY N.2:&-&(!IJ?+CEP
MU;%V9[S]'5;2:>Z)'5=A(=1N=W77%V5F^SGG^(VE3\QYW7M:&UH^3%I5;[2*
MXG9N*=0+6XN$&OY;B@V W1A0STY1IF/+F9IGI[[NU<Q&=6K X_SOT'8:NNKC
MJ;G%A?HVDK1NC-I=!WQ'ZQE]359"7"4V&Q*B5SY#K'$[N+BYIT#6R(&H\2L\
M)IR4HX;)TUAZ.2N^GM\YF[JZ?ZM+=*_B'+O3W6,=71YQCC&1+Z[J.C"VQ:FB
M+VBACF^M$JES*1\21I6C6JP.A@BQ%'& & 6QECK$8\XAK1U[[MELL'-%VIZB
MYSN2B^K8LV<NR9DC-K)Z,?US!2O55MIJNAEYMB=':3W!9$K+?4BQ@$PJE8EK
M1)U"3;DD^6!4J0RVL<(N+F\6VO7=_=25(C]O2JJA?H''+8ZEN)#34]F=\5V&
M?;CQS1SK9EK/;FNA]2V- (V.3K9%7@4RD+6[":2=J#=I=C*"5O=9QB)N^$-5
MH/[K%B()$W1OH1L;(W/:*MKW!*COJ-49%T,LK*Y57'G.T9O]+*X3*Y_,6:6U
M:G=(=+$9Q#686]GZ>/7;UJDDDO2H46<.G":\4MD7ON\\PLJKU$\IFYH""QZ\
MA-V*&R9O5(,,MC5%6E+!1&K;)##%%M;D4W630Q*K=/JW'"7:2MC(B-4KD2<P
M1"<ZD>7,\&<Z$]VV5P[G[I'H#GSDBQ[5KFB+:)I)HMF42VJX?6]ASADNIJI"
MQSHVS'V"&SU49B<R5*&Y,X#:""'->3_A;TE":I (PUB)G65P+O=.@3/99T,?
M*%O!K@\3N:E^8[GNOQK!?7=+=-WHU09=$Z=DQ;=8BJ6203,Z64Q-+U(&%N<X
M^W.;H0#XLTKU3BB;)K]<%/%^]?62B-5%+0\V7LP1N^;FF]*U)*K'D%$5=!I:
M_5>Y/K'8;D.>3:W&J*1Q&AD;"8ULB9U5(G"4N.AEM:=0 H9FB^G/6-&^0KAM
MRF*6ZPN[IN,QLN/TH_7Y8M?MM8'A5NTDYMK>/'2N%JW4+N[?!%V.\L[6L I*
M$<E3!/\ 3\=%!WO>&:B9B(<_G_WT>>X:Z5HV3VG[AKY1/(C75GNS9-'ND626
M0RI+HG*N#T[.C809;)DIG*J9@0G/:IBC*9X?F!@+VI<DJ<[8$PC7ISR7*J]U
M>#;C$VL)DY\O.25F3?X.4:$F;6;59.^J.B@VDZTXO@E3QUSL9"_,S"W3=@<M
M#D<G)8V82!L5J@'""6 )A-G*XO\ A I-[RM=Q] A:$O,W1#_ '&C=^IHQ8U(
MMPZ?32BJ)/Q_$(#8=MHI7)G2T4, <6A57]BM[NQ.+0Z.*=X(.*++T%0:$G1?
M3GK%?[?QJ]YZJG5C4.I?-_2:=V=G?B[58PM2AJ?4MM2&]\.$B9.>)PQIRK3-
M98ZE=WR*+2'-O>US<Y-0-%FGDZ",7D'I]L<_!X(W[VE)#0.,@M*A>A*4AS17
M_6TH72R8HZO>V\^:<./29BZ0J]G10>R9*[N;W&5ZTHIK<MIR69]/]0M*IWLO
M>]CTYY3%Z>)#_>MIV?,D>3PFC+<F]JR;H*)<XME20&74#.%9LTL.F9I>$&=P
MV5&[?75 .+KHO!'!*ZG!?=J6!S2J"5I -$^<8GRYCGI2H^@O>M0N7*M@S7EF
MC[P>KA3\3WMT^Z&K&&L5"'F)/7$HL.ET+S:[4^V F233;7=U>.I)K='/G9JE
MI9U2X(!$>31@CR]=:JVS1'ND1*,7#3G-<HKU^E]JVE!XP5''6&V%02D4JMQV
MH)5>2>'KJYU:B>R:W02E SK$"!XD+.UL^G/18!G 2&DK!DV:7R:N5![R:I]K
M7G_H_HZ(2B@(++N8^S[^F%;QZ.0RRVN71SGB;U'&6>11B<()]];VAV.5S@32
MVLAK0$QZ<SCAJ!(4Y*,Q5&I\O6HUFX;)O'NX1:('K(38/*G2<+Z 2VSSG59?
M.ZP5-.DY<M]8)IP*D)DV25HM=76AT7>7.O'5N=1&O1*EC7HC@*R@E T:.L[)
MXQ,4^40]X.I9E-.:JT3T[9T8L#H.:7%7SBQV%)J;@3764SH.X]4=:$,6S"2V
M2ABEDSULEX3%;>P1%6]NSLRDC6)B!?:E"&R=>D.O.&# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8'!GN3^>-[)OX&>X%_DLQ9.;IC[>7<[S97,P& P&!P8L+_
M ))?//\ M,VI_J0#DYND>U/W.\^5S:Z]>TN\='<J=(\_1U[:XV_7;1MIU2RR
M%[2*%[,QNL^A3S%T#LZH4FPJEC<WJG,)IQ1>]#&6'>@_3O"XS642U2J3VH^8
M*Z8HX-]3V-.Y^UR?F"<KIQ,+>LF7NY+[R.<<ZTG%HXX2:0."]GJF"R-R<%:.
M/A%I(;M<9\3H[>];#*:G/+NU\4^/]M7ELVZ7&\26FPT#^NLM^O5-"D-JSLFG
MV/H>21A9#W;H=@J43R9!6NYCF->=H#P%'O92PT:T!85HA*-U-\U376W_ &F*
MI9N<+TIOCZ*PNNY#T+1,8YNL)79\GLM]A+O%693(=I[KDK$SN9R^;])1<R5K
M'!))EAQ3H[KM% <%VRP%C*+&<W>7)T K#FBKZQY@A_)*-H ]5+%Z;0TBM;'0
M&M#E$3#%/JF_&ONR1!V>X2M*:H/<#="\YRA4:/>]B%O>&9F9G=S:\5%[7'&E
M'RGF":U]7CT@D_($ L"MZ3=G.=2]\4-D?LU<_N<K52;YJ[J@320G+Y<\&IG%
MSTI5HQNRS9(P>N/Q+NRG3JQS9[4_&31$&>#(81*RXZQ5A1M0-R8=BS(T\J#\
MZ= N/3E6H#%8W7:@Y8TVZZG+%*H0MGKDHM)#Q#(UH&#?EQ_6JR>H>":&ZXE4
M.G5G*;689M H+8]:QB65-;\_J5]10BW!QK5C1\]9!WIIVY(94BBJ5*>%3HW0
M2-C]/R&;"8$1E..D,1#O;IYIK*R(C9%2(+$J R*L%6QE5!*RM2<Q.KYPU4E&
M4L,JD%BP)$\[99>IAT40)FXLY0'U5J-*04M$J 27H(W3/%9EV<>4!T+:_.UU
MVM##)#8G+$N=IO3CP4].[62S/KR2U_$;>&YM6)D,G;DSDPM[BF2KP'D)G-O3
M*BPA.*"+"1,QI"KXA[<'*\(O4N_F*-3+3^W6!/[>BD <;+G3I2<!N.UT#HUV
M9;<$IY<^'0:,3^;H7YQ"L6D)-! -S6&IRR3E1Y@R[IF*5O'_ &F.4X:PU\QP
M1TO^ F58BF46@,BA?0EH,$NCE33I[:I$\T0FDR1]TZ'TPB>F5.H:V8X9OR<X
M(AHCB!FFB&7?ESI+5?MB<I*[W2]!Z:K,12A!?#9U AAK=<-BH:?2]"H(L.%+
M;=*J5._@A&YG(XR+25S4"2""K\NS-@T<8<883?E5+(N7A;G2^IU*+&LF-/KG
M*IC%Z)A[ZK02^1,R8]BYPO WHBJB"4+:N(2I3FBT3A*U)I8=#7)O_&/V,G[3
M!&4Q%1^K2=!R%0R*'=/U^9$E3G#NQ)9/YE?S$Z2!\5II>[6? 6"LYJ4E-^/+
M5QYM=H=&DJ;1" Q. D6A&%^4P8A83=.D]&KR/VC>04D:?640;N72-Y>J0E*.
MUG&_+15V_$)?SDTRN.4U*X%8 Y#IWA;O#(I,U[06%!Z*12V';3J"#@",\YK?
MDE;E[7_*SX[V.OD*:V)"SW?7B&O[_@SU<]BK:_OPYL@;=6R&R;:B6WT#;([C
M311F1 U*2])G;:M$G5[-VK(). 3?E^SU0KVRN6X:X,TC/26E/)^T7=6/0!UI
M6C<-@V'9C_/J7B<F@]4D228R1[6.3O$()%I@XI4#,/>F\(E1AXRAJ###1C?/
M@C9_M,<7K+/<K.7Q2PE^W":778)%;J[ALLRF6*7=(0>5U_?;Q&JL#) 1-@4V
MLQS5R,=-IB >"Q0(]/Z Q#\PWY53ZU[[4O(U<&,BIN;[7D3G'I-S)*FMXG5S
MV),G-,LX[>Y6]\[MA)[V^*2TT;K[<Q5I2VXD!214DT "@!HM"&(N_+^?%('7
MVS>854@9)K'@6Q7%A1^WKMN5LL:L+DL""S<+YT=+FV<79%5;XR/) W*MI])6
M5$I4L"@!J @:0H28!(@^;";YX<EG41Q73?-LUDLLJ5=9S"R2 ^7+$-3*[1F3
MQ2D)<)]*?KK,W"OZP<W-1'(FH?9.,U5Y4Y?I(_B3RD8$Y)QA8B3E,\5<7![9
M''EZ3GHZQ[$KQV7S'JNHXO2MQ/#9-98QF.D/ASFQO$?5L)34ZIB(I+4;A%&8
M>WAO"0O,^2H-",WI*7X%C*8T>J6^VKR+-8U,X@]P%WU'9QS#57(+HVMLTE32
M6@I2D7U[D]6MD?,;W0@YBD40D+Z:K3NR<05PCBR=F&#T6'6#?EQ[;>I-[=?-
M@0NYSLBL*5/,CN?G/H.3R>5V7+GR32:W.66"%1NII<^O"EPT>N4IF^OVT3F5
MO6B'8\!ABD Q&C\1OE8U[<?4UT1/*QLR?$S)%-*H8[)B,>>(7.9'#=NL$MYJ
M:FFQH!+TK&M3(Y7#)0!@;SSD2PLS0%2 @TL0!!%YA&4Q%<E/O/MA\@/\99XF
MZPB2GM<<YLI?E6-'$V'-4#Q&JPYXFY=D4RO8'MO>4KJTV% IVG)<T<A)-"Z;
M4D ]0T8-;!L;\O&UU$<HUJ?SC/N7I8]V=95<VE%9[#9^Z659,HF$_DC%9+:O
M9Y0F43=Q6_.46AM;B-.E"D$G*0E! $@ -!UA-TW?-K*T>TAQLT1&01W33;[M
M)WQ^J.3)+GDE^6[)+WASS029W1TD?7ML/<M72B"HJP22)R*:T3:8G0Z)<E99
MY)P%!H1%WY,;(?9ZXFDD70Q55'[70$FPRZX!/GYEO2U6F979%^B9$DF=S(;O
MF".3@D-EF3R;MZ=W6&KU C-JDY98=Z2!^&PN_+BM>5^W#RY+XA:40<(_,V\%
ML6_6-_NTGC]C3!@G$6NBFH?7T&K2R*ZES8Z)W>#22+,-8M(2AH1EEFF%G".
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M?%2!&XO9I*%.,[9*! 62E(" @DL 3,ZK$P& P& P& P& P& P& P& P& P&
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MTS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MY)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P&!P9[D_GC>R;^!GN!?Y+,63FZ8^WEW.\V5S,!@,!@<&+
M"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P&!P9[D_GC>R;^!GN!?Y+,63FZ8^WEW.\V5S,!@,!@<
M&+"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P&!P9[D_GC>R;^!GN!?Y+,63FZ8^WEW.\V5S,!@,!
M@<&+"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P&!P9[D_GC>R;^!GN!?Y+,63FZ8^WEW.\V5S,!@
M,!@<&+"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P&!P9[D_GC>R;^!GN!?Y+,63FZ8^WEW.\V5S,
M!@,!@<&+"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P&!P9[D_GC>R;^!GN!?Y+,63FZ8^WEW.\V5
MS,!@,!@<&+"_Y)?//^TS:G^I .3FZ1[4_<[SY7,P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M"* ,)8MAV7=-5>B_L(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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$!@?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
